gene_symbol	variant	allele_registry_id	disease	doid	therapy
JAK2	V617F	CA:124183	Lymphoid Leukemia	DOID:1037	
PDGFRA	D842V	CA:123194	Gastrointestinal Stromal Tumor	DOID:9253	
DNMT3A	R882		Acute Myeloid Leukemia	DOID:9119	
JAK2	V617F	CA:124183	Chronic Myeloid Leukemia	DOID:8552	
JAK2	V617F	CA:124183	Bone Marrow Cancer	DOID:4960	
KRAS	G12		Acute Leukemia	DOID:12603	
NRAS	Q61		Melanoma	DOID:1909	
DNMT3A	R882		Acute Myeloid Leukemia	DOID:9119	Daunorubicin
MAP2K1	P124S	CA:16602456	Melanoma	DOID:1909	Selumetinib
MAP2K1	Q56P	CA:16602453	Melanoma	DOID:1909	Selumetinib
NRAS	Q61		Melanoma	DOID:1909	Vemurafenib
PDGFRA	D842V	CA:123194	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
ARAF	S214C	CA:16602595	Lung Non-small Cell Carcinoma	DOID:3908	Sorafenib
DNMT3A	R882		Acute Myeloid Leukemia	DOID:9119	Idarubicin
JAK2	V617F	CA:124183	Polycythemia Vera	DOID:8997	Peginterferon Alfa-2b
JAK2	V617F	CA:124183	Polycythemia Vera	DOID:8997	Fedratinib
NRAS	G13D	CA:123620	Melanoma	DOID:1909	Tanespimycin
NRAS	Q61L	CA:16602361	Melanoma	DOID:1909	Temozolomide
NRAS	Q61R	CA:123618	Melanoma	DOID:1909	Temozolomide
KIT	D816V	CA:123513	Acute Myeloid Leukemia	DOID:9119	
NRAS	Mutation		Colorectal Cancer	DOID:9256	
BRAF	V600		Melanoma	DOID:1909	
ALK	F1174L	CA:279586	Inflammatory Myofibroblastic Tumor	DOID:50905	Crizotinib
ALK	F1174L	CA:279586	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
KIT	L576P	CA:16602401	Melanoma	DOID:1909	Imatinib
KIT	L576P	CA:16602401	Melanoma	DOID:1909	Nilotinib
KIT	L576P	CA:16602401	Melanoma	DOID:1909	Sorafenib
KRAS	G12/G13		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
KRAS	G12/G13		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
NRAS	Q61		Colorectal Cancer	DOID:9256	Cetuximab
NRAS	Q61		Colorectal Cancer	DOID:9256	Chemotherapy
ALK	F1174L	CA:279586	Neuroblastoma	DOID:769	Alectinib
ALK	F1174L	CA:279586	Neuroblastoma	DOID:769	Crizotinib
ALK	R1275Q	CA:341482	Cancer	DOID:162	ALK Inhibitor TAE684
ARAF	S214C	CA:16602595	Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
KIT	L576P	CA:16602401	Melanoma	DOID:1909	Dasatinib
PDGFRA	D842I	CA:16602522	Gastrointestinal Stromal Tumor	DOID:9253	Crenolanib
PDGFRA	D842V	CA:123194	Gastrointestinal Stromal Tumor	DOID:9253	Crenolanib
PDGFRA	D842Y	CA:16602703	Gastrointestinal Stromal Tumor	DOID:9253	Crenolanib
PDGFRA	I843DEL	CA:645526434	Gastrointestinal Stromal Tumor	DOID:9253	Crenolanib
PDGFRA	D842_I843delinsVM	CA:658820703	Gastrointestinal Stromal Tumor	DOID:9253	Crenolanib
ALK	R1275Q	CA:341482	Neuroblastoma	DOID:769	ALK Inhibitor TAE684
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	
KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	
NRAS	Mutation		Acute Myeloid Leukemia	DOID:9119	
NRAS	G12		Acute Myeloid Leukemia	DOID:9119	
KIT	Exon 11 Mutation		Melanoma	DOID:1909	Imatinib
KIT	Exon 14 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	
NRAS	Mutation		Melanoma	DOID:1909	
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Dabrafenib
BRAF	V600M	CA:135101	Melanoma	DOID:1909	Dabrafenib
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	
RET	C634W	CA:008378	Medullary Thyroid Carcinoma	DOID:3973	Motesanib
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	Motesanib
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	JAK2 Inhibitor AZD1480
BRAF	V600E	CA:123643	Thyroid Cancer	DOID:1781	
BRAF	V600E	CA:123643	Papillary Thyroid Carcinoma	DOID:3969	
BRAF	V600E	CA:123643	Melanoma	DOID:1909	
PIK3CA	E542K	CA:333572	Colorectal Cancer	DOID:9256	Regorafenib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Mirdametinib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Trametinib
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Regorafenib
BRAF	V600		Colorectal Cancer	DOID:9256	Panitumumab
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Panitumumab
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Sorafenib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Vemurafenib
NF1	Loss		Melanoma	DOID:1909	Vemurafenib
KRAS	G12D	CA:122538	Lung Non-small Cell Carcinoma	DOID:3908	Dabrafenib
BRAF	Amplification		Colorectal Cancer	DOID:9256	Selumetinib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Selumetinib
BRAF	V600		Melanoma	DOID:1909	Trametinib
BRAF	V600		Melanoma	DOID:1909	Dabrafenib
BRAF	V600D	CA:16602419	Melanoma	DOID:1909	Dabrafenib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	PLX4720
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Pictilisib Bismesylate
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Nutlin-3
BRAF	V600E	CA:123643	Melanoma	DOID:1909	PLX4720
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Capecitabine
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Bevacizumab
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Vemurafenib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	
NPM1	MUTATION		Acute Myeloid Leukemia With Mutated NPM1	DOID:81089	
NPM1	W288FS	CA:280199	Acute Myeloid Leukemia	DOID:9119	
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	
CEBPA	Mutation		Acute Myeloid Leukemia	DOID:9119	Tretinoin
PIK3CA	Exon 10 Mutation		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	Exon 10 Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Cetuximab
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Tretinoin
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Daunorubicin
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	SU5614
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G12V	CA:122540	Colorectal Cancer	DOID:9256	Cetuximab
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	Tretinoin
PIK3CA	Exon 21 Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
PIK3CA	Exon 21 Mutation		Colorectal Cancer	DOID:9256	Cetuximab
WT1	Exon 7 Mutation		Acute Myeloid Leukemia	DOID:9119	Daunorubicin
WT1	Exon 7 Mutation		Acute Myeloid Leukemia	DOID:9119	Cytarabine
ALK	L1196M	CA:16602593	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	F1174L	CA:279586	Neuroblastoma	DOID:769	ALK Inhibitor TAE684
ALK	R1275Q	CA:341482	Neuroblastoma	DOID:769	Crizotinib
FGFR3::BAIAP2L1	Fusion		Bladder Carcinoma	DOID:4007	PD173074
KRAS	G13D	CA:122534	Colorectal Cancer	DOID:9256	Cetuximab
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	Daunorubicin
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	Valproic Acid
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	NSC348884
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	Anti-CD123
NPM1	EXON 11 MUTATION		Acute Myeloid Leukemia	DOID:9119	Anti-CD33
NPM1	W288FS	CA:280199	Acute Myeloid Leukemia	DOID:9119	NSC348884
NPM1	W288FS	CA:280199	Acute Myeloid Leukemia	DOID:9119	Daunorubicin
NPM1	W288FS	CA:280199	Acute Myeloid Leukemia	DOID:9119	Cytarabine
NPM1	W288FS	CA:280199	Acute Myeloid Leukemia	DOID:9119	Etoposide
TSC1	Frameshift Truncation		Lung Non-small Cell Carcinoma	DOID:3908	Sirolimus
TSC1	Loss-of-function		Bladder Carcinoma	DOID:4007	Everolimus
FLT3	Mutation		Acute Myeloid Leukemia	DOID:9119	
IDH1	R132		Acute Myeloid Leukemia	DOID:9119	
WT1	Exon 7 Mutation		Acute Myeloid Leukemia	DOID:9119	
WT1	Exon 9 Mutation		Acute Myeloid Leukemia	DOID:9119	
CEBPA	Mutation		Acute Myeloid Leukemia	DOID:9119	
CEBPA	N-TERMINAL FRAME SHIFT		Acute Myeloid Leukemia	DOID:9119	
FLT3	TKD MUTATION		Acute Myeloid Leukemia	DOID:9119	
MGMT	Promoter Methylation		Glioblastoma	DOID:3068	
DNMT3A	Mutation		Acute Myeloid Leukemia	DOID:9119	
KRAS	G12/G13		Colorectal Cancer	DOID:9256	
BRCA1	Loss-of-function		Ovarian Cancer	DOID:2394	Olaparib
BRCA2	Loss-of-function		Ovarian Cancer	DOID:2394	Olaparib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	
KRAS	G12		Lung Non-small Cell Carcinoma	DOID:3908	
CCND2	PROMOTER DEMETHYLATION		Stomach Cancer	DOID:10534	
CCND1	Overexpression		Breast Cancer	DOID:1612	
IDH1	R132C	CA:16602374	Acute Myeloid Leukemia	DOID:9119	
KRAS	G12C	CA:122528	Lung Cancer	DOID:1324	
KRAS	G12D	CA:122538	Lung Cancer	DOID:1324	
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
AKT1	E17K	CA:123660	Breast Cancer	DOID:1612	Akt Inhibitor MK2206
BCR::ABL1	Fusion		Acute Myeloid Leukemia	DOID:9119	Imatinib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ALK	C1156Y	CA:16602783	Lung Adenocarcinoma	DOID:3910	Crizotinib
EML4::ALK	Fusion		Lung Adenocarcinoma	DOID:3910	Crizotinib
ALK	L1196M	CA:16602593	Lung Adenocarcinoma	DOID:3910	Crizotinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
ERBB2	L755S	CA:16602502	Breast Cancer	DOID:1612	Lapatinib
ESR1	L536Q	CA:645542628	Breast Cancer	DOID:1612	Hormone Therapy
ESR1	D538G	CA:366085705	Breast Cancer	DOID:1612	Hormone Therapy
ESR1	Y537C	CA:366085697	Breast Cancer	DOID:1612	Hormone Therapy
ESR1	Y537N	CA:366085693	Breast Cancer	DOID:1612	Hormone Therapy
ESR1	Y537S	CA:366085696	Breast Cancer	DOID:1612	Hormone Therapy
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Sorafenib
FLT3	D835Y	CA:126347	Acute Myeloid Leukemia	DOID:9119	Sorafenib
FLT3	TKD MUTATION		Acute Myeloid Leukemia	DOID:9119	Sorafenib
KIT	V654A	CA:16602402	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12A	CA:135567	Lung Adenocarcinoma	DOID:3910	Gefitinib
KRAS	G12A	CA:135567	Lung Adenocarcinoma	DOID:3910	Erlotinib
PIK3CA	H1047R	CA:123326	Colorectal Cancer	DOID:9256	Panitumumab
PIK3CA	H1047R	CA:123326	Colorectal Cancer	DOID:9256	Cetuximab
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Nilotinib
CCND3	Loss		T-cell Lymphoblastic Leukemia/lymphoma	DOID:715	Palbociclib
CDK4	EXPRESSION		Estrogen-receptor Positive Breast Cancer	DOID:60075	Alpelisib
DDR2	G253C	CA:16602599	Cancer	DOID:162	Dasatinib
DDR2	G505S	CA:1217584	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	G774V	CA:16602601	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	I638F	CA:16602600	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	L239R	CA:16602598	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	L63V	CA:1217196	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	S768R	CA:16602365	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
DDR2	S768R	CA:16602365	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	G719S	CA:126722	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Staurosporine
ERBB2	D769H	CA:16602465	Breast Cancer	DOID:1612	Neratinib
ERBB2	D769H	CA:16602465	Breast Cancer	DOID:1612	Lapatinib
ERBB2	D769Y	CA:16602466	Breast Cancer	DOID:1612	Neratinib
ERBB2	L755_T759del	CA:645372623	Breast Cancer	DOID:1612	Neratinib
ERBB2	G309A	CA:16602660	Breast Cancer	DOID:1612	Neratinib
ERBB2	L755S	CA:16602502	Breast Cancer	DOID:1612	Neratinib
ERBB2	L755W	CA:16602786	Breast Cancer	DOID:1612	Neratinib
ERBB2	G778_P780dup		Breast Cancer	DOID:1612	Neratinib
ERBB2	R678Q	CA:16602787	Breast Cancer	DOID:1612	Neratinib
ERBB2	R678Q	CA:16602787	Breast Cancer	DOID:1612	Lapatinib
ERBB2	R896C	CA:8534359	Breast Cancer	DOID:1612	Neratinib
ERBB2	V777L	CA:135387	Breast Cancer	DOID:1612	Neratinib
ERBB2	V842I	CA:16602468	Breast Cancer	DOID:1612	Neratinib
ESR1	L536Q	CA:645542628	Breast Cancer	DOID:1612	Tamoxifen
ESR1	L536Q	CA:645542628	Breast Cancer	DOID:1612	Fulvestrant
ESR1	D538G	CA:366085705	Breast Cancer	DOID:1612	Fulvestrant
ESR1	D538G	CA:366085705	Breast Cancer	DOID:1612	Tamoxifen
ESR1	Y537C	CA:366085697	Breast Cancer	DOID:1612	Fulvestrant
ESR1	Y537C	CA:366085697	Breast Cancer	DOID:1612	Tamoxifen
ESR1	Y537N	CA:366085693	Breast Cancer	DOID:1612	Tamoxifen
ESR1	Y537N	CA:366085693	Breast Cancer	DOID:1612	Fulvestrant
ESR1	Y537S	CA:366085696	Breast Cancer	DOID:1612	Fulvestrant
ESR1	Y537S	CA:366085696	Breast Cancer	DOID:1612	Tamoxifen
FGFR2::OGA	Fusion		Cholangiocarcinoma	DOID:4947	Ponatinib
FGFR2::TACC3	Fusion		Cholangiocarcinoma	DOID:4947	Pazopanib
FGFR2::TACC3	Fusion		Cholangiocarcinoma	DOID:4947	Ponatinib
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Lestaurtinib
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Tyrphostin AG 1296
GATA2	EXPRESSION		Lung Adenocarcinoma	DOID:3910	Bortezomib
GATA2	EXPRESSION		Lung Adenocarcinoma	DOID:3910	Fasudil
KIT	Internal Duplication		Malignant Anus Melanoma	DOID:14145	Imatinib
KIT	L576P	CA:16602401	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
KIT	L576P	CA:16602401	Lung Non-small Cell Carcinoma	DOID:3908	Nilotinib
KIT	L576P	CA:16602401	Lung Non-small Cell Carcinoma	DOID:3908	Imatinib
KIT	V654A	CA:16602402	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KRAS	G12D	CA:122538	Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
KRAS	G12D	CA:122538	Lung Non-small Cell Carcinoma	DOID:3908	Dactolisib
MGMT	Promoter Methylation		Glioblastoma	DOID:3068	Temozolomide
MGMT	Promoter Methylation		Glioblastoma	DOID:3068	Carmustine
MGMT	Promoter Methylation		Glioblastoma	DOID:3068	O6-Benzylguanine
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	Izorlisib
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	Sirolimus
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	Izorlisib
PML::RARA	Fusion		Acute Promyelocytic Leukemia	DOID:60318	Tretinoin
PTEN	R233*	CA:000549	Breast Cancer	DOID:1612	MTOR Inhibitor
TP53	R175H	CA:000251	Breast Cancer	DOID:1612	Doxorubicin
TSC1	Frameshift Truncation		Invasive Bladder Transitional Cell Carcinoma	DOID:6477	Everolimus
IDH2	R140		Acute Myeloid Leukemia	DOID:9119	
IDH2	Mutation		Acute Myeloid Leukemia	DOID:9119	
IDH2	R140		Myelodysplastic Syndrome	DOID:50908	
IDH2	R172K	CA:16602462	Acute Myeloid Leukemia	DOID:9119	
IDH2	R172K	CA:16602462	Myelodysplastic Syndrome	DOID:50908	
KIT	Exon 11 Mutation		Lung Cancer	DOID:1324	
KRAS	G12		Colorectal Cancer	DOID:9256	
U2AF1	Q157P/R		Acute Myeloid Leukemia	DOID:9119	
U2AF1	Q157P/R		Myelodysplastic Syndrome	DOID:50908	
U2AF1	S34Y/F		Acute Myeloid Leukemia	DOID:9119	
CCND1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	
PTEN	R233*	CA:000549	Glioblastoma	DOID:3068	
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	
IDH1	R132		Malignant Astrocytoma	DOID:3069	
IDH1	R132		Glioblastoma	DOID:3068	
SF3B1	Mutation		Myelodysplastic Syndrome	DOID:50908	
CCND1	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	
CCND1	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	
CCND1	Overexpression		Mantle Cell Lymphoma	DOID:50746	
CCND2	OVEREXPRESSION		Stomach Cancer	DOID:10534	
CCNE1	Overexpression		Breast Cancer	DOID:1612	
CCNE1	Overexpression		Gastric Adenosquamous Carcinoma	DOID:5635	
CDKN2A	Promoter Hypermethylation		Lung Non-small Cell Carcinoma	DOID:3908	
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	
IDH1	R132		Myelodysplastic Syndrome	DOID:50908	
KRAS	G12		Multiple Myeloma	DOID:9538	
NOTCH1	D1642H	CA:16602788	Lung Non-small Cell Carcinoma	DOID:3908	
NOTCH1	R2327W	CA:5339772	Lung Non-small Cell Carcinoma	DOID:3908	
NOTCH1	S2275FS	CA:645544343	Lung Non-small Cell Carcinoma	DOID:3908	
NOTCH1	V2444FS	CA:913157307	Lung Non-small Cell Carcinoma	DOID:3908	
PIK3CA	Exon 10 Mutation		Colorectal Cancer	DOID:9256	
PIK3CA	E545K	CA:123334	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	E545K	CA:123334	Colorectal Cancer	DOID:9256	Panitumumab
TP53	R175H	CA:000251	Breast Cancer	DOID:1612	
TP53	R248Q	CA:000387	Breast Cancer	DOID:1612	
TP53	R248W	CA:000382	Breast Cancer	DOID:1612	
TP53	R249	CA:16602484	Breast Cancer	DOID:1612	
TP53	R273C	CA:000432	Breast Cancer	DOID:1612	
TP53	R273H	CA:000434	Breast Cancer	DOID:1612	
TP53	R249	CA:16602484	Breast Cancer	DOID:1612	Doxorubicin
U2AF1	S34Y/F		Myelodysplastic Syndrome	DOID:50908	
MEF2D::CSF1R	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	GW-2580
MEF2D::CSF1R	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Imatinib
DNAJB1::PRKACA	Fusion		Fibrolamellar Carcinoma	DOID:5015	
BCL2	reg_e@[IGH]::BCL2		Diffuse Large B-cell Lymphoma	DOID:50745	
FOXP1	AMPLIFICATION		Diffuse Large B-cell Lymphoma	DOID:50745	
REL	AMPLIFICATION		Diffuse Large B-cell Lymphoma	DOID:50745	
RUNX1	Mutation		Acute Myeloid Leukemia	DOID:9119	Cytarabine
IGF2	Overexpression		Prostate Cancer	DOID:10283	Linsitinib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
IGF2	Overexpression		Prostate Cancer	DOID:10283	Cabazitaxel
IGF2	Overexpression		Prostate Cancer	DOID:10283	Docetaxel
TET2	Mutation		Acute Myeloid Leukemia	DOID:9119	
AURKA	EXPRESSION		Ovarian Carcinoma	DOID:4001	
TET2	Mutation		Myelodysplastic Syndrome	DOID:50908	
VHL	Mutation		Clear Cell Renal Cell Carcinoma	DOID:4467	
PBRM1	Mutation		Clear Cell Renal Cell Carcinoma	DOID:4467	
BCL2	Overexpression		Diffuse Large B-cell Lymphoma	DOID:50745	
EZH2	Mutation		Myelodysplastic Syndrome	DOID:50908	
VHL	Loss-of-function		Clear Cell Renal Cell Carcinoma	DOID:4467	
RUNX1	Mutation		Acute Myeloid Leukemia	DOID:9119	
EWSR1::FLI1	e7::e6		Ewing Sarcoma	DOID:3369	
EZH2	Y646		Diffuse Large B-cell Lymphoma	DOID:50745	
EZH2	Y646		Follicular Lymphoma	DOID:50873	
KMT2D	Loss-of-function		Follicular Lymphoma	DOID:50873	
BTK	C481S	CA:16602659	Chronic Lymphocytic Leukemia	DOID:1040	Ibrutinib
AKT1	Q79K	CA:16602625	Melanoma	DOID:1909	Vemurafenib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	G1202R	CA:16602592	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	L1196M	CA:16602593	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	S1206Y	CA:16602591	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	T1151dup	CA:645528802	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
APC	Mutation		Colon Carcinoma	DOID:1520	JW55
APC	Mutation		Colorectal Cancer	DOID:9256	G007-LK
AR	F877L	CA:16602789	Prostate Cancer	DOID:10283	Enzalutamide
AR	F877L	CA:16602789	Prostate Cancer	DOID:10283	Apalutamide
AR	W742		Prostate Carcinoma	DOID:10286	Bicalutamide
ASXL1	Mutation		Acute Myeloid Leukemia	DOID:9119	
ATM	Mutation		Glioblastoma	DOID:3068	Temozolomide
ATM	Mutation		Melanoma	DOID:1909	Temozolomide
ATM	Underexpression		Cancer	DOID:162	KU-0060648
ATM	Underexpression		Cancer	DOID:162	NU7441
ATM	Mutation		Hematologic Cancer	DOID:2531	Olaparib
AURKA	Amplification		Esophagus Adenocarcinoma	DOID:4914	Cisplatin
AURKA	Amplification		Esophagus Adenocarcinoma	DOID:4914	Alisertib
AURKA	Overexpression		Cervical Adenocarcinoma	DOID:3702	Paclitaxel
BAP1	EXPRESSION		Uveal Melanoma	DOID:6039	
BAP1	Mutation		Clear Cell Renal Cell Carcinoma	DOID:4467	
BAP1	Mutation		Renal Cell Carcinoma	DOID:4450	
AKAP9::BRAF	Fusion		Papillary Thyroid Carcinoma	DOID:3969	
BRAF	V600E	CA:123643	Multiple Myeloma	DOID:9538	
BRCA1	Mutation		Epithelial Ovarian Cancer	DOID:2152	
BRCA2	Mutation		Epithelial Ovarian Cancer	DOID:2152	
CCNE1	Amplification		Ovarian Carcinoma	DOID:4001	
DNMT3A	Mutation		T-cell Acute Lymphoblastic Leukemia	DOID:5603	
EGFR	Amplification		Barrett's Adenocarcinoma	DOID:7941	
EGFR	Amplification		Cervical Squamous Cell Carcinoma	DOID:3744	
EGFR	Copy Number Variation		Head And Neck Squamous Cell Carcinoma	DOID:5520	
EGFR	Amplification		Head And Neck Squamous Cell Carcinoma	DOID:5520	
EGFR	Overexpression		Brain Glioblastoma Multiforme	DOID:3073	
EWSR1::ERG	Fusion		Ewing Sarcoma	DOID:3369	
TMPRSS2::ERG	Fusion		Prostate Carcinoma	DOID:10286	
FGFR3	Y373C	CA:341413	Bladder Carcinoma	DOID:4007	
EWSR1::FLI1	Fusion		Ewing Sarcoma	DOID:3369	
FOXL2	C134W	CA:16602790	Granulosa Cell Tumor	DOID:2999	
IDH2	R172		Glioblastoma	DOID:3068	
IDH2	R172		Malignant Astrocytoma	DOID:3069	
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
KIT	M541L	CA:160347	Chronic Myeloid Leukemia	DOID:8552	
KIT	V560DEL	CA:123529	Thymic Carcinoma	DOID:3284	Imatinib
KRAS	G13		Multiple Myeloma	DOID:9538	
KRAS	Q61		Multiple Myeloma	DOID:9538	
MGMT	Promoter Methylation		Oligodendroglioma	DOID:3181	
NCOA3	AMPLIFICATION		Breast Cancer	DOID:1612	
NCOA3	OVEREXPRESSION		Breast Cancer	DOID:1612	
NOTCH1	Mutation		Mantle Cell Lymphoma	DOID:50746	
NOTCH1	P2514FS		Chronic Lymphocytic Leukemia	DOID:1040	
NRAS	Mutation		Multiple Myeloma	DOID:9538	
NRAS	Q61		Follicular Thyroid Carcinoma	DOID:3962	
PAX8::PPARG	Fusion		Follicular Thyroid Carcinoma	DOID:3962	
PBRM1	Mutation		Renal Cell Carcinoma	DOID:4450	
PGR	Expression		Breast Cancer	DOID:1612	
PGR	Expression		Breast Cancer	DOID:1612	Tamoxifen
PGR	Expression		Breast Cancer	DOID:1612	Exemestane
PIK3CA	Amplification		Gastric Adenocarcinoma	DOID:3717	
PTEN	Deletion		Prostate Adenocarcinoma	DOID:2526	
PTEN	Loss		Colorectal Cancer	DOID:9256	Cetuximab
PTEN	Loss		Prostate Cancer	DOID:10283	Temsirolimus
RUNX1	Mutation		Acute Lymphoblastic Leukemia	DOID:9952	
SF3B1	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	
SMAD4	Mutation		Pancreatic Adenocarcinoma	DOID:4074	
SMARCA4	Mutation		Small-cell Carcinoma Of The Ovary Of Hypercalcemic Type	DOID:7651	
SMARCA4	INACTIVATING MUTATION		Lung Adenocarcinoma	DOID:3910	
TERT	Amplification		Acral Lentiginous Melanoma	DOID:6367	
TERT	Promoter Mutation		Skin Melanoma	DOID:8923	
TERT	Promoter Mutation		Glioblastoma	DOID:3068	
TP53	Deleterious Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	
TP53	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	
TP53	Mutation		Esophagus Squamous Cell Carcinoma	DOID:3748	
TP53	Mutation		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
TP53	Mutation		Myelodysplastic Syndrome	DOID:50908	
TP53	Mutation		Myeloid Neoplasm	DOID:70004	
TP53	Truncating Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	
TTF1	AMPLIFICATION		Lung Adenocarcinoma	DOID:3910	
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
CHEK2	Loss-of-function		Cancer	DOID:162	
KRAS	G12/G13		Pancreatic Adenocarcinoma	DOID:4074	Trametinib
KRAS	G12/G13		Pancreatic Adenocarcinoma	DOID:4074	Gemcitabine
CDK12	Loss-of-function		Ovarian Serous Carcinoma	DOID:50933	Olaparib
IKZF1	Deletion		Acute Lymphoblastic Leukemia	DOID:9952	
IDH2	R172		Peripheral T-cell Lymphoma	DOID:50749	
NT5C2	R367Q	CA:16602791	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Thioguanine
NT5C2	R367Q	CA:16602791	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Mercaptopurine
NT5C2	K359Q	CA:16602792	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Mercaptopurine
NT5C2	K359Q	CA:16602792	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Thioguanine
NT5C2	D407A	CA:16602793	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Mercaptopurine
NT5C2	D407A	CA:16602793	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Thioguanine
NT5C2	R367Q	CA:16602791	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Nelarabine
NT5C2	R367Q	CA:16602791	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Arabinosylguanine
NT5C2	D407A	CA:16602793	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Arabinosylguanine
NT5C2	D407A	CA:16602793	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Nelarabine
NT5C2	K359Q	CA:16602792	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Arabinosylguanine
NT5C2	K359Q	CA:16602792	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Nelarabine
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Ponatinib
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Ponatinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Ponatinib
TP53	DNA Binding Domain Mutation		Oral Squamous Cell Carcinoma	DOID:50866	
EGFR	T790M	CA:090928	Lung Cancer	DOID:1324	Multikinase Inhibitor AEE788
EGFR	T790M	CA:090928	Lung Cancer	DOID:1324	Gefitinib
PTEN	Loss		Bladder Carcinoma	DOID:4007	Everolimus
PTEN	Loss		Breast Cancer	DOID:1612	Trastuzumab
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Rociletinib
ATM	S2289*	CA:10588507	Prostate Cancer	DOID:10283	Olaparib
ATM	N2875H	CA:16602795	Prostate Cancer	DOID:10283	Olaparib
NF2	Y177fs	CA:645601016	Peritoneal Mesothelioma	DOID:1788	Cisplatin
NF2	Y177fs	CA:645601016	Peritoneal Mesothelioma	DOID:1788	Carboplatin
BRCA2	Loss-of-function		Prostate Cancer	DOID:10283	Olaparib
PDGFRA	V561A	CA:16602796	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
TERT	C228T	CA:557858711	Papillary Thyroid Carcinoma	DOID:3969	
TERT	Promoter Mutation		Thyroid Cancer	DOID:1781	
XRCC1	R194W	CA:9488737	Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
XRCC1	R194W	CA:9488737	Lung Non-small Cell Carcinoma	DOID:3908	Vinorelbine
XRCC1	R194W	CA:9488737	Lung Non-small Cell Carcinoma	DOID:3908	Gemcitabine
GSTP1	Deletion		Ovarian Carcinoma	DOID:4001	Carboplatin
GSTP1	Deletion		Ovarian Carcinoma	DOID:4001	Paclitaxel
GSTP1	Deletion		Ovarian Carcinoma	DOID:4001	Cisplatin
BIRC7	Amplification		Colon Cancer	DOID:219	Cisplatin
EGFR	Exon 4 Deletion		Epithelial Ovarian Cancer	DOID:2152	Cisplatin
KRAS	RS61764370	CA:10637079	Epithelial Ovarian Cancer	DOID:2152	Carboplatin
KRAS	RS61764370	CA:10637079	Epithelial Ovarian Cancer	DOID:2152	Paclitaxel
ERCC5	RS751402	CA:10642711	Parietal Lobe Ependymoma	DOID:50903	
KIT	rs17084733	CA:10621234	Acral Lentiginous Melanoma	DOID:6367	
NT5C2	K359Q	CA:16602792	Acute Lymphoblastic Leukemia	DOID:9952	
EZH2	Intron 6 Mutation	CA:1139771703	Colorectal Cancer	DOID:9256	
MTHFR	A222V	CA:170990	Stomach Cancer	DOID:10534	Fluorouracil
GSTP1	I105V	CA:6142790	Colorectal Cancer	DOID:9256	FOLFOX Regimen
ABCG2	Q141K	CA:129179	Ovarian Cancer	DOID:2394	
XRCC1	Q399R	CA:9488516	Lung Non-small Cell Carcinoma	DOID:3908	
XRCC1	Q399R	CA:9488516	Cervical Cancer	DOID:4362	Cisplatin
XRCC1	Q399R	CA:9488516	Cervical Cancer	DOID:4362	Carboplatin
ABCB1	S893T	CA:179696	Ovarian Cancer	DOID:2394	Paclitaxel
ABCB1	I1145I	CA:4327768	Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
ABCB1	I1145I	CA:4327768	Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
ERCC2	K751Q	CA:158782	Osteosarcoma	DOID:3347	Cisplatin
ERCC2	K751Q	CA:158782	Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
ERCC2	K751Q	CA:158782	Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
TYMS	5' TANDEM REPEAT		Colorectal Cancer	DOID:9256	Irinotecan
TYMS	5' TANDEM REPEAT		Colorectal Cancer	DOID:9256	Fluorouracil
LRP1B	EXON 12-22 DELETION		Ovarian Cancer	DOID:2394	Doxorubicin
FGFR1	Amplification		Lung Squamous Cell Carcinoma	DOID:3907	PD173074
FGFR1	Expression		Lung Cancer	DOID:1324	Ponatinib
FGFR1	Amplification		Lung Squamous Cell Carcinoma	DOID:3907	
FGFR1	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	
FGFR1	Amplification		Cancer	DOID:162	
FGFR1	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	PD173074
v::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
MET	Amplification		Gastric Adenocarcinoma	DOID:3717	Onartuzumab
ATR	I774FS		Endometrial Cancer	DOID:1380	
EGFR	Amplification		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
EGFR	Amplification		Head And Neck Squamous Cell Carcinoma	DOID:5520	Platinum Compound
EGFR	Amplification		Head And Neck Squamous Cell Carcinoma	DOID:5520	Fluorouracil
EGFR	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
EGFR	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	
CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Panitumumab
CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
KIF5B::RET	Fusion		Lung Adenocarcinoma	DOID:3910	Vandetanib
HRAS	G13D	CA:256488	Colorectal Cancer	DOID:9256	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
HRAS	Mutation		Cancer	DOID:162	Selumetinib
HRAS	Mutation		Cancer	DOID:162	MTOR Kinase Inhibitor AZD8055
HRAS	Mutation		Cancer	DOID:162	Everolimus
HRAS	Mutation		Cancer	DOID:162	Mirdametinib
HRAS	Mutation		Cancer	DOID:162	Binimetinib
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	
CD274	Expression		Lung Squamous Cell Carcinoma	DOID:3907	
CD274	Expression		Ovarian Serous Carcinoma	DOID:50933	
CD274	Expression		Melanoma	DOID:1909	Pembrolizumab
CD274	Expression		Melanoma	DOID:1909	Nivolumab
MTOR	Mutation		Bladder Carcinoma	DOID:4007	Pazopanib
MTOR	Mutation		Bladder Carcinoma	DOID:4007	Everolimus
AKT2	EXPRESSION		Breast Cancer	DOID:1612	Trastuzumab
AKT1	E17K	CA:123660	Melanoma	DOID:1909	Uprosertib
PTEN	Loss		Melanoma	DOID:1909	Uprosertib
AKT1	E17K	CA:123660	Breast Cancer	DOID:1612	Capivasertib
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	Akt Inhibitor MK2206
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	Pictilisib
PTEN	Loss		Breast Cancer	DOID:1612	PI3Kbeta Inhibitor AZD8186
MTOR	Mutation		Melanoma	DOID:1909	
MTOR	H1968Y	CA:16602797	Melanoma	DOID:1909	Capivasertib
MTOR	H1968Y	CA:16602797	Melanoma	DOID:1909	PI3K/BET Inhibitor LY294002
PTEN	Loss		Cancer	DOID:162	Paclitaxel
PTEN	Loss		Cancer	DOID:162	Buparlisib
PTEN	Loss		Cancer	DOID:162	Carboplatin
NF2	K159fs	CA:915940524	Breast Cancer	DOID:1612	Temsirolimus
PTEN	Loss		Breast Cancer	DOID:1612	Alpelisib
EGFR	S492R	CA:16602784	Colorectal Cancer	DOID:9256	Cetuximab
FBXW7	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
FBXW7	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
SMAD4	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
SMAD4	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
SMAD4	Underexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
MTOR	P2213S	CA:16602798	Melanoma	DOID:1909	Capivasertib
MTOR	P2213S	CA:16602798	Melanoma	DOID:1909	PI3K/BET Inhibitor LY294002
AGK::BRAF	Fusion		Melanoma	DOID:1909	Sorafenib
AGK::BRAF	Fusion		Melanoma	DOID:1909	Vemurafenib
PAPSS1::BRAF	Fusion		Melanoma	DOID:1909	Vemurafenib
PAPSS1::BRAF	Fusion		Melanoma	DOID:1909	Trametinib
TRIM24::BRAF	Fusion		Melanoma	DOID:1909	Trametinib
BRAF	L597R	CA:123649	Melanoma	DOID:1909	Vemurafenib
ERBB3	Overexpression		Colorectal Cancer	DOID:9256	Cetuximab
NT5E	Overexpression		Colorectal Cancer	DOID:9256	Cetuximab
EZH2	Overexpression		Cancer	DOID:162	
IDH1	R132C	CA:16602374	Acute Myeloid Leukemia	DOID:9119	GSK321
MET	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
MYD88	Overexpression		Breast Cancer	DOID:1612	Paclitaxel
MET	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
MET	Exon 14 Skipping Mutation		Cancer	DOID:162	Crizotinib
PIK3CA	P471L	CA:16602799	Merkel Cell Carcinoma	DOID:3965	Idelalisib
RET	Overexpression		Breast Cancer	DOID:1612	Vandetanib
RIT1	OVEREXPRESSION		Endometrial Cancer	DOID:1380	
RIT1	Mutation		Lung Adenocarcinoma	DOID:3910	Pictilisib
RIT1	Mutation		Lung Adenocarcinoma	DOID:3910	Selumetinib
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Pembrolizumab
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Nivolumab
MYCN	Amplification		Neuroblastoma	DOID:769	FACT Complex-targeting Curaxin CBL0137
SMO	D473H	CA:16602418	Medulloblastoma	DOID:50902	Vismodegib
SMO	Mutation		Basal Cell Carcinoma	DOID:2513	Vismodegib
SMO	Mutation		Basal Cell Carcinoma	DOID:2513	Arsenic Trioxide
SMO	Mutation		Basal Cell Carcinoma	DOID:2513	PSI
PTCH1	Mutation		Medulloblastoma	DOID:50902	Sonidegib
PTCH1	LOH		Medulloblastoma	DOID:50902	Vismodegib
STK11	EXON 1-2 MUTATION		Lung Non-small Cell Carcinoma	DOID:3908	
STK11	Underexpression		Prostate Cancer	DOID:10283	SB202190
SYK	OVEREXPRESSION		Ovarian Cancer	DOID:2394	Paclitaxel
SMO	D473H	CA:16602418	Basal Cell Carcinoma	DOID:2513	Vismodegib
PIK3CA	Amplification		Epithelial Ovarian Cancer	DOID:2152	Pictilisib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Pictilisib
CDKN2A	p16 Expression		Oropharynx Cancer	DOID:8557	
CDKN2A	p16 Expression		Oropharynx Cancer	DOID:8557	Cetuximab
ERBB2	Amplification		Breast Cancer	DOID:1612	AKTi-1/2
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Neratinib
ALK	L1152R	CA:16602594	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	G1269A	CA:16602590	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ERBB4	Mutation		Melanoma	DOID:1909	Lapatinib
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Cabozantinib
EGFR	VIII		Glioblastoma	DOID:3068	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
EGFR	EGFRVIII		Glioblastoma	DOID:3068	Afatinib
EGFR	Amplification		Glioblastoma	DOID:3068	Afatinib
PTEN	Expression		Glioblastoma	DOID:3068	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
PTEN	Expression		Glioblastoma	DOID:3068	Dacomitinib
NRG1	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Lapatinib
NRG1	Expression		Colorectal Cancer	DOID:9256	Cetuximab
NRG1	Expression		Ovarian Cancer	DOID:2394	Seribantumab
NRG1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Gemcitabine
NRG1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
NRG1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
NRG1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
AREG	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EGFR	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	
EGFR	Overexpression		Esophagus Squamous Cell Carcinoma	DOID:3748	Nimotuzumab
EGFR	Overexpression		Esophagus Squamous Cell Carcinoma	DOID:3748	
TGFA	EXPRESSION		Head And Neck Squamous Cell Carcinoma	DOID:5520	
EGFR	G724S	CA:16602800	Colorectal Cancer	DOID:9256	Cetuximab
EGFR	G719S	CA:126722	Colorectal Cancer	DOID:9256	Cetuximab
AREG	Expression		Colorectal Cancer	DOID:9256	Cetuximab
EREG	EXPRESSION		Colorectal Cancer	DOID:9256	Cetuximab
MAPK1	E322K	CA:16602885	Head And Neck Squamous Cell Carcinoma	DOID:5520	Erlotinib
MAPK1	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	WZ4002
FGFR1	Expression		Breast Cancer	DOID:1612	
KRAS	A146V	CA:16602440	Lung Non-small Cell Carcinoma	DOID:3908	Abemaciclib
KRAS	G12V	CA:122540	Lung Non-small Cell Carcinoma	DOID:3908	Palbociclib
MET	Mutation		Papillary Renal Cell Carcinoma	DOID:4465	Foretinib
MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	DOID:3910	Crizotinib
FGFR1	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	
FGFR1	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Infigratinib
FGFR1	Expression		Gastric Adenocarcinoma	DOID:3717	Infigratinib
FGFR1	Expression		Bladder Carcinoma	DOID:4007	Dovitinib
FGFR1	Expression		Bladder Carcinoma	DOID:4007	PD173074
FGFR3	Overexpression		Bladder Carcinoma	DOID:4007	Tyrosine Kinase Inhibitor SU5402
FGFR3	Overexpression		Bladder Carcinoma	DOID:4007	Dovitinib
FGFR3	Overexpression		Bladder Carcinoma	DOID:4007	PD173074
CBLC	EXPRESSION		Cancer	DOID:162	Olaparib
PTPRD	Mutation		Head And Neck Carcinoma	DOID:1542	JSI-124
DEFA1	EXPRESSION		Prostate Cancer	DOID:10283	Docetaxel
ERCC1	Expression		Bladder Carcinoma	DOID:4007	Cisplatin
ERCC1	Expression		Bladder Carcinoma	DOID:4007	
NOTCH1	Amplification		Colorectal Cancer	DOID:9256	NOTCH1 Antibody (PF-06293622)
NOTCH1	Amplification		Colorectal Cancer	DOID:9256	
NRG1	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Patritumab
WEE1	RS3910384	CA:15681425	Lung Non-small Cell Carcinoma	DOID:3908	Platinum Compound
WEE1	RS3910384	CA:15681425	Lung Non-small Cell Carcinoma	DOID:3908	Gemcitabine
FNTB	RS11623866	CA:13941207	Ovarian Cancer	DOID:2394	Lonafarnib
PTPRT	Promoter Hypermethylation		Head And Neck Squamous Cell Carcinoma	DOID:5520	JSI-124
PTPRT	Promoter Hypermethylation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Stattic
VEGFA	Decreased Peri-therapeutic Expression		Colorectal Cancer	DOID:9256	Bevacizumab
VEGFA	Decreased Peri-therapeutic Expression		Colorectal Cancer	DOID:9256	Levoleucovorin
VEGFA	Decreased Peri-therapeutic Expression		Colorectal Cancer	DOID:9256	Irinotecan
VEGFA	Decreased Peri-therapeutic Expression		Colorectal Cancer	DOID:9256	Fluorouracil
DNMT1	EXPRESSION		Ovarian Cancer	DOID:2394	Decitabine
KRAS	Mutation		Ovarian Cancer	DOID:2394	Decitabine
PDCD4	EXPRESSION		Lung Cancer	DOID:1324	Paclitaxel
MGMT	RS16906252	CA:5747879	Glioblastoma	DOID:3068	Temozolomide
TFF3	EXPRESSION		Breast Cancer	DOID:1612	Tamoxifen
TFF3	EXPRESSION		Breast Cancer	DOID:1612	Aminoglutethimide
DKK1	NUCLEAR EXPRESSION		Colorectal Cancer	DOID:9256	Irinotecan
DKK1	NUCLEAR EXPRESSION		Colorectal Cancer	DOID:9256	Fluorouracil
DKK1	NUCLEAR EXPRESSION		Colorectal Cancer	DOID:9256	Oxaliplatin
DKK1	NUCLEAR EXPRESSION		Colorectal Cancer	DOID:9256	Levoleucovorin
CD44	CD44s Expression		Cancer	DOID:162	RG7356
EGF	EXPRESSION		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
MDM2	EXPRESSION		Malignant Pleural Mesothelioma	DOID:7474	Cisplatin
MDM2	EXPRESSION		Malignant Pleural Mesothelioma	DOID:7474	Pemetrexed
MDM2	EXPRESSION		Malignant Pleural Mesothelioma	DOID:7474	
HMOX1	EXPRESSION		Renal Cell Carcinoma	DOID:4450	Sorafenib
HMOX1	EXPRESSION		Renal Cell Carcinoma	DOID:4450	Sunitinib
SPHK1	OVEREXPRESSION		Cervical Cancer	DOID:4362	
CASP8	Overexpression		Ewing Sarcoma Of Bone	DOID:3368	Conatumumab
TYMS	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
PBK	OVEREXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
MET	Amplification		Lung Adenocarcinoma	DOID:3910	Crizotinib
SMARCA4	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
SMARCA4	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Vinorelbine
SMARCA4	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	
SETBP1	Exon 4 Mutation		Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative	DOID:60597	
SETBP1	G870S	CA:114719	Chronic Myeloid Leukemia	DOID:8552	
ALK	C1156Y	CA:16602783	Lung Non-small Cell Carcinoma	DOID:3908	Luminespib
ALK	C1156Y	CA:16602783	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	C1156Y	CA:16602783	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Luminespib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	C1156Y	CA:16602783	Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
ALK	L1198F	CA:346473048	Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
ALK	L1198F	CA:346473048	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
BRCA1	Loss-of-function		Prostate Cancer	DOID:10283	Olaparib
AREG	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Docetaxel
AREG	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
EGFR	VIII		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cetuximab
EGFR	VIII		Head And Neck Squamous Cell Carcinoma	DOID:5520	Docetaxel
EGFR	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Docetaxel
TP53	Mutation		Gastric Adenocarcinoma	DOID:3717	Chemotherapy
TP53	Mutation		Breast Cancer	DOID:1612	Doxorubicin
CDKN1A	EXPRESSION		Colorectal Cancer	DOID:9256	Fluorouracil
ALCAM	EXPRESSION		Colorectal Cancer	DOID:9256	Fluorouracil
EGFR	Amplification		Colorectal Cancer	DOID:9256	Panitumumab
EGFR	Amplification		Colorectal Cancer	DOID:9256	Cetuximab
STMN1	EXPRESSION		Endometrial Carcinoma	DOID:2871	Paclitaxel
CCND1	Overexpression		Estrogen-receptor Positive Breast Cancer	DOID:60075	Tamoxifen
RSF1	Amplification		Breast Cancer	DOID:1612	Tamoxifen
CCND1	Amplification		Breast Cancer	DOID:1612	Tamoxifen
AR	OVEREXPRESSION		Breast Cancer	DOID:1612	Dactolisib
CDKN1B	CYTOPLASMIC MISLOCALIZATION		Breast Cancer	DOID:1612	Lapatinib
NRG1	Expression		Cancer	DOID:162	Anti-ErbB3 Monoclonal Antibody AV-203
ERBB3	EXPRESSION		Cancer	DOID:162	Anti-ErbB3 Monoclonal Antibody AV-203
AR	AR-V7		Prostate Cancer	DOID:10283	Enzalutamide
AR	AR-V7		Prostate Cancer	DOID:10283	Abiraterone
PTEN	Loss		Gastric Adenocarcinoma	DOID:3717	Trastuzumab
PTEN	Loss		Gastric Adenocarcinoma	DOID:3717	Lapatinib
ERBB3	EXPRESSION		Pancreatic Ductal Adenocarcinoma	DOID:3498	Pertuzumab
ERBB3	EXPRESSION		Pancreatic Ductal Adenocarcinoma	DOID:3498	9F7-F11
UGT1A	EXPRESSION		Colorectal Cancer	DOID:9256	Ganetespib
ERBB4	NUCLEAR TRANSLOCATION		Breast Cancer	DOID:1612	Trastuzumab
ERBB4	EXPRESSION		Breast Cancer	DOID:1612	Trastuzumab
ERBB4	EXPRESSION		Breast Cancer	DOID:1612	Lapatinib
SLFN11	EXPRESSION		Colorectal Cancer	DOID:9256	7-Ethyl-10-Hydroxycamptothecin
AURKA	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
KRAS	RS61764370	CA:10637079	Head And Neck Squamous Cell Carcinoma	DOID:5520	Cisplatin
RAC1	P29S	CA:16602801	Melanoma	DOID:1909	Dabrafenib
RAC1	P29S	CA:16602801	Melanoma	DOID:1909	Vemurafenib
BIRC5	NUCLEAR EXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	Platinum Compound
BIRC5	NUCLEAR EXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	Taxane Compound
TP53	Wildtype		Colorectal Cancer	DOID:9256	Cetuximab
TP53	Wildtype		Colorectal Cancer	DOID:9256	Capecitabine
TP53	Wildtype		Colorectal Cancer	DOID:9256	Oxaliplatin
MRE11	Loss		Endometrial Cancer	DOID:1380	Talazoparib
ATM	Underexpression		Gastric Adenocarcinoma	DOID:3717	Olaparib
EGFR	L858R	CA:126713	Lung Adenocarcinoma	DOID:3910	Afatinib
EGFR	Exon 19 Deletion		Lung Adenocarcinoma	DOID:3910	Afatinib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
ERBB2	Amplification		Uterine Corpus Endometrial Carcinoma	DOID:50939	Afatinib
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Afatinib
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
TOP1	Amplification		Colorectal Cancer	DOID:9256	Irinotecan
CDKN1B	EXPRESSION		Head And Neck Squamous Cell Carcinoma	DOID:5520	Fluorouracil
CDKN1B	EXPRESSION		Head And Neck Squamous Cell Carcinoma	DOID:5520	Cisplatin
MET	Amplification		Lung Squamous Cell Carcinoma	DOID:3907	Crizotinib
AGR2	EXPRESSION		Breast Cancer	DOID:1612	Tamoxifen
PIK3CA	Mutation		Endometrial Cancer	DOID:1380	Temsirolimus
PIK3CA	Mutation		Endometrial Cancer	DOID:1380	Ridaforolimus
PTEN	Loss		Endometrial Cancer	DOID:1380	Ridaforolimus
PTEN	Loss		Endometrial Cancer	DOID:1380	Temsirolimus
KRAS	Mutation		Endometrial Cancer	DOID:1380	Ridaforolimus
KRAS	Mutation		Endometrial Cancer	DOID:1380	Temsirolimus
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Oxaliplatin
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Capecitabine
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Cetuximab
FGFR1	Expression		Colorectal Cancer	DOID:9256	Infigratinib
NAPRT	Promoter Hypermethylation		Cancer	DOID:162	GNE-617
EGFR	Exon 18 Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Exon 18 Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Bevacizumab
ZEB1	Expression		Mantle Cell Lymphoma	DOID:50746	Doxorubicin
ZEB1	Expression		Mantle Cell Lymphoma	DOID:50746	Cytarabine
ZEB1	Expression		Mantle Cell Lymphoma	DOID:50746	Gemcitabine
ZEB1	Expression		Mantle Cell Lymphoma	DOID:50746	Salinomycin
TIMP1	Overexpression		Breast Cancer	DOID:1612	Fulvestrant
PTP4A3	OVEREXPRESSION		Colorectal Cancer	DOID:9256	Cetuximab
TYMS	Amplification		Lung Adenocarcinoma	DOID:3910	Pemetrexed
IGF1R	EXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EPHB4	EXPRESSION		Colorectal Cancer	DOID:9256	Bevacizumab
TP53	Wildtype		Esophageal Carcinoma	DOID:1107	Chemotherapy
TYMS	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
TYMS	Underexpression		Prostate Cancer	DOID:10283	Pemetrexed
TOP2A	EXPRESSION		Breast Cancer	DOID:1612	Doxorubicin
TOP1	EXPRESSION		Ovarian Cancer	DOID:2394	Cyclophosphamide
TOP1	EXPRESSION		Ovarian Cancer	DOID:2394	Topotecan
TOP1	EXPRESSION		Ovarian Cancer	DOID:2394	Carboplatin
TOP1	EXPRESSION		Colorectal Cancer	DOID:9256	Irinotecan
PRKAA2	T172 PHOSPHORYLATION		Cancer	DOID:162	ACLY SiRNA
HSPA5	EXPRESSION		Colorectal Cancer	DOID:9256	Fluorouracil
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Anti-EGFR Monoclonal Antibody
KRAS	Exon 2 Mutation		Pancreatic Carcinoma	DOID:4905	Erlotinib
KRAS	Exon 2 Mutation		Pancreatic Carcinoma	DOID:4905	
EIF4EBP1	PHOSPHORYLATION		Gastric Adenocarcinoma	DOID:3717	Everolimus
KIT	Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Pictilisib
KIT	Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
TUBB3	EXPRESSION		Cancer	DOID:162	Paclitaxel
TUBB3	EXPRESSION		Breast Cancer	DOID:1612	Taxane Compound
EGFR	Y1092 PHOSPHORYLATION		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Y1092 PHOSPHORYLATION		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
IGF1R	NUCLEAR EXPRESSION		Sarcoma	DOID:1115	IGF1R Monoclonal Antibody
CFLAR	EXPRESSION		Prostate Cancer	DOID:10283	Bicalutamide
PROM1	EXPRESSION		Hepatocellular Carcinoma	DOID:684	Sorafenib
TIMP1	Overexpression		Breast Cancer	DOID:1612	Paclitaxel
FOXP3	EXPRESSION		Breast Cancer	DOID:1612	Epirubicin
TYMS	Overexpression		Gastric Adenocarcinoma	DOID:3717	Raltitrexed
RPS6	PHOSPHORYLATION		Gastric Adenocarcinoma	DOID:3717	Everolimus
JAK1	OVEREXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	Enzastaurin
EIF4EBP1	PHOSPHORYLATION		Colorectal Cancer	DOID:9256	MTOR Kinase Inhibitor PP242
EIF4EBP1	PHOSPHORYLATION		Colorectal Cancer	DOID:9256	Dactolisib
EIF4EBP1	PHOSPHORYLATION		Colorectal Cancer	DOID:9256	WYE354
BRCA1	Expression		Malignant Mesothelioma	DOID:1790	Vinorelbine
DUSP6	EXPRESSION		Cancer	DOID:162	Trametinib
KRAS	Mutation		Cancer	DOID:162	Trametinib
BRAF	Mutation		Cancer	DOID:162	Trametinib
KRAS	G12D	CA:122538	Pancreatic Carcinoma	DOID:4905	Akt Inhibitor MK2206
PTEN	Loss		Pancreatic Carcinoma	DOID:4905	Akt Inhibitor MK2206
HSPB1	EXPRESSION		Pancreatic Ductal Adenocarcinoma	DOID:3498	Gemcitabine
NQO1	EXPRESSION		Lung Cancer	DOID:1324	Amrubicin
NQO1	P187S	CA:126904	Lung Cancer	DOID:1324	Amrubicin
BRCA1	Underexpression		Ovarian Cancer	DOID:2394	Taxane Compound
BRCA1	Underexpression		Ovarian Cancer	DOID:2394	Platinum Compound
KRAS	Mutation		Colorectal Cancer	DOID:9256	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
KRAS	Mutation		Colorectal Cancer	DOID:9256	Immunomodulatory Oligonucleotide
ABCB1	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
DNMT1	EXPRESSION		Gastric Adenocarcinoma	DOID:3717	Cisplatin
KRAS	Mutation		Colorectal Cancer	DOID:9256	Dasatinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
EGFR	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
CXCR4	EXPRESSION		Gastric Adenocarcinoma	DOID:3717	Docetaxel
MAGEH1	EXPRESSION		Bile Duct Adenocarcinoma	DOID:4896	Gemcitabine
ABCC3	Amplification		Breast Cancer	DOID:1612	Paclitaxel
ABCC3	Amplification		Breast Cancer	DOID:1612	Monomethyl Auristatin E
ABCC10	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
ASNS	Amplification		Ovarian Cancer	DOID:2394	Asparaginase
EGFR	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
PTEN	Expression		Breast Cancer	DOID:1612	Trastuzumab
CDX2	EXPRESSION		Colorectal Cancer	DOID:9256	
STAT3	SH2 DOMAIN MUTATION		T-cell Large Granular Lymphocyte Leukemia	DOID:50751	
POU5F1	EXPRESSION		Colon Cancer	DOID:219	Oxaliplatin
ERBB2	Kinase Domain Mutation		Lung Adenocarcinoma	DOID:3910	Afatinib
ERBB2	Y772_A775DUP	CA:135369	Lung Non-small Cell Carcinoma	DOID:3908	Sirolimus
ERBB2	Y772_A775DUP	CA:135369	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
ERBB2	Amplification		Pancreatic Adenocarcinoma	DOID:4074	Afatinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	C797S	CA:16602785	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
EGFR	VIII		Glioblastoma	DOID:3068	Rindopepimut
ERBB2	SERUM LEVELS		Breast Cancer	DOID:1612	Lapatinib
ERBB2	SERUM LEVELS		Breast Cancer	DOID:1612	
THBS2	UNDEREXPRESSION		Colorectal Cancer	DOID:9256	
TERT	Promoter Mutation		Brain Glioma	DOID:60108	
EGFR	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
TPM3::NTRK1	Fusion		Colorectal Cancer	DOID:9256	Larotrectinib
LMNA::NTRK1	Fusion		Colorectal Cancer	DOID:9256	Larotrectinib
IDH1	R132H	CA:170874	Oligodendroglioma	DOID:3181	AGI-5198
TERT	RS2736100	CA:11915794	Brain Glioma	DOID:60108	
STAG2	Underexpression		Bladder Carcinoma	DOID:4007	
HLA-DRA	EXPRESSION		Skin Melanoma	DOID:8923	Pembrolizumab
HLA-DRA	EXPRESSION		Skin Melanoma	DOID:8923	Atezolizumab
HLA-DRA	EXPRESSION		Skin Melanoma	DOID:8923	Nivolumab
MYD88	L265P	CA:130043	Lymphoplasmacytic Lymphoma	DOID:60901	Ibrutinib
KRAS	G12V	CA:122540	Lung Non-small Cell Carcinoma	DOID:3908	
KRAS	Mutation		Colorectal Cancer	DOID:9256	B-Raf/VEGFR-2 Inhibitor RAF265
KRAS	Mutation		Colorectal Cancer	DOID:9256	Selumetinib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	B-Raf/VEGFR-2 Inhibitor RAF265
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Trametinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Afatinib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	MEK Inhibitor RO4987655
BRAF	Wildtype		Melanoma	DOID:1909	MEK Inhibitor RO4987655
NRAS	Mutation		Melanoma	DOID:1909	MEK Inhibitor RO4987655
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	MEK Inhibitor RO4987655
KRAS	Mutation		Colorectal Cancer	DOID:9256	MEK Inhibitor RO4987655
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
BRAF	V600		Melanoma	DOID:1909	Refametinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Refametinib
NRAS	Q61K	CA:151263	Neuroblastoma	DOID:769	Binimetinib
NRAS	Q61K	CA:151263	Neuroblastoma	DOID:769	Everolimus
KRAS	Mutation		Pancreatic Adenocarcinoma	DOID:4074	PI3Kbeta Inhibitor AZD8186
KRAS	Mutation		Pancreatic Adenocarcinoma	DOID:4074	SCH772984
KRAS	Mutation		Colorectal Cancer	DOID:9256	Teprotumumab
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Dactolisib
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Selumetinib
ERBB2	Amplification		Breast Cancer	DOID:1612	Trastuzumab
ERBB2	Amplification		Breast Cancer	DOID:1612	Lapatinib
EZH2	Mutation		Follicular Lymphoma	DOID:50873	
MRE11	Frameshift		Prostate Cancer	DOID:10283	Olaparib
EGFR	VIII		Brain Glioma	DOID:60108	Nimotuzumab
TP53	Mutation		Acute Myeloid Leukemia	DOID:9119	
v::NTRK1	Fusion		Lung Adenocarcinoma	DOID:3910	Crizotinib
v::NTRK1	Fusion		Lung Adenocarcinoma	DOID:3910	Larotrectinib
v::NTRK1	Fusion		Lung Adenocarcinoma	DOID:3910	Lestaurtinib
AREG	Expression		Colorectal Cancer	DOID:9256	Panitumumab
EREG	EXPRESSION		Colorectal Cancer	DOID:9256	Panitumumab
ERBB2	Amplification		Gastric Adenocarcinoma	DOID:3717	Trastuzumab
ERBB2	Amplification		Gastric Adenocarcinoma	DOID:3717	Lapatinib
KIT	EXPRESSION		Endometrial Cancer	DOID:1380	Imatinib
CBFB::MYH11	Fusion		Acute Myeloid Leukemia	DOID:9119	
TP53	Mutation		Adrenocortical Carcinoma	DOID:3948	
KMT2A::v	Fusion		Acute Myeloid Leukemia With MLL Rearrangement	DOID:81094	
HIF1A	3' UTR Polymorphism	CA:7216212	Pancreatic Adenocarcinoma	DOID:4074	
HIF1A	OVEREXPRESSION		Colorectal Cancer	DOID:9256	
EPAS1	Overexpression		Colorectal Cancer	DOID:9256	
HIF1A	OVEREXPRESSION		Sarcoma	DOID:1115	
VHL	Loss		Renal Carcinoma	DOID:4451	Temsirolimus
FLT3	D835		Acute Myeloid Leukemia	DOID:9119	Quizartinib
FLT3	D835		Acute Myeloid Leukemia	DOID:9119	Ponatinib
FLT3	D835		Acute Myeloid Leukemia	DOID:9119	SU5614
FLT3	D835		Acute Myeloid Leukemia	DOID:9119	Sorafenib
ERBB2	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab
ERBB2	Kinase Domain Mutation		Lung Adenocarcinoma	DOID:3910	Trastuzumab
ERBB2	Amplification		Lung Small Cell Carcinoma	DOID:5409	Trastuzumab
ERBB2	Amplification		Lung Small Cell Carcinoma	DOID:5409	Irinotecan
ERBB2	Y772_A775DUP	CA:135369	Lung Adenocarcinoma	DOID:3910	Afatinib
ERBB2	Y772_A775DUP	CA:135369	Lung Carcinoma	DOID:3905	Afatinib
ERBB2	G778_P780dup		Lung Adenocarcinoma	DOID:3910	Dacomitinib
ERBB2	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Emtansine
PSMB8	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	DOID:3717	
PBK	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	DOID:3717	
PTTG1	OVEREXPRESSION		Meningioma	DOID:3565	
LEPR	UNDEREXPRESSION		Meningioma	DOID:3565	
EREG	EXPRESSION		Lung Adenocarcinoma	DOID:3910	
EGFR	G465R	CA:367579504	Colorectal Cancer	DOID:9256	Futuximab/Modotuximab Mixture
EGFR	G465R	CA:367579504	Colorectal Cancer	DOID:9256	Panitumumab
EGFR	G465R	CA:367579504	Colorectal Cancer	DOID:9256	Cetuximab
NEDD9	EXPRESSION		Hepatocellular Carcinoma	DOID:684	
ETS2	RS461155	CA:10025650	Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
ETS2	RS461155	CA:10025650	Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
KRT18	UNDEREXPRESSION		Prostate Cancer	DOID:10283	
FGF13	CYTOPLASMIC EXPRESSION		Prostate Cancer	DOID:10283	
SS18::SSX1	Fusion		Synovial Sarcoma	DOID:5485	
SS18::SSX2	Fusion		Synovial Sarcoma	DOID:5485	
SS18::SSX1	Fusion		Malignant Peripheral Nerve Sheath Tumor	DOID:5940	
SS18::SSX4	Fusion		Synovial Sarcoma	DOID:5485	
ABCB1	S893A/T	CA:179699	Breast Cancer	DOID:1612	
ABCB1	I1145I	CA:4327768	Breast Cancer	DOID:1612	
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Docetaxel
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Pertuzumab
EGFR	S492R	CA:16602784	Colorectal Cancer	DOID:9256	Panitumumab
EGFR	S492R	CA:16602784	Colorectal Cancer	DOID:9256	Futuximab/Modotuximab Mixture
EGFR	R451C	CA:158917074	Colorectal Cancer	DOID:9256	Cetuximab
EGFR	R451C	CA:158917074	Colorectal Cancer	DOID:9256	Panitumumab
EGFR	R451C	CA:158917074	Colorectal Cancer	DOID:9256	Futuximab/Modotuximab Mixture
EGFR	K467T	CA:367579521	Colorectal Cancer	DOID:9256	Futuximab/Modotuximab Mixture
EGFR	K467T	CA:367579521	Colorectal Cancer	DOID:9256	Panitumumab
EGFR	K467T	CA:367579521	Colorectal Cancer	DOID:9256	Cetuximab
FCGR2A	H167R	CA:124361	Breast Cancer	DOID:1612	
FCGR3A	F212V	CA:1211378	Breast Cancer	DOID:1612	
FCGR2B	I232T	CA:117549	Breast Cancer	DOID:1612	
FCGR3A	F212V	CA:1211378	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
FCGR2A	H167R	CA:124361	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
EGFR	P753S	CA:4266020	Skin Squamous Cell Carcinoma	DOID:3151	Cetuximab
EGFR	P753S	CA:4266020	Skin Squamous Cell Carcinoma	DOID:3151	Sirolimus
PML::RARA	Fusion		Acute Promyelocytic Leukemia	DOID:60318	
PML::RARA	Fusion		Acute Promyelocytic Leukemia	DOID:60318	Arsenic Trioxide
PML	B2 DOMAIN MUTATION		Acute Promyelocytic Leukemia	DOID:60318	Tretinoin
PML	A216V	CA:393121894	Acute Promyelocytic Leukemia	DOID:60318	Tretinoin
PML	L218P	CA:393121927	Acute Promyelocytic Leukemia	DOID:60318	Tretinoin
MET	Splice Site (c.3028G>A)	CA:368987525	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ERBB2	Amplification		Endometrial Serous Adenocarcinoma	DOID:5750	
ERBB2	Amplification		Endometrial Serous Adenocarcinoma	DOID:5750	Trastuzumab
ERBB2	Amplification		Endometrial Cancer	DOID:1380	Trastuzumab
SMO	D473H	CA:16602418	Medulloblastoma	DOID:50902	Patidegib
CD74::ROS1	Fusion		Lung Adenocarcinoma	DOID:3910	Crizotinib
ROS1	G2032R	CA:16602597	Lung Adenocarcinoma	DOID:3910	Crizotinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Cabozantinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Cabozantinib
CEBPA	N-TERMINAL FRAME SHIFT		Acute Myeloid Leukemia	DOID:9119	OICR-9429
ZMYM2::FGFR1	Fusion		Myeloproliferative Neoplasm	DOID:2226	Midostaurin
FGFR1	Amplification		Breast Cancer	DOID:1612	Afimoxifene
KDR	A1065T	CA:2924178	Angiosarcoma	DOID:1816	Sunitinib
KDR	A1065T	CA:2924178	Angiosarcoma	DOID:1816	Sorafenib
KDR	D717V	CA:356908090	Angiosarcoma	DOID:1816	Sorafenib
KDR	D717V	CA:356908090	Angiosarcoma	DOID:1816	Sunitinib
TSC2	Q1178*	CA:019253	Thyroid Gland Carcinoma	DOID:3963	Everolimus
FLT3	ITD		Acute Promyelocytic Leukemia	DOID:60318	
MTOR	F2108L	CA:338391533	Thyroid Gland Carcinoma	DOID:3963	Everolimus
RAD51D	R186*	CA:129082	Breast Cancer	DOID:1612	
FLT3	ITD		Acute Promyelocytic Leukemia	DOID:60318	Anthracycline Antineoplastic Antibiotic
FLT3	ITD		Acute Promyelocytic Leukemia	DOID:60318	Tretinoin
ALDH1A2	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	
ALDH1A2	Underexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Tretinoin
CIP2A	EXPRESSION		Pancreatic Ductal Adenocarcinoma	DOID:3498	
CIP2A	Underexpression		Pancreatic Ductal Adenocarcinoma	DOID:3498	Gemcitabine
MIR218-1	EXPRESSION		Colorectal Cancer	DOID:9256	
EML4::ALK	Fusion		Lung Acinar Adenocarcinoma	DOID:6482	Erlotinib
BRCA1	P968FS	CA:001889	Breast Cancer	DOID:1612	
BRCA1	P968FS	CA:001889	Ovarian Cancer	DOID:2394	
ERBB2	Y772_A775DUP	CA:135369	Lung Adenocarcinoma	DOID:3910	Trastuzumab Emtansine
BRAF	V600E	CA:123643	Hairy Cell Leukemia	DOID:285	
EGFR	VIII		Glioblastoma	DOID:3068	Erlotinib
EGFR	VIII		Glioblastoma	DOID:3068	Gefitinib
PTEN	Expression		Glioblastoma	DOID:3068	Erlotinib
PTEN	Expression		Glioblastoma	DOID:3068	Gefitinib
KRAS	Q22*	CA:384157370	Colon Mucinous Adenocarcinoma	DOID:3029	Panitumumab
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Capecitabine
DDX43	Overexpression		Uveal Melanoma	DOID:6039	Selumetinib
DDX43	Overexpression		Uveal Melanoma	DOID:6039	Trametinib
DDX43	Overexpression		Uveal Melanoma	DOID:6039	Mirdametinib
KIT	RS3733542	CA:2923796	Acute Myeloid Leukemia	DOID:9119	Selumetinib
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Selumetinib
TBK1	Overexpression		Melanoma	DOID:1909	AZ909
TBK1	Overexpression		Melanoma	DOID:1909	Selumetinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	Mutation		Colorectal Cancer	DOID:9256	Bevacizumab
KRAS	Mutation		Cancer	DOID:162	G-573
KRAS	Mutation		Cancer	DOID:162	MEK Inhibitor GDC-0623
BRAF	V600E	CA:123643	Cancer	DOID:162	Cobimetinib
KRAS	G12C	CA:122528	Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
KRAS	G12C	CA:122528	Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
KRAS	G12V	CA:122540	Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
KRAS	G12V	CA:122540	Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
STK11	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
STK11	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
TP53	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
TP53	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
TP53	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Docetaxel
TP53	Deleterious Mutation		Lung Non-small Cell Carcinoma	DOID:3908	
TP53	Deleterious Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Adjuvant Chemotherapy
TP53	Wildtype		Lung Non-small Cell Carcinoma	DOID:3908	Adjuvant Chemotherapy
HAVCR2	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	PD1 Inhibitor
HAVCR2	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Anti-TIM-3 Monoclonal Antibody
ERBB3	Overexpression		Cancer	DOID:162	Afatinib
ERBB3	Overexpression		Cancer	DOID:162	Selumetinib
ERBB3	Overexpression		Cancer	DOID:162	Gefitinib
ERBB3	Overexpression		Cancer	DOID:162	HER2 Inhibitor CP-724
ERBB3	Overexpression		Cancer	DOID:162	714
CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Afatinib
MMP2	SERUM LEVELS		Inflammatory Breast Carcinoma	DOID:6263	Bevacizumab
MMP9	SERUM LEVELS		Inflammatory Breast Carcinoma	DOID:6263	Bevacizumab
MMP2	SERUM LEVELS		Brain Glioma	DOID:60108	Bevacizumab
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
ACTA1	EXPRESSION		Lung Adenocarcinoma	DOID:3910	
HSPH1	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	DOID:3717	
HSPH1	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	DOID:3717	Cisplatin
HSPH1	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	DOID:3717	Fluorouracil
HSPH1	T17 DELETION		Colorectal Cancer	DOID:9256	Fluorouracil
HSPH1	T17 DELETION		Colorectal Cancer	DOID:9256	Oxaliplatin
ECSCR	EXPRESSION		Cancer	DOID:162	Angiogenesis Inhibitor
ROBO4	EXPRESSION		Cancer	DOID:162	Angiogenesis Inhibitor
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Avelumab
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Atezolizumab
PIM1	NUCLEAR EXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	
MDM2	SNP309	CA:123622	Head And Neck Cancer	DOID:11934	
TP53	Deleterious Mutation		Sarcoma	DOID:1115	Pazopanib
PIK3CA	E545K	CA:123334	Lung Adenocarcinoma	DOID:3910	Gefitinib
KRAS	G12C	CA:122528	Cancer	DOID:162	ARS-853
KRAS	G12C	CA:122528	Cancer	DOID:162	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
ERBB2	V842I	CA:16602468	Colon Cancer	DOID:219	Lapatinib
ERBB2	V842I	CA:16602468	Colon Cancer	DOID:219	Trastuzumab
ERBB2	V842I	CA:16602468	Colon Cancer	DOID:219	Neratinib
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ERBB2	L755S	CA:16602502	Colon Cancer	DOID:219	Trastuzumab
ERBB2	L755S	CA:16602502	Colon Cancer	DOID:219	Lapatinib
ERBB2	L755S	CA:16602502	Colon Cancer	DOID:219	Neratinib
ERBB2	V777L	CA:135387	Colon Cancer	DOID:219	Lapatinib
ERBB2	V777L	CA:135387	Colon Cancer	DOID:219	Neratinib
ERBB2	V777L	CA:135387	Colon Cancer	DOID:219	Trastuzumab
ERBB2	L866M	CA:399304874	Colon Cancer	DOID:219	Trastuzumab
ERBB2	L866M	CA:399304874	Colon Cancer	DOID:219	Neratinib
ERBB2	L866M	CA:399304874	Colon Cancer	DOID:219	Lapatinib
ERBB2	S310F/Y		Colon Cancer	DOID:219	Neratinib
ERBB2	S310F/Y		Colon Cancer	DOID:219	Trastuzumab
ERBB2	S310F/Y		Colon Cancer	DOID:219	Lapatinib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Ixazomib
KRAS	Mutation		Cancer	DOID:162	AZD5438
MIR218-1	UNDEREXPRESSION		Pancreatic Cancer	DOID:1793	
MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	DOID:3910	Capmatinib
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	WHI-P154
EML4::ALK	e20::e20		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EML4::ALK	e2::e20		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
KDR	R961W	CA:2924278	Colorectal Adenocarcinoma	DOID:50861	Regorafenib
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	2
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	4-pyrimidinediamine
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Retaspimycin Hydrochloride
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Retaspimycin Hydrochloride
EML4::ALK	e20::e20		Lung Non-small Cell Carcinoma	DOID:3908	Alvespimycin
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	Alvespimycin
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Alvespimycin
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
TP53	P47S	CA:000053	Cancer	DOID:162	Cisplatin
GNAQ	Mutation		Uveal Melanoma	DOID:6039	JQ1
GNA11	Mutation		Uveal Melanoma	DOID:6039	JQ1
GNA11	Q209		Uveal Melanoma	DOID:6039	Selumetinib
GNAQ	Q209		Uveal Melanoma	DOID:6039	Selumetinib
PMS2	K706FS*19		Glioblastoma	DOID:3068	Nivolumab
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Gefitinib
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Erlotinib
KRAS	G12C	CA:122528	Lung Non-small Cell Carcinoma	DOID:3908	
KRAS	Mutation		Lung Adenocarcinoma	DOID:3910	Salirasib
KRAS	Exon 2 Mutation		Pancreatic Cancer	DOID:1793	Gemcitabine
KRAS	Exon 2 Mutation		Pancreatic Cancer	DOID:1793	Erlotinib
KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	Mutation		Melanoma	DOID:1909	Imatinib
KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	Exon 11 Mutation		Melanoma	DOID:1909	Sunitinib
NRAS	Mutation		Skin Melanoma	DOID:8923	Docetaxel
NRAS	Mutation		Skin Melanoma	DOID:8923	Trametinib
NRAS	Q61		Skin Melanoma	DOID:8923	Binimetinib
NRAS	Mutation		Melanoma	DOID:1909	Trametinib
GNA11	Mutation		Uveal Melanoma	DOID:6039	Trametinib
GNAQ	Mutation		Uveal Melanoma	DOID:6039	Trametinib
NRAS	Mutation		Cancer	DOID:162	Trametinib
NRAS	Mutation		Cancer	DOID:162	Metformin
PTEN	Deletion		Prostate Cancer	DOID:10283	Everolimus
PTEN	Mutation		Endometrial Carcinoma	DOID:2871	Everolimus
GNAQ	Q209		Uveal Melanoma	DOID:6039	Refametinib
BAP1	Mutation		Uveal Melanoma	DOID:6039	Trichostatin A
BAP1	Mutation		Uveal Melanoma	DOID:6039	Panobinostat
BAP1	Mutation		Uveal Melanoma	DOID:6039	Vorinostat
BAP1	Mutation		Uveal Melanoma	DOID:6039	Valproic Acid
BAP1	Mutation		Malignant Mesothelioma	DOID:1790	MC1568
BAP1	Mutation		Malignant Mesothelioma	DOID:1790	Mocetinostat
BAP1	Mutation		Malignant Mesothelioma	DOID:1790	Vorinostat
FGFR2	Mutation		Endometrial Cancer	DOID:1380	Ponatinib
ALK	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
DNMT3A	Mutation		Myelodysplastic Syndrome	DOID:50908	
NPM1::ALK	Fusion		Anaplastic Large Cell Lymphoma	DOID:50744	Crizotinib
v::ALK	Fusion		Anaplastic Large Cell Lymphoma	DOID:50744	Crizotinib
v::ALK	Fusion		Inflammatory Myofibroblastic Tumor	DOID:50905	Crizotinib
RANBP2::ALK	Fusion		Inflammatory Myofibroblastic Tumor	DOID:50905	Crizotinib
EML4::ALK	e6::e20		Cancer	DOID:162	Crizotinib
FGFR1	N546K	CA:357830	Ewing Sarcoma Of Bone	DOID:3368	Ponatinib
FGFR1	Amplification		Ewing Sarcoma Of Bone	DOID:3368	Ponatinib
CD72::ROS1	Fusion		Lung Adenocarcinoma	DOID:3910	Ceritinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Foretinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Foretinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	AZD3463
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Brigatinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	AZD3463
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Brigatinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ROS1	G2032R	CA:16602597	Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
v::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
ROS1	L2026M	CA:365441006	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ROS1	L2026M	CA:365441006	Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
CD74::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
ROS1	L2155S	CA:365440144	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ROS1	L2155S	CA:365440144	Lung Non-small Cell Carcinoma	DOID:3908	Foretinib
ROS1	L2155S	CA:365440144	Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
ROS1	L2026M	CA:365441006	Lung Non-small Cell Carcinoma	DOID:3908	Foretinib
ROS1	G2101A	CA:365440505	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ROS1	G2101A	CA:365440505	Lung Non-small Cell Carcinoma	DOID:3908	Foretinib
CLTC::ALK	Fusion		Diffuse Large B-cell Lymphoma	DOID:50745	ALK Inhibitor TAE684
U2AF1	MUTATION		Myelofibrosis	DOID:4971	
CLTC::ALK	Fusion		Diffuse Large B-cell Lymphoma	DOID:50745	
v::ALK	Fusion		Diffuse Large B-cell Lymphoma	DOID:50745	Crizotinib
CLTC::ALK	Fusion		Diffuse Large B-cell Lymphoma	DOID:50745	Crizotinib
EML4::ALK	e2::e20		Renal Cell Carcinoma	DOID:4450	
BRAF	DEL 485-490	unregistered	Cancer	DOID:162	Pan-RAF Inhibitor LY3009120
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
CD274	Expression		Papillary Thyroid Carcinoma	DOID:3969	
CD274	Expression		Stomach Carcinoma	DOID:5517	
DUX4::v	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	
B4GALT1	Overexpression		Renal Cell Carcinoma	DOID:4450	
BCL2L11	Deletion Polymorphism		Chronic Myeloid Leukemia	DOID:8552	Imatinib
BCL2L11	Deletion Polymorphism		Lung Non-small Cell Carcinoma	DOID:3908	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
ALK	I1171	CA:346462880	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	I1171	CA:346462880	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	I1171	CA:346462880	Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
ALK	V1180L	CA:346473150	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	I1171	CA:346462880	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	V1180L	CA:346473150	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	V1180L	CA:346473150	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	V1180L	CA:346473150	Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
ALK	V1180L	CA:346473150	Lung Non-small Cell Carcinoma	DOID:3908	Brigatinib
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Brigatinib
ATM	Underexpression		Pancreatic Cancer	DOID:1793	
SIRT1	Overexpression		Pancreatic Ductal Carcinoma	DOID:3587	
SIRT1	Overexpression		Pancreatic Cancer	DOID:1793	Niacinamide
FLT3	TKD MUTATION		Acute Myeloid Leukemia	DOID:9119	Midostaurin
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Everolimus
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Everolimus
KRAS	G12R	CA:122531	Pancreatic Cancer	DOID:1793	
KRAS	G12D	CA:122538	Pancreatic Cancer	DOID:1793	
v::ROS1	Fusion		Colorectal Adenocarcinoma	DOID:50861	Crizotinib
TP53	R72P		Breast Cancer	DOID:1612	
TP53	P72R	CA:000072	Lung Carcinoma	DOID:3905	
TP53	P72R	CA:000072	Cervical Cancer	DOID:4362	
PALB2	Biallelic Inactivation		Pancreatic Cancer	DOID:1793	Mitomycin
SMAD4	Expression		Pancreatic Ductal Adenocarcinoma	DOID:3498	
FANCC	Loss-of-function		Pancreatic Cancer	DOID:1793	Melphalan
FANCC	Loss-of-function		Pancreatic Cancer	DOID:1793	Chlorambucil
FANCC	Loss-of-function		Pancreatic Cancer	DOID:1793	Cisplatin
FANCC	Loss-of-function		Pancreatic Cancer	DOID:1793	Mitomycin
FANCC	Loss-of-function		Pancreatic Cancer	DOID:1793	Gemcitabine
BRCA2	Loss-of-function		Pancreatic Cancer	DOID:1793	Mitomycin
PDGFRA	I843DEL	CA:645526434	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
EBF1::PDGFRB	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Imatinib
KRAS	G12D	CA:122538	Malignant Exocrine Pancreas Neoplasm	DOID:1795	
RB1	EXPRESSION		Lung Non-small Cell Carcinoma	DOID:3908	
CDKN2A	p16 Expression		Lung Non-small Cell Carcinoma	DOID:3908	
MLH1	METHYLATION		Stomach Carcinoma	DOID:5517	Oxaliplatin
PTPN11	Overexpression		Laryngeal Carcinoma	DOID:2600	
FLT3	T227M	CA:159846	Renal Cell Carcinoma	DOID:4450	Sunitinib
PALB2	L531FS*30		Breast Cancer	DOID:1612	
MTOR	S2215Y	CA:16602587	Endometrial Adenocarcinoma	DOID:2870	Sirolimus
MTOR	C1483Y	CA:16602888	T-cell Acute Lymphoblastic Leukemia	DOID:5603	Sirolimus
MTOR	E1799K	CA:279594	Clear Cell Renal Cell Carcinoma	DOID:4467	Sirolimus
FGFR2	N550K	CA:16602614	Endometrial Cancer	DOID:1380	PD173074
RB1	Overexpression		Pancreatic Adenocarcinoma	DOID:4074	Mitomycin
RB1	Overexpression		Pancreatic Adenocarcinoma	DOID:4074	Doxorubicin
RB1	Overexpression		Pancreatic Adenocarcinoma	DOID:4074	Fluorouracil
RB1	Overexpression		Pancreatic Adenocarcinoma	DOID:4074	Gemcitabine
PPP1R15A	RS557806	CA:9560103	Colorectal Cancer	DOID:9256	Bevacizumab
PPP1R15A	RS557806	CA:9560103	Colorectal Cancer	DOID:9256	FOLFIRI Regimen
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Selumetinib
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Irinotecan
ALK	F1174L	CA:279586	Neuroblastoma	DOID:769	AZD3463
MYCN	Amplification		Neuroblastoma	DOID:769	
ALK	F1174L	CA:279586	Neuroblastoma	DOID:769	Lorlatinib
ALK	F1245C	CA:279597	Neuroblastoma	DOID:769	Lorlatinib
ALK	R1275Q	CA:341482	Neuroblastoma	DOID:769	Lorlatinib
ALK	F1245C	CA:279597	Neuroblastoma	DOID:769	Crizotinib
v::ALK	Fusion		Colorectal Adenocarcinoma	DOID:50861	Crizotinib
v::ALK	Fusion		Breast Cancer	DOID:1612	Crizotinib
ALK	Exon 4-11 Deletion		Neuroblastoma	DOID:769	Brigatinib
ALK	F1245C	CA:279597	Cancer	DOID:162	Crizotinib
EML4::ALK	Fusion		Cancer	DOID:162	Crizotinib
ALK	F1245C	CA:279597	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	F1245C	CA:279597	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EML4::ALK	e6::e20		Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	L1196M	CA:16602593	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	G1269A	CA:16602590	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
EML4::ALK	Fusion		Cancer	DOID:162	Ceritinib
ALK	S1206Y	CA:16602591	Cancer	DOID:162	Ceritinib
ALK	G1202R	CA:16602592	Lung Non-small Cell Carcinoma	DOID:3908	Ceritinib
ALK	T1151dup	CA:645528802	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	T1151dup	CA:645528802	Lung Non-small Cell Carcinoma	DOID:3908	ALK Inhibitor TAE684
ALK	T1151dup	CA:645528802	Lung Non-small Cell Carcinoma	DOID:3908	Tanespimycin
EML4::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Tanespimycin
EML4::ALK	Fusion		Cancer	DOID:162	Alectinib
ALK	G1202R	CA:16602592	Cancer	DOID:162	Alectinib
EML4::ALK	Fusion		Cancer	DOID:162	Brigatinib
ALK	G1202R	CA:16602592	Cancer	DOID:162	Brigatinib
ALK	G1202R	CA:16602592	Lung Non-small Cell Carcinoma	DOID:3908	Tanespimycin
ALK	G1269A	CA:16602590	Cancer	DOID:162	Brigatinib
v::ALK	Fusion		Cancer	DOID:162	Brigatinib
ALK	G1269A	CA:16602590	Cancer	DOID:162	Alectinib
v::ALK	Fusion		Cancer	DOID:162	Alectinib
ALK	G1269A	CA:16602590	Cancer	DOID:162	Ceritinib
v::ALK	Fusion		Cancer	DOID:162	Ceritinib
NPM1::ALK	Fusion		Cancer	DOID:162	Crizotinib
v::ALK	Fusion		Lung Adenocarcinoma	DOID:3910	Crizotinib
ALK	G1202R	CA:16602592	Lung Adenocarcinoma	DOID:3910	Crizotinib
PIK3CA	Mutation		Cancer	DOID:162	Tanespimycin
PIK3CA	Mutation		Cancer	DOID:162	Pictilisib
PTEN	Mutation		Head And Neck Cancer	DOID:11934	Pictilisib
PTEN	Mutation		Head And Neck Cancer	DOID:11934	Tanespimycin
PIK3CA	Mutation		Head And Neck Cancer	DOID:11934	Dactolisib
PIK3CA	H1047R	CA:123326	Head And Neck Cancer	DOID:11934	Dactolisib
PIK3CA	H1047R	CA:123326	Head And Neck Cancer	DOID:11934	Cetuximab
PIK3CA	Mutation		Head And Neck Cancer	DOID:11934	Trametinib
PIK3CA	Mutation		Head And Neck Cancer	DOID:11934	Tanespimycin
PIK3CA	Mutation		Head And Neck Cancer	DOID:11934	Pictilisib
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	Sorafenib
CDK4	Amplification		Liposarcoma	DOID:3382	Palbociclib
BRCA1	Mutation		Cancer	DOID:162	Olaparib
BRCA2	Mutation		Cancer	DOID:162	Olaparib
CDKN2A	Loss		Skin Melanoma	DOID:8923	Alvocidib
CDKN2A	Loss		Renal Cell Carcinoma	DOID:4450	Palbociclib
CDKN2B	Loss		Renal Cell Carcinoma	DOID:4450	Palbociclib
CDKN2A	Loss		Skin Melanoma	DOID:8923	Palbociclib
CDK4	R24C	CA:126982	Skin Melanoma	DOID:8923	Palbociclib
CDKN2A	Loss		Ovarian Cancer	DOID:2394	Palbociclib
ASXL1	EXON 12 MUTATION		Acute Myeloid Leukemia	DOID:9119	
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	A66
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Tgx 221
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
CALR	EXON 9 FRAMESHIFT		Myelofibrosis	DOID:4971	
CSF3R	Mutation		Chronic Neutrophilic Leukemia	DOID:80187	
CSF3R	Mutation		Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative	DOID:60597	
EGFR	T790M	CA:090928	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	T790M	CA:090928	Lung Adenocarcinoma	DOID:3910	Gefitinib
MET	Amplification		Lung Adenocarcinoma	DOID:3910	Gefitinib
MET	Amplification		Lung Adenocarcinoma	DOID:3910	Erlotinib
ERBB2	Amplification		Lung Adenocarcinoma	DOID:3910	Erlotinib
ERBB2	Amplification		Lung Adenocarcinoma	DOID:3910	Gefitinib
EGFR	S768I	CA:135840	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	S768I	CA:135840	Lung Adenocarcinoma	DOID:3910	Gefitinib
EGFR	Exon 19 Deletion		Lung Adenocarcinoma	DOID:3910	Osimertinib
EGFR	C797S	CA:16602785	Lung Adenocarcinoma	DOID:3910	Osimertinib
EGFR	T790M	CA:090928	Lung Adenocarcinoma	DOID:3910	Osimertinib
BRAF	V600K	CA:16602420	Melanoma	DOID:1909	Vemurafenib
PIK3CA	H1047R	CA:123326	Head And Neck Cancer	DOID:11934	Alpelisib
PIK3CA	Mutation		Cancer	DOID:162	Alpelisib
PIK3CA	Amplification		Stomach Carcinoma	DOID:5517	Alpelisib
BRAF	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
BRAF	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Dabrafenib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Gefitinib
BRAF	V600E	CA:123643	Skin Melanoma	DOID:8923	Vemurafenib
BRAF	V600		Skin Melanoma	DOID:8923	Trametinib
BRAF	V600		Skin Melanoma	DOID:8923	Dabrafenib
SMAD4	LOSS		Pancreatic Cancer	DOID:1793	
BRAF	V600E	CA:123643	Papillary Thyroid Carcinoma	DOID:3969	Vemurafenib
BRAF	V600		Colorectal Cancer	DOID:9256	Dabrafenib
BRAF	V600		Colorectal Cancer	DOID:9256	Trametinib
TRIM24::BRAF	Fusion		Skin Melanoma	DOID:8923	Vemurafenib
SF3B1	K700E	CA:2042597	Breast Cancer	DOID:1612	Spliceostatin A
SF3B1	K666N	CA:280929	Breast Cancer	DOID:1612	Spliceostatin A
MAP2K7	E116K	CA:304968685	Lung Cancer	DOID:1324	
BRAF	V600E	CA:123643	Melanoma	DOID:1909	Cobimetinib
BRAF	V600		Melanoma	DOID:1909	Vemurafenib
BRAF	V600		Melanoma	DOID:1909	Cobimetinib
KIT	M541L	CA:160347	Chronic Leukemia	DOID:1036	Imatinib
v::PDGFRA	Fusion		Chronic Myelomonocytic Leukemia	DOID:80188	
v::PDGFRB	Fusion		Chronic Myelomonocytic Leukemia	DOID:80188	
v::FGFR1	Fusion		Chronic Myelomonocytic Leukemia	DOID:80188	
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Dactolisib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	GDC-0879
NRAS	Mutation		Melanoma	DOID:1909	Omipalisib
BRAF	V600E	CA:123643	Gastrointestinal Neuroendocrine Tumor	DOID:50626	Trametinib
BRAF	V600E	CA:123643	Gastrointestinal Neuroendocrine Tumor	DOID:50626	Vemurafenib
BRAF	V600E	CA:123643	Gastrointestinal Neuroendocrine Tumor	DOID:50626	Dabrafenib
v::PDGFRA	Fusion		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	
v::PDGFRB	Fusion		Hematologic Cancer	DOID:2531	
v::FGFR1	Fusion		Hematologic Cancer	DOID:2531	
PCM1::JAK2	Fusion		Hematologic Cancer	DOID:2531	
MTOR	E2419K		Transitional Cell Carcinoma	DOID:2671	Pazopanib
MTOR	E2419K		Transitional Cell Carcinoma	DOID:2671	Everolimus
MTOR	E2014K	CA:16602589	Transitional Cell Carcinoma	DOID:2671	Pazopanib
MTOR	E2014K	CA:16602589	Transitional Cell Carcinoma	DOID:2671	Everolimus
RICTOR	Amplification		Lung Adenocarcinoma	DOID:3910	Sapanisertib
RICTOR	Amplification		Lung Adenocarcinoma	DOID:3910	Onatasertib
FIP1L1::PDGFRA	Fusion		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	Imatinib
v::ROS1	Fusion		Bronchiolo-alveolar Adenocarcinoma	DOID:4926	Crizotinib
TFG::ROS1	Fusion		Inflammatory Myofibroblastic Tumor	DOID:50905	Crizotinib
PDGFRA	T674I	CA:123215	Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	Imatinib
PIK3CA	H1047R	CA:123326	Lung Adenocarcinoma	DOID:3910	Dactolisib
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Pilaralisib
BIRC5	Overexpression		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
TP53	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
BRAF	D594A	CA:16602532	Skin Melanoma	DOID:8923	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	D594A	CA:16602532	Skin Melanoma	DOID:8923	Sorafenib
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	PI3K/BET Inhibitor LY294002
BRAF	D594V	CA:16602425	Skin Melanoma	DOID:8923	Sorafenib
BRAF	D594V	CA:16602425	Skin Melanoma	DOID:8923	Trametinib
BRAF	K483M	CA:913112072	Skin Melanoma	DOID:8923	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	K483M	CA:913112072	Skin Melanoma	DOID:8923	Sorafenib
BRAF	L597R	CA:123649	Skin Melanoma	DOID:8923	Trametinib
BRAF	L597R	CA:123649	Skin Melanoma	DOID:8923	Vemurafenib
BRAF	L597S	CA:16602421	Skin Melanoma	DOID:8923	Trametinib
BRAF	L597S	CA:16602421	Skin Melanoma	DOID:8923	Vemurafenib
BRAF	L597S	CA:16602421	Skin Melanoma	DOID:8923	MEK Inhibitor REC-4881
BRAF	L597Q	CA:16602257	Skin Melanoma	DOID:8923	Trametinib
BRAF	L597Q	CA:16602257	Skin Melanoma	DOID:8923	Vemurafenib
BRAF	K601E	CA:123645	Skin Melanoma	DOID:8923	Trametinib
BRAF	K601E	CA:123645	Skin Melanoma	DOID:8923	Vemurafenib
BRAF	L597V	CA:123651	Skin Melanoma	DOID:8923	Trametinib
PIK3CA	Amplification		Head And Neck Squamous Cell Carcinoma	DOID:5520	Taselisib
PIK3CA	H1047R	CA:123326	Head And Neck Squamous Cell Carcinoma	DOID:5520	Taselisib
KIT	Amplification		Mucosal Melanoma	DOID:50929	Imatinib
PTEN	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Taselisib
NF1	Mutation		Skin Melanoma	DOID:8923	Vemurafenib
NF1	Mutation		Skin Melanoma	DOID:8923	Mirdametinib
NF1	Mutation		Skin Melanoma	DOID:8923	Sirolimus
NF1	Mutation		Skin Melanoma	DOID:8923	VTX-11e
NF1	Mutation		Skin Melanoma	DOID:8923	AZ628
NRAS	Mutation		Skin Melanoma	DOID:8923	Binimetinib
NRAS	Q61		Skin Melanoma	DOID:8923	Selumetinib
NRAS	Q61K	CA:151263	Skin Melanoma	DOID:8923	Vemurafenib
NRAS	Q61K	CA:151263	Skin Melanoma	DOID:8923	Selumetinib
NRAS	Mutation		Skin Melanoma	DOID:8923	Amuvatinib
SMO	Mutation		Basal Cell Carcinoma	DOID:2513	Sonidegib
NOTCH1	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	
TP53	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	Alemtuzumab
CALR	EXON 9 FRAMESHIFT		Essential Thrombocythemia	DOID:2224	Peginterferon Alfa-2a
HIP1::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
HIP1::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	I1171N	CA:16602371	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	I1171N	CA:16602371	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ALK	I1171S	CA:346462883	Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ALK	I1171S	CA:346462883	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
BIRC3	TRUNCATING MUTATION		Chronic Lymphocytic Leukemia	DOID:1040	
MYD88	L265P	CA:130043	Chronic Lymphocytic Leukemia	DOID:1040	
PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Radiation Therapy
PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Taselisib
PTEN	Mutation		Cancer	DOID:162	Ipatasertib
PTEN	Loss		Ovarian Cancer	DOID:2394	Cisplatin
PTEN	Loss		Stomach Carcinoma	DOID:5517	Chemotherapy
EZH2	Y646		Skin Melanoma	DOID:8923	GSK126
CCND1	Amplification		Skin Melanoma	DOID:8923	Sorafenib
CCND1	Amplification		Skin Melanoma	DOID:8923	Carboplatin
CCND1	Amplification		Skin Melanoma	DOID:8923	Paclitaxel
RAF1	Amplification		Skin Melanoma	DOID:8923	Carboplatin
RAF1	Amplification		Skin Melanoma	DOID:8923	Sorafenib
RAF1	Amplification		Skin Melanoma	DOID:8923	Paclitaxel
KRAS	Amplification		Skin Melanoma	DOID:8923	Carboplatin
KRAS	Amplification		Skin Melanoma	DOID:8923	Docetaxel
KRAS	Amplification		Skin Melanoma	DOID:8923	Sorafenib
v::PDGFRB	Fusion		Myeloproliferative Neoplasm	DOID:2226	Imatinib
PTEN	Loss		Stomach Cancer	DOID:10534	Capivasertib
PTEN	Loss		Stomach Cancer	DOID:10534	Docetaxel
PIK3CA	Mutation		Stomach Cancer	DOID:10534	Capivasertib
PTEN	Loss		Cancer	DOID:162	Capivasertib
PIK3CA	Mutation		Cancer	DOID:162	Capivasertib
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Capivasertib
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Capivasertib
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
ASXL1	Mutation		Myelofibrosis	DOID:4971	
NRAS	Mutation		Melanoma	DOID:1909	Binimetinib
IDH2	R172		Acute Myeloid Leukemia	DOID:9119	
CEBPA	BIALLELIC INACTIVATION		Acute Myeloid Leukemia	DOID:9119	
SRSF2	MUTATION		Acute Myeloid Leukemia	DOID:9119	
NRAS	G12/G13		Acute Myeloid Leukemia	DOID:9119	
CD274	Expression		Cancer	DOID:162	Nivolumab
RET	Overexpression		Papillary Adenocarcinoma	DOID:3112	Sunitinib
CTLA4::CD28	Fusion		Sezary's Disease	DOID:8541	Ipilimumab
AR	Mutation		Prostate Cancer	DOID:10283	Cyproterone Acetate
AR	Mutation		Prostate Cancer	DOID:10283	Flutamide
AR	Mutation		Prostate Cancer	DOID:10283	Bicalutamide
AR	Mutation		Prostate Cancer	DOID:10283	Nilutamide
PTEN	Mutation		Prostate Cancer	DOID:10283	Enzalutamide
PTEN	Mutation		Prostate Cancer	DOID:10283	Alpelisib
PTEN	Mutation		Prostate Cancer	DOID:10283	PI3Kbeta Inhibitor AZD8186
BRCA1	Loss-of-function		Prostate Cancer	DOID:10283	
BRCA2	Loss-of-function		Prostate Cancer	DOID:10283	
NOTCH1	Loss-of-function		Head And Neck Squamous Cell Carcinoma	DOID:5520	Porcupine Inhibitor WNT974
CDK6	Overexpression		Estrogen-receptor Positive Breast Cancer	DOID:60075	Fulvestrant
CDK6	Overexpression		Estrogen-receptor Positive Breast Cancer	DOID:60075	Palbociclib
FLT3	Overexpression		B-cell Adult Acute Lymphocytic Leukemia	DOID:60592	Sunitinib
BRCA1	Mutation		Ovarian Carcinoma	DOID:4001	Platinum Compound
BRCA2	Mutation		Ovarian Carcinoma	DOID:4001	Platinum Compound
GNAQ	Q209P	CA:16602436	Skin Melanoma	DOID:8923	Vemurafenib
PTEN	V317FS	CA:000646	Skin Melanoma	DOID:8923	MEK Inhibitor CI-1040
PTEN	V317FS	CA:000646	Skin Melanoma	DOID:8923	Akt Inhibitor MK2206
RB1	Loss-of-function		Breast Cancer	DOID:1612	Palbociclib
CCND1	Overexpression		Mantle Cell Lymphoma	DOID:50746	Palbociclib
GNAQ	Q209P	CA:16602436	Skin Melanoma	DOID:8923	PLX4720
ATM	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	
ESR1	Overexpression		Breast Cancer	DOID:1612	Palbociclib
ESR1	Overexpression		Breast Cancer	DOID:1612	Letrozole
MTOR	F2108L	CA:338391533	Breast Cancer	DOID:1612	Sirolimus
MTOR	M2327I	CA:338383476	Breast Cancer	DOID:1612	MTOR Kinase Inhibitor AZD8055
MTOR	M2327I	CA:338383476	Breast Cancer	DOID:1612	RapaLink-1
MTOR	M2327I	CA:338383476	Breast Cancer	DOID:1612	Sirolimus
MTOR	A2034V	CA:338393920	Breast Cancer	DOID:1612	Sirolimus
MTOR	A2034V	CA:338393920	Breast Cancer	DOID:1612	MTOR Kinase Inhibitor AZD8055
MTOR	A2034V	CA:338393920	Breast Cancer	DOID:1612	RapaLink-1
PIK3CA	E542K	CA:333572	Head And Neck Squamous Cell Carcinoma	DOID:5520	Apitolisib
PIK3CA	E545K	CA:123334	Cancer	DOID:162	Apitolisib
BRAF	D594G	CA:123657	Colorectal Cancer	DOID:9256	
BRAF	D594G	CA:123657	Colorectal Cancer	DOID:9256	Panitumumab
BRAF	D594G	CA:123657	Colorectal Cancer	DOID:9256	Cetuximab
FLT3	D835H	CA:280208	Acute Myeloid Leukemia	DOID:9119	Sorafenib
FLT3	D835H/Y		Acute Myeloid Leukemia	DOID:9119	Sorafenib
CCND1	Amplification		Renal Cell Carcinoma	DOID:4450	Palbociclib
ERBB2	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Palbociclib
CCND1	Amplification		Breast Cancer	DOID:1612	Palbociclib
ATM	Underexpression		Chronic Lymphocytic Leukemia	DOID:1040	
MET	Amplification		Glioblastoma	DOID:3068	Crizotinib
JAK1	Q503*	CA:340669637	Skin Melanoma	DOID:8923	Pembrolizumab
JAK2	c.1641+1dup	CA:913189235	Skin Melanoma	DOID:8923	Pembrolizumab
B2M	S14FS	CA:645576720	Skin Melanoma	DOID:8923	Pembrolizumab
PPFIBP2::BRAF	Fusion		Skin Melanoma	DOID:8923	Trametinib
KIAA1549::BRAF	Fusion		Skin Melanoma	DOID:8923	Trametinib
EGFR	Expression		Colorectal Cancer	DOID:9256	Cetuximab
BRAF	V600		Lung Non-small Cell Carcinoma	DOID:3908	Vemurafenib
BRAF	V600		Langerhans-cell Histiocytosis	DOID:2571	Vemurafenib
BRAF	V600		Colorectal Cancer	DOID:9256	Vemurafenib
CD274	Expression		Merkel Cell Carcinoma	DOID:3965	Pembrolizumab
BRAF	V600E	CA:123643	Hairy Cell Leukemia	DOID:285	Vemurafenib
KRAS	G12D	CA:122538	Hairy Cell Leukemia	DOID:285	Vemurafenib
MET	Overexpression		Skin Melanoma	DOID:8923	Vemurafenib
MET	Overexpression		Uveal Melanoma	DOID:6039	Crizotinib
DNMT3A	Mutation		Acute Myeloid Leukemia	DOID:9119	Decitabine
MET	Amplification		Colorectal Cancer	DOID:9256	Vemurafenib
MET	Amplification		Colorectal Cancer	DOID:9256	Crizotinib
POT1	MUTATION		Chronic Lymphocytic Leukemia	DOID:1040	
MKI67	EXPRESSION		Breast Cancer	DOID:1612	
MKI67	EXPRESSION		Prostate Cancer	DOID:10283	
RB1	Loss-of-function		Glioblastoma	DOID:3068	Palbociclib
KRAS	Mutation		Pseudomyxoma Peritonei	DOID:3559	
RAD23B	EXPRESSION		Sarcoma	DOID:1115	Vorinostat
BRAF	V600		Colorectal Cancer	DOID:9256	Cetuximab
CCND1	Amplification		Ovarian Cancer	DOID:2394	Palbociclib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Ribociclib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Phosphatidylinositide 3-Kinase Inhibitor
CCDC6::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Nintedanib
MAP2K1	C121S	CA:16602455	Melanoma	DOID:1909	Vemurafenib
FGFR3	S249C	CA:126380	Transitional Cell Carcinoma	DOID:2671	Pazopanib
FGFR1	Amplification		Breast Cancer	DOID:1612	Dovitinib
FGFR2	Amplification		Breast Cancer	DOID:1612	Dovitinib
FGF3	Amplification		Breast Cancer	DOID:1612	Dovitinib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Palbociclib
VHL	R200W (c.598C>T)	CA:020510	Chuvash Polycythemia	DOID:60474	Ruxolitinib
RB1	PHOSPHORYLATION		Breast Cancer	DOID:1612	Alpelisib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Everolimus
PIK3CA	Mutation		Breast Cancer	DOID:1612	MTOR Kinase Inhibitor PP242
PTEN	Loss		Breast Cancer	DOID:1612	Everolimus
PTEN	Loss		Breast Cancer	DOID:1612	MTOR Kinase Inhibitor PP242
PIK3R1	Mutation		Breast Cancer	DOID:1612	MTOR Kinase Inhibitor PP242
ERBB2	Amplification		Breast Cancer	DOID:1612	MTOR Kinase Inhibitor PP242
CD274	Expression		Melanoma	DOID:1909	Ipilimumab
PIK3CA	Mutation		Endometrial Cancer	DOID:1380	Pictilisib
STK11	D194E	CA:023096	Pancreatic Cancer	DOID:1793	Everolimus
STK11	Loss		Peutz-Jeghers Syndrome	DOID:3852	Sirolimus
STK11	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Everolimus
STK11	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Sirolimus
AKT2	Amplification		Lung Adenocarcinoma	DOID:3910	Vandetanib
AKT2	Amplification		Lung Adenocarcinoma	DOID:3910	Everolimus
KIF5B::RET	Fusion		Lung Adenocarcinoma	DOID:3910	Everolimus
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Everolimus
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Fulvestrant
PTEN	Expression		Her2-receptor Positive Breast Cancer	DOID:60079	Everolimus
PTEN	Expression		Her2-receptor Positive Breast Cancer	DOID:60079	Fulvestrant
PIK3CA	H1047R	CA:123326	Thyroid Cancer	DOID:1781	Temsirolimus
PIK3CA	H1047R	CA:123326	Thyroid Cancer	DOID:1781	Perifosine
PIK3CA	E542K	CA:333572	Thyroid Cancer	DOID:1781	Perifosine
PIK3CA	E542K	CA:333572	Thyroid Cancer	DOID:1781	Temsirolimus
PTEN	R130*	CA:000433	Thyroid Cancer	DOID:1781	Perifosine
PTEN	R130*	CA:000433	Thyroid Cancer	DOID:1781	Temsirolimus
FBXW7	Loss-of-function		Renal Cell Carcinoma	DOID:4450	Everolimus
CCNE1	Amplification		Estrogen-receptor Positive Breast Cancer	DOID:60075	Palbociclib
RB1	M695FS*26	CA:913189236	Estrogen-receptor Positive Breast Cancer	DOID:60075	Palbociclib
FBXW7	Mutation		Cancer	DOID:162	MTOR Inhibitor
FBXW7	Loss-of-function		Cancer	DOID:162	Sirolimus
JUN	Overexpression		Colorectal Adenocarcinoma	DOID:50861	Irbesartan
FOS	Overexpression		Colon Adenocarcinoma	DOID:234	Irbesartan
CDKN2A	RS3814960	CA:12951936	Esophagus Squamous Cell Carcinoma	DOID:3748	
MDM2	RS34886328	CA:238461468	Esophagus Squamous Cell Carcinoma	DOID:3748	
CBLB	RS2305035	CA:2524814	Lung Non-small Cell Carcinoma	DOID:3908	
PRDM1	MUTATION		Diffuse Large B-cell Lymphoma	DOID:50745	
IDH1	Mutation		Brain Glioma	DOID:60108	
IDH2	Mutation		Brain Glioma	DOID:60108	
MYD88	L265P	CA:130043	Lymphoplasmacytic Lymphoma	DOID:60901	IRAK-1/4 Inhibitor
MYD88	L265P	CA:130043	Lymphoplasmacytic Lymphoma	DOID:60901	IMG-2005-5
KRAS	Mutation		Hepatocellular Carcinoma	DOID:684	Refametinib
KRAS	Mutation		Hepatocellular Carcinoma	DOID:684	Sorafenib
DNAJB1::PRKACA	Fusion		Mixed Fibrolamellar Hepatocellular Carcinoma	DOID:80182	
SMAD4	Deletion		Colorectal Cancer	DOID:9256	Fluorouracil
LRP1B	DELETION		Glioblastoma	DOID:3068	
TERT	C228T	CA:557858711	Thyroid Cancer	DOID:1781	
ATRX	Underexpression		Malignant Astrocytoma	DOID:3069	PCV Regimen
ATRX	Underexpression		Malignant Astrocytoma	DOID:3069	Temozolomide
ATRX	Underexpression		Glioblastoma	DOID:3068	
AURKA	Overexpression		Ovarian Serous Carcinoma	DOID:50933	Platinum Compound
MET	D1228N	CA:257000	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
AURKA	EXPRESSION		Esophagus Squamous Cell Carcinoma	DOID:3748	Fluorouracil
AURKA	EXPRESSION		Esophagus Squamous Cell Carcinoma	DOID:3748	Radiation Therapy
AURKA	EXPRESSION		Esophagus Squamous Cell Carcinoma	DOID:3748	Cisplatin
CASP8	D302H	CA:119051	Neuroblastoma	DOID:769	
AXL	EXPRESSION		Esophagus Squamous Cell Carcinoma	DOID:3748	
GAS6	EXPRESSION		Prostate Cancer	DOID:10283	Docetaxel
GAS6	EXPRESSION		Oral Squamous Cell Carcinoma	DOID:50866	
ETV4	Overexpression		Prostate Cancer	DOID:10283	
STAG2	Underexpression		Melanoma	DOID:1909	Vemurafenib
STAG3	Underexpression		Melanoma	DOID:1909	Vemurafenib
MAP2K1	Q56_V60del	CA:912992484	Ovarian Serous Carcinoma	DOID:50933	Selumetinib
BRAF::CUL1	Fusion		Ovarian Serous Carcinoma	DOID:50933	Mitogen-Activated Protein Kinase Kinase Inhibitor
ZKSCAN1::BRAF	Fusion		Melanoma	DOID:1909	Trametinib
KIAA1549::BRAF	Fusion		Spindle Cell Sarcoma	DOID:4235	Sorafenib
KIAA1549::BRAF	Fusion		Spindle Cell Sarcoma	DOID:4235	Bevacizumab
KIAA1549::BRAF	Fusion		Spindle Cell Sarcoma	DOID:4235	Temsirolimus
BRAF	L505H	CA:369588358	Melanoma	DOID:1909	Vemurafenib
PIK3CA	E545K	CA:123334	Lung Adenocarcinoma	DOID:3910	Erlotinib
VHL	Mutation		Renal Cell Carcinoma	DOID:4450	Pazopanib
EPAS1	Overexpression		Renal Cell Carcinoma	DOID:4450	Pazopanib
HIF1A	EXPRESSION		Renal Cell Carcinoma	DOID:4450	Pazopanib
BRCA1	Mutation		Ovarian Cancer	DOID:2394	
BRCA2	Mutation		Ovarian Cancer	DOID:2394	
BRCA1	Mutation		Ovarian Cancer	DOID:2394	Olaparib
BRCA1	Mutation		Ovarian Cancer	DOID:2394	Cediranib
BRCA2	Mutation		Ovarian Cancer	DOID:2394	Cediranib
BRCA2	Mutation		Ovarian Cancer	DOID:2394	Olaparib
BRCA2	D3095E	CA:10586089	Breast Cancer	DOID:1612	
MLH1	EXPRESSION		Stomach Carcinoma	DOID:5517	
BCOR	Mutation		Stomach Cancer	DOID:10534	
CDH1	MUTATION		Stomach Carcinoma	DOID:5517	
RHOA	MUTATION		Stomach Carcinoma	DOID:5517	
BRCA1	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Carboplatin
BRCA1	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Cisplatin
BRCA2	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Carboplatin
BRCA2	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Cisplatin
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Panitumumab
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Trastuzumab
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Lapatinib
SDC4::ROS1	Fusion		Lung Adenocarcinoma	DOID:3910	Crizotinib
ERBB2	Amplification		Scrotum Paget's Disease	DOID:3444	Trastuzumab
ERBB2	Mutation		Bladder Carcinoma	DOID:4007	Platinum Compound
MEN1	FRAMESHIFT TRUNCATION	CA:16044439	Oncocytic Carcinoma Of The Thyroid	DOID:8161	
KMT2C	Mutation		Skin Squamous Cell Carcinoma	DOID:3151	
STAG2	MUTATION		Ewing Sarcoma Of Bone	DOID:3368	
BRAF	V600E	CA:123643	Multiple Myeloma	DOID:9538	Vemurafenib
KRAS	Mutation		Lung Adenocarcinoma	DOID:3910	
EGFR	Mutation		Lung Adenocarcinoma	DOID:3910	
NRAS	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Cetuximab
MYCL	EXPRESSION		Multiple Myeloma	DOID:9538	I-BET151
MYCL	EXPRESSION		Multiple Myeloma	DOID:9538	JQ1
HGF	EXPRESSION		Glioblastoma	DOID:3068	MET Tyrosine Kinase Inhibitor SGX523
EGFR	Expression		Colorectal Cancer	DOID:9256	Panitumumab
SOX10	Loss		Melanoma	DOID:1909	Vemurafenib
FGF2	EXPRESSION		Acute Myeloid Leukemia	DOID:9119	Quizartinib
EIF1AX	MUTATION		Uveal Melanoma	DOID:6039	
MET	Amplification		Cancer	DOID:162	Crizotinib
KRAS	G12V	CA:122540	Cancer	DOID:162	Crizotinib
PAX8	Expression		Female Reproductive Organ Cancer	DOID:120	
ERRFI1	E384*	CA:338219584	Cholangiocarcinoma	DOID:4947	Erlotinib
KIT	D816V	CA:123513	Systemic Mastocytosis	DOID:349	Midostaurin
KIT	D816V	CA:123513	Systemic Mastocytosis	DOID:349	
ESR1	S463P	CA:16602414	Estrogen-receptor Positive Breast Cancer	DOID:60075	Aromatase Inhibitor
EGFR	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
SGK1	Overexpression		Breast Cancer	DOID:1612	Alpelisib
SGK1	Overexpression		Breast Cancer	DOID:1612	SGK1-Inh
KRAS	G12D	CA:122538	Pancreatic Ductal Carcinoma	DOID:3587	
CCNE1	Overexpression		Ovarian Cancer	DOID:2394	CDK Inhibitor SNS-032
CCNE1	Amplification		Ovarian Serous Cystadenocarcinoma	DOID:5746	Dinaciclib
CCNE1	Amplification		Ovarian Serous Cystadenocarcinoma	DOID:5746	Akt Inhibitor MK2206
EGFR	G719S	CA:126722	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
STK11	Loss		Peutz-Jeghers Syndrome	DOID:3852	
BRAF	G596C	CA:135098	Lung Non-small Cell Carcinoma	DOID:3908	Dabrafenib
BRAF	G596C	CA:135098	Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
SMARCB1	Underexpression		Synovial Sarcoma	DOID:5485	Tazemetostat
SMARCB1	Deletion		Rhabdoid Cancer	DOID:3672	Tazemetostat
PTEN	Deletion		Prostate Cancer	DOID:10283	
NF2	Loss		Thyroid Gland Carcinoma	DOID:3963	Selumetinib
NF1	Loss		Malignant Peripheral Nerve Sheath Tumor	DOID:5940	JQ1 Compound
SH2B3	RS3184504	CA:6789733	Colorectal Cancer	DOID:9256	
KIF23	EXPRESSION		Hepatocellular Carcinoma	DOID:684	
ERBB3	V104M	CA:16602847	Transitional Cell Carcinoma	DOID:2671	Afatinib
ERBB3	R103G	CA:385279657	Transitional Cell Carcinoma	DOID:2671	Afatinib
ERBB3	G284R	CA:16602624	Transitional Cell Carcinoma	DOID:2671	Afatinib
GADD45A	rs681673	CA:10728634	Ovarian Cancer	DOID:2394	
EWSR1::FLI1	Fusion		Ewing Sarcoma Of Bone	DOID:3368	
MTHFR	A222V	CA:170990	Pancreatic Cancer	DOID:1793	
MTHFR	A222V	CA:170990	Rectum Cancer	DOID:1993	Fluorouracil
BRCA2	TRUNCATING MUTATION		Breast Cancer	DOID:1612	
BRCA1	Alu insertion		Breast Cancer	DOID:1612	
HOXB13	G84E	CA:288225	Prostate Cancer	DOID:10283	
KLLN	PROMOTER METHYLATION		Breast Cancer	DOID:1612	
KLLN	PROMOTER METHYLATION		Renal Cell Carcinoma	DOID:4450	
EGFR	D761Y	CA:135827	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	D761Y	CA:135827	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
CDKN2A	Loss		Her2-receptor Negative Breast Cancer	DOID:60080	Letrozole
CDKN2A	Loss		Her2-receptor Negative Breast Cancer	DOID:60080	Palbociclib
CRBN	Mutation		Multiple Myeloma	DOID:9538	Lenalidomide
CRBN	Mutation		Multiple Myeloma	DOID:9538	Pomalidomide
FGFR1	Amplification		Estrogen-receptor Positive Breast Cancer	DOID:60075	Ponatinib
TSC1	R1062W	CA:007223	Tuberous Sclerosis	DOID:13515	
STK11	Mutation		Peutz-Jeghers Syndrome	DOID:3852	
PDGFRA	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Sunitinib
BRCA1	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Olaparib
BRCA2	Mutation		Triple-receptor Negative Breast Cancer	DOID:60081	Olaparib
FIP1L1::PDGFRA	Fusion		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	Ponatinib
EWSR1::DDIT3	Fusion		Myxoid Liposarcoma	DOID:5363	
PDGFRA	T674I	CA:123215	Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	Ponatinib
EGFR	G719		Lung Adenocarcinoma	DOID:3910	Erlotinib
BRD4::NUTM1	Fusion		NUT Midline Carcinoma	DOID:60463	JQ1
EGFR	S720		Lung Adenocarcinoma	DOID:3910	Erlotinib
v::ALK	Fusion		Inflammatory Myofibroblastic Tumor	DOID:50905	
CYP2D6	Loss-of-function		Breast Cancer	DOID:1612	
FUS::DDIT3	Fusion		Myxoid Liposarcoma	DOID:5363	
EGFR	K757R	CA:4266023	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	E746G	CA:367584149	Lung Adenocarcinoma	DOID:3910	Erlotinib
MLH1	E13fs	CA:010006	Endometrial Cancer	DOID:1380	
MSH2	R383*	CA:017356	Endometrial Cancer	DOID:1380	
MLH1	V534R	CA:913102764	Colorectal Cancer	DOID:9256	
UGT1A1	UGT1A1*28	unregistered	Cancer	DOID:162	Belinostat
MLH1	G606FS*2	CA:913102766	Endometrial Cancer	DOID:1380	
MLH1	c.790+1G>A	CA:012109	Colorectal Cancer	DOID:9256	
UGT1A1	UGT1A1*60		Cancer	DOID:162	Belinostat
MLH1	K618DEL	CA:007087	Colorectal Cancer	DOID:9256	
MLH1	P138T		Colorectal Cancer	DOID:9256	
MLH1	R687FS	CA:279809	Colorectal Cancer	DOID:9256	
EGFR	V769_D770insASV	CA:180588	Lung Adenocarcinoma	DOID:3910	Erlotinib
DPYD	DPYD*2A HOMOZYGOSITY	CA:114277	Cancer	DOID:162	Capecitabine
DPYD	DPYD*2A HOMOZYGOSITY	CA:114277	Cancer	DOID:162	Tegafur
DPYD	DPYD*2A HOMOZYGOSITY	CA:114277	Cancer	DOID:162	Fluorouracil
DPYD	DPYD*13 HOMOZYGOSITY	CA:228118	Cancer	DOID:162	Fluorouracil
DPYD	DPYD*13 HOMOZYGOSITY	CA:228118	Cancer	DOID:162	Tegafur
DPYD	DPYD*13 HOMOZYGOSITY	CA:228118	Cancer	DOID:162	Capecitabine
FOS::v	Fusion		Bone Epithelioid Hemangioma	DOID:6610	
DPYD	RS67376798 HOMOZYGOSITY		Cancer	DOID:162	Tegafur
DPYD	RS67376798 HOMOZYGOSITY		Cancer	DOID:162	Capecitabine
DPYD	RS67376798 HOMOZYGOSITY		Cancer	DOID:162	Fluorouracil
MLH1	R100*	CA:009575	Colorectal Cancer	DOID:9256	
WWTR1::CAMTA1	Fusion		Malignant Epithelioid Hemangioendothelioma	DOID:80190	
MLH1	T117M	CA:009872	Colorectal Cancer	DOID:9256	
MLH1	Q426FS	CA:913102760	Colorectal Cancer	DOID:9256	
MLH1	V49A	CA:352035388	Colorectal Cancer	DOID:9256	
EGFR	Exon 20 Insertion		Lung Adenocarcinoma	DOID:3910	Afatinib
MLH1	D667FS	CA:913102767	Colorectal Cancer	DOID:9256	
MLH1	M1L	CA:352059785	Colorectal Cancer	DOID:9256	
MLH1	*757L	CA:352069936	Villous Adenoma	DOID:50869	
MLH1	R265G	CA:352045752	Colorectal Cancer	DOID:9256	
MLH1	V213FS	CA:913102758	Colorectal Cancer	DOID:9256	
MLH1	N551T	CA:006238	Colorectal Cancer	DOID:9256	
MLH1	A424T	CA:028060	Colorectal Cancer	DOID:9256	
MLH1	Q149*	CA:010427	Colorectal Cancer	DOID:9256	
MLH1	R226*	CA:011496	Colorectal Cancer	DOID:9256	
MLH1	P536FS	CA:913102765	Colorectal Cancer	DOID:9256	
MLH1	G67R	CA:008104	Colorectal Cancer	DOID:9256	
MLH1	I68S	CA:352035494	Colorectal Cancer	DOID:9256	
MLH1	G65D	CA:007735	Colorectal Cancer	DOID:9256	
MLH1	A681V	CA:008313	Colorectal Cancer	DOID:9256	
MSH6	P138T	CA:346737117	Colorectal Cancer	DOID:9256	
MSH2	V273FS	CA:913090558	Colorectal Cancer	DOID:9256	
MSH2	E28FS	CA:913189237	Colorectal Cancer	DOID:9256	
VHL	E55FS (c.163_164delGA)	CA:645524641	Renal Cell Carcinoma	DOID:4450	
MSH6	I891FS	CA:913090565	Colorectal Cancer	DOID:9256	
VHL	E55RfsTer11 (c.163delG)	CA:432536363	Von Hippel-Lindau Disease	DOID:14175	
MSH6	R1242H	CA:014077	Colorectal Cancer	DOID:9256	
PMS2	R315*	CA:013335	Endometrial Cancer	DOID:1380	
MLH1	M490T	CA:352056416	Endometrial Cancer	DOID:1380	
MSH2	K172*	CA:346730730	Colorectal Cancer	DOID:9256	
VHL	A56FS (c.164_165insG)	CA:645524645	Von Hippel-Lindau Disease	DOID:14175	
MSH2	E483G	CA:346726930	Endometrial Cancer	DOID:1380	
TNKS2::PDGFRA	Fusion		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	DOID:80164	Imatinib
MSH6	V352I	CA:007915	Endometrial Cancer	DOID:1380	
MSH6	R1242C	CA:10578156	Colorectal Cancer	DOID:9256	
SLCO1B1	RS4149056	CA:6476722	Cancer	DOID:162	Methotrexate
SLCO1B1	N130D	CA:6476674	Cancer	DOID:162	Methotrexate
TYMS	RS34743033		Cancer	DOID:162	Methotrexate
ACTB::GLI1	Fusion		Pericytoma With T(7;12)	DOID:80896	
ERBB3	V855A	CA:385313732	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
ERBB3	V855A	CA:385313732	Lung Non-small Cell Carcinoma	DOID:3908	Pertuzumab
FGFR2::BICC1	Fusion		Cholangiocarcinoma	DOID:4947	
FGFR2::AHCYL1	Fusion		Cholangiocarcinoma	DOID:4947	
CDKN2B	METHYLATION		Acute Promyelocytic Leukemia	DOID:60318	
CHEK2	1100DELC	CA:288251	Prostate Cancer	DOID:10283	
FGFR2::BICC1	Fusion		Cholangiocarcinoma	DOID:4947	Infigratinib
FGFR2::BICC1	Fusion		Cholangiocarcinoma	DOID:4947	PD173074
CHEK2	I157T	CA:117630	Prostate Cancer	DOID:10283	
FGFR2::AHCYL1	Fusion		Cholangiocarcinoma	DOID:4947	Infigratinib
FGFR2::AHCYL1	Fusion		Cholangiocarcinoma	DOID:4947	PD173074
CHEK2	IVS2+1G>A		Prostate Cancer	DOID:10283	
PTPRD	V253I	CA:4984656	Ewing Sarcoma Of Bone	DOID:3368	Cixutumumab
PTPRD	V253I	CA:4984656	Ewing Sarcoma Of Bone	DOID:3368	Teprotumumab
VHL	A56fs (c.164_165insA)	CA:658795187	Von Hippel-Lindau Disease	DOID:14175	
VHL	E55= (c.165G>A)	CA:432536364	Von Hippel-Lindau Disease	DOID:14175	
RRM1	Overexpression		Pancreatic Cancer	DOID:1793	Gemcitabine
RRM2	OVEREXPRESSION		Pancreatic Cancer	DOID:1793	Gemcitabine
POLE	Mutation		Glioblastoma	DOID:3068	Pembrolizumab
POLE	Mutation		Endometrial Cancer	DOID:1380	Pembrolizumab
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
MET	D1228V	CA:368991571	Lung Non-small Cell Carcinoma	DOID:3908	Cabozantinib
MET	D1228V	CA:368991571	Lung Non-small Cell Carcinoma	DOID:3908	Savolitinib
RB1	Mutation		Lung Small Cell Carcinoma	DOID:5409	Chemotherapy
SQSTM1::NTRK1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Entrectinib
ETV6::NTRK3	Fusion		Mammary Analogue Secretory Carcinoma	DOID:80808	Entrectinib
ETV6::NTRK3	Fusion		Mammary Analogue Secretory Carcinoma	DOID:80808	Crizotinib
RUNX1	K83E	CA:248613	Acute Myeloid Leukemia	DOID:9119	
RUNX1	Y260*	CA:248619	Acute Myeloid Leukemia	DOID:9119	
RUNX1	R135FSX177		Acute Myeloid Leukemia	DOID:9119	
NTRK3	G623R	CA:393914380	Mammary Analogue Secretory Carcinoma	DOID:80808	Entrectinib
RUNX1	D198Y	CA:410207975	Acute Myeloid Leukemia	DOID:9119	
RUNX1	A107P	CA:248623	Acute Myeloid Leukemia	DOID:9119	
MSH2	Loss		Transitional Cell Carcinoma	DOID:2671	Durvalumab
MSH2	Loss		Transitional Cell Carcinoma	DOID:2671	Anti-PD-1 Monoclonal Antibody MEDI0680
MSH6	LOSS		Transitional Cell Carcinoma	DOID:2671	Anti-PD-1 Monoclonal Antibody MEDI0680
MSH6	LOSS		Transitional Cell Carcinoma	DOID:2671	Durvalumab
CDKN2A	Loss		Ewing Sarcoma	DOID:3369	Palbociclib
CDKN2A	Loss		Ewing Sarcoma	DOID:3369	Linsitinib
CDKN2B	Loss		Ewing Sarcoma	DOID:3369	Palbociclib
CDKN2B	Loss		Ewing Sarcoma	DOID:3369	Linsitinib
CDKN2A	Loss		Dermatofibrosarcoma Protuberans	DOID:3507	Palbociclib
RUNX1	T148HFSX9	CA:248627	Acute Myeloid Leukemia	DOID:9119	
DDX41	R164W	CA:358665	Hematologic Cancer	DOID:2531	
ERBB2	G776L	CA:913189238	Lung Adenocarcinoma	DOID:3910	Afatinib
ERBB2	G778_P780dup		Lung Adenocarcinoma	DOID:3910	Afatinib
ERBB2	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
ERBB2	G778_P780dup		Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
ERBB2	Y772_A775DUP	CA:135369	Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
ERBB2	M774DELINSWLV	unregistered	Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
PTPRB	Loss-of-function		Angiosarcoma	DOID:1816	Sunitinib
PTPRB	Loss-of-function		Angiosarcoma	DOID:1816	Vatalanib
VHL	A149S (c.445G>T)	CA:020355	Von Hippel-Lindau Disease	DOID:14175	
BRCA1	Mutation		Ovarian Cancer	DOID:2394	Rucaparib
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Therapeutic Tumor Infiltrating Lymphocytes
HLA-C	COPY-NEUTRAL LOSS OF HETEROZYGOSITY		Colorectal Cancer	DOID:9256	Therapeutic Tumor Infiltrating Lymphocytes
JAK1	S703I	CA:340667333	Hepatocellular Carcinoma	DOID:684	Ruxolitinib
EPCAM	3' Exon Deletion		Lynch Syndrome	DOID:3883	
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Irinotecan
ARAF	S490T	CA:412818377	Colorectal Cancer	DOID:9256	Vemurafenib
ARAF	S490T	CA:412818377	Colorectal Cancer	DOID:9256	Cetuximab
ARAF	S490T	CA:412818377	Colorectal Cancer	DOID:9256	Irinotecan
GNAS	R201C	CA:126067	Colorectal Cancer	DOID:9256	Cetuximab
GNAS	R201C	CA:126067	Colorectal Cancer	DOID:9256	Irinotecan
GNAS	R201C	CA:126067	Colorectal Cancer	DOID:9256	Vemurafenib
ATM	Mutation		Mantle Cell Lymphoma	DOID:50746	Olaparib
FGFR1	Amplification		Lung Squamous Cell Carcinoma	DOID:3907	Infigratinib
FGFR1	Amplification		Breast Cancer	DOID:1612	Infigratinib
FGFR3	Mutation		Bladder Carcinoma	DOID:4007	Infigratinib
FGFR1	Amplification		Bladder Carcinoma	DOID:4007	Infigratinib
FGFR2	Mutation		Cholangiocarcinoma	DOID:4947	Infigratinib
FGFR2::?	Fusion		Cholangiocarcinoma	DOID:4947	Infigratinib
FGFR2::v	Fusion		Cholangiocarcinoma	DOID:4947	Infigratinib
VHL	M54IFS (c.162_166delGGAGG)	CA:645524639	Clear Cell Renal Cell Carcinoma	DOID:4467	
FGFR2::BICC1	Fusion		Transitional Cell Carcinoma	DOID:2671	Erdafitinib
FGFR2::v	Fusion		Cancer	DOID:162	Erdafitinib
FGFR3::TACC3	Fusion		Cancer	DOID:162	Erdafitinib
FGFR2::BICC1	Fusion		Endometrial Cancer	DOID:1380	Erdafitinib
AKT3	Overexpression		Breast Cancer	DOID:1612	Akt Inhibitor MK2206
AKT3	Overexpression		Triple-receptor Negative Breast Cancer	DOID:60081	Pan-AKT Kinase Inhibitor GSK690693
BRCA1	Loss-of-function		Breast Cancer	DOID:1612	Quarfloxin
BRCA1	Loss-of-function		Breast Cancer	DOID:1612	Pidnarulex
BRCA2	Loss-of-function		Breast Cancer	DOID:1612	Pidnarulex
BRCA2	Loss-of-function		Breast Cancer	DOID:1612	Quarfloxin
PTEN	R173C	CA:000498	Cancer	DOID:162	
PTEN	Mutation		Glioblastoma	DOID:3068	
PTEN	R173C	CA:000498	Endometrial Hyperplasia	DOID:80365	
PTEN	R173C	CA:000498	Obsolete PTEN Hamartoma Tumor Syndrome	DOID:80191	
ALK	Alternative Transcript (ATI)		Skin Melanoma	DOID:8923	Crizotinib
EGFR	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
VHL	Exon 1-3 Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	Exon 1 Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	Exon 1-2 Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	M1FS (c.1_17del17)	CA:645524623	Chromophobe Renal Cell Carcinoma	DOID:4471	
VHL	M1? (c.1-1_20del21)	CA:645524624	Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	M1? (c.3G>A)	CA:020331	Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	N7D (c.19A>G)	CA:351747044	Renal Cell Carcinoma	DOID:4450	
VHL	P25L (c.74C>T)	CA:020538	Von Hippel-Lindau Disease	DOID:14175	
VHL	P59fs (c.173_174insC)	CA:658795188	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y98FS (c.291_310del20)	CA:645524819	Clear Cell Renal Cell Carcinoma	DOID:4467	
GNA11	Mutation		Uveal Melanoma	DOID:6039	Sotrastaurin Acetate
GNA11	Mutation		Uveal Melanoma	DOID:6039	Mirdametinib
GNAQ	Mutation		Uveal Melanoma	DOID:6039	Sotrastaurin Acetate
GNAQ	Mutation		Uveal Melanoma	DOID:6039	Mirdametinib
NF1	Mutation		Plexiform Neurofibroma	DOID:5151	Selumetinib
ATM	Mutation		Prostate Cancer	DOID:10283	Olaparib
PALB2	Biallelic Inactivation		Prostate Cancer	DOID:10283	Olaparib
MET	Amplification		Colorectal Cancer	DOID:9256	Anti-EGFR Monoclonal Antibody
NTRK1	Overexpression		Neuroblastoma	DOID:769	
PDGFRA	P577S	CA:16602636	Melanoma	DOID:1909	Crenolanib
PDGFRA	P577S	CA:16602636	Melanoma	DOID:1909	Imatinib
PDGFRA	R841K	CA:16602638	Melanoma	DOID:1909	Crenolanib
PDGFRA	R841K	CA:16602638	Melanoma	DOID:1909	Imatinib
PDGFRA	H845Y	CA:16602639	Melanoma	DOID:1909	Imatinib
PDGFRA	H845Y	CA:16602639	Melanoma	DOID:1909	Crenolanib
PDGFRA	G853D	CA:16602640	Melanoma	DOID:1909	Crenolanib
PDGFRA	G853D	CA:16602640	Melanoma	DOID:1909	Imatinib
MET	Amplification		Colorectal Cancer	DOID:9256	Cetuximab
MTAP	Underexpression		Breast Cancer	DOID:1612	Pyrimidine Antagonist
VPS37A	Underexpression		Ovarian Cancer	DOID:2394	Cetuximab
EGFR	Expression		Chordoma	DOID:3302	Lapatinib
BTK	T316A	CA:413928923	Chronic Lymphocytic Leukemia	DOID:1040	Ibrutinib
ERBB2	T862A	CA:399304738	Cancer	DOID:162	Lapatinib
ERBB2	V773A	CA:399302815	Cancer	DOID:162	Lapatinib
ERBB2	N857S	CA:123601	Cancer	DOID:162	Lapatinib
ERBB2	H878Y	CA:399305170	Cancer	DOID:162	Lapatinib
FGFR2	Amplification		Stomach Carcinoma	DOID:5517	Fexagratinib
FGFR1	Amplification		Breast Cancer	DOID:1612	Fexagratinib
ERBB2	Overexpression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Lapatinib
GNAS	R201		Pseudomyxoma Peritonei	DOID:3559	
GNAS	c.393T>C	CA:409455494	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
GNAS	c.393T>C	CA:409455494	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
GNAS	c.393T>C	CA:409455494	Intrahepatic Cholangiocarcinoma	DOID:4928	
GNAS	c.393T>C	CA:409455494	Breast Carcinoma	DOID:3459	
PIK3CA	C420R	CA:180900	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12V	CA:122540	Colorectal Cancer	DOID:9256	Dactolisib
KRAS	G12V	CA:122540	Colorectal Cancer	DOID:9256	Selumetinib
NRAS	G12D	CA:130425	Colorectal Cancer	DOID:9256	Cetuximab
NRAS	G12D	CA:130425	Colorectal Cancer	DOID:9256	Irinotecan
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Panitumumab
KRAS	G12A	CA:135567	Lung Cancer	DOID:1324	Gefitinib
KRAS	G12A	CA:135567	Multiple Myeloma	DOID:9538	Melphalan
IDH1	R132		High Grade Glioma	DOID:3070	Sunitinib
IDH1	R132		High Grade Glioma	DOID:3070	Bevacizumab
PIK3CA	E542K	CA:333572	Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
PIK3CA	Mutation		Breast Cancer	DOID:1612	
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	Pictilisib
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
PIK3CA	Wildtype		Colorectal Cancer	DOID:9256	Aspirin
PIK3CA	E545K	CA:123334	Lung Non-small Cell Carcinoma	DOID:3908	PI103
KRAS	G13D	CA:122534	Breast Cancer	DOID:1612	Pictilisib
PIK3CA	Rare Mutation		Breast Cancer	DOID:1612	
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
EGFR	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
PIK3CA	E542K	CA:333572	Her2-receptor Positive Breast Cancer	DOID:60079	PI-103
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
ERBB2	Amplification		Breast Cancer	DOID:1612	Pictilisib
PTEN	Loss		Breast Cancer	DOID:1612	Pictilisib
PIK3CA	C420R	CA:180900	Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Trastuzumab
PIK3CA	H1047L	CA:123328	Breast Cancer	DOID:1612	Pictilisib
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Pictilisib
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	Pictilisib
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	
PIK3CA	E545K	CA:123334	Rectum Cancer	DOID:1993	
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Oxaliplatin
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Lapatinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Neratinib
EGFR	T790M	CA:090928	Lung Non-small Cell Carcinoma	DOID:3908	Canertinib
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
KRAS	G13D	CA:122534	Colorectal Cancer	DOID:9256	Panitumumab
NRAS	Q61L	CA:16602361	Colorectal Cancer	DOID:9256	Irinotecan
NRAS	Q61L	CA:16602361	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G13D	CA:122534	Colorectal Cancer	DOID:9256	Selumetinib
KRAS	G13D	CA:122534	Colorectal Cancer	DOID:9256	Dactolisib
NRAS	Q61R	CA:123618	Colorectal Cancer	DOID:9256	Cetuximab
BRAF	Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
NRAS	Q61K	CA:151263	Colorectal Cancer	DOID:9256	Chemotherapy
NRAS	Q61K	CA:151263	Colorectal Cancer	DOID:9256	Cetuximab
NRAS	Q61K	CA:151263	Colorectal Cancer	DOID:9256	Selumetinib
NRAS	Q61K	CA:151263	Colorectal Cancer	DOID:9256	Dactolisib
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Panitumumab
PIK3CA	Q546K	CA:123338	Colorectal Cancer	DOID:9256	Irinotecan
PIK3CA	Q546K	CA:123338	Colorectal Cancer	DOID:9256	Cetuximab
BRAF	D594G	CA:123657	Colorectal Cancer	DOID:9256	Irinotecan
NRAS	G13R	CA:151261	Colorectal Cancer	DOID:9256	Cetuximab
NRAS	G13R	CA:151261	Colorectal Cancer	DOID:9256	Irinotecan
KRAS	A146T	CA:245262	Colorectal Cancer	DOID:9256	Dactolisib
KRAS	A146T	CA:245262	Colorectal Cancer	DOID:9256	Selumetinib
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	A146V	CA:16602440	Colorectal Cancer	DOID:9256	Dactolisib
KRAS	A146V	CA:16602440	Colorectal Cancer	DOID:9256	Selumetinib
NRAS	Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Selumetinib
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Dactolisib
PIK3CA	E545Q	CA:16602379	Colorectal Cancer	DOID:9256	Irinotecan
PIK3CA	E545Q	CA:16602379	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Selumetinib
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Dactolisib
ATM	T2666A	CA:349494	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	Mutation		Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	R3008C	CA:294307	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	c.902-1G>T		Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
KRAS	A146P	CA:16602441	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	A146P	CA:16602441	Colorectal Cancer	DOID:9256	Irinotecan
KRAS	G12V	CA:122540	Colorectal Cancer	DOID:9256	Panitumumab
KRAS	G12D	CA:122538	Lung Cancer	DOID:1324	Gefitinib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
KRAS	G12D	CA:122538	Multiple Myeloma	DOID:9538	Melphalan
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Panitumumab
KRAS	G12C	CA:122528	Lung Cancer	DOID:1324	Gefitinib
KRAS	G12C	CA:122528	Multiple Myeloma	DOID:9538	Melphalan
KRAS	G12R	CA:122531	Colorectal Cancer	DOID:9256	Panitumumab
KRAS	G12V	CA:122540	Lung Cancer	DOID:1324	Gefitinib
KRAS	G12S	CA:135565	Colorectal Cancer	DOID:9256	Panitumumab
KRAS	G12S	CA:135565	Lung Cancer	DOID:1324	Gefitinib
KRAS	G12S	CA:135565	Multiple Myeloma	DOID:9538	Melphalan
TP53	R273L	CA:001530	Ovarian Cancer	DOID:2394	Carboplatin
TP53	R273L	CA:001530	Ovarian Cancer	DOID:2394	Cisplatin
TP53	R273C	CA:000432	Stomach Carcinoma	DOID:5517	Etoposide
TP53	R273C	CA:000432	Stomach Carcinoma	DOID:5517	Mitomycin
TP53	R273C	CA:000432	Stomach Carcinoma	DOID:5517	Cisplatin
TP53	Y220C	CA:000315	Stomach Carcinoma	DOID:5517	Cisplatin
TP53	Y220C	CA:000315	Stomach Carcinoma	DOID:5517	Mitomycin
TP53	Y220C	CA:000315	Stomach Carcinoma	DOID:5517	Etoposide
TP53	R175H	CA:000251	Stomach Carcinoma	DOID:5517	EAP Protocol
IDH1	R132C	CA:16602374	Brain Glioma	DOID:60108	Temozolomide
IDH1	R132C	CA:16602374	High Grade Glioma	DOID:3070	AGI-5198
IDH1	R132C	CA:16602374	Acute Myeloid Leukemia	DOID:9119	Ivosidenib
IDH1	R132C	CA:16602374	Acute Myeloid Leukemia	DOID:9119	BPTES
PIK3CA	C420R	CA:180900	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
PIK3CA	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
PIK3CA	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
KIT	T417_D419delinsY		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	F506_F508DUP		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	N822H	CA:356911968	Cancer	DOID:162	Imatinib
KIT	N822K	CA:16602411	Cancer	DOID:162	Imatinib
KIT	D816V	CA:123513	Cancer	DOID:162	Imatinib
PDGFRA	V561D	CA:123203	Cancer	DOID:162	Imatinib
PDGFRA	D842_H845DELDIMH		Cancer	DOID:162	Imatinib
PDGFRA	D842V	CA:123194	Cancer	DOID:162	Imatinib
KIT	K484_G487DEL		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	V560G	CA:16602398	Cancer	DOID:162	Imatinib
KIT	K642E	CA:123547	Cancer	DOID:162	Imatinib
PDGFRA	V561D	CA:123203	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	Exon 13 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	EXPRESSION		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	W557_K558del	CA:356974	Cancer	DOID:162	Imatinib
KIT	Y503_F504insAY	CA:645516719	Cancer	DOID:162	Imatinib
PDGFRA	Exon 18 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
PDGFRA	Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
BRAF	V600K	CA:16602420	Melanoma	DOID:1909	Dabrafenib
BRAF	V600K	CA:16602420	Melanoma	DOID:1909	Trametinib
EGFR	G719A	CA:135775	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	Wildtype		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	E746_A750del	CA:175996	Bronchiolo-alveolar Adenocarcinoma	DOID:4926	Erlotinib
EGFR	Exon 19 Deletion		Lung Adenocarcinoma	DOID:3910	Gefitinib
EGFR	L858R	CA:126713	Lung Adenocarcinoma	DOID:3910	Gefitinib
EGFR	E746_A750del	CA:175996	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Lapatinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Neratinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Canertinib
ABL1	M244V	CA:16602545	Chronic Myeloid Leukemia	DOID:8552	Imatinib
BCR::ABL1	Fusion		Cancer	DOID:162	Imatinib
ABL1	M244V	CA:16602545	Cancer	DOID:162	Imatinib
BCR::ABL1	Fusion		Cancer	DOID:162	Dasatinib
BCR::ABL1	Fusion		Cancer	DOID:162	Nilotinib
ABL1	M244V	CA:16602545	Cancer	DOID:162	Dasatinib
ABL1	M244V	CA:16602545	Cancer	DOID:162	Nilotinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	G250E	CA:16602547	Cancer	DOID:162	Nilotinib
ABL1	Q252H	CA:16602548	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	Q252H	CA:16602548	Cancer	DOID:162	Dasatinib
ABL1	Q252H	CA:16602548	Cancer	DOID:162	Nilotinib
ABL1	Y253H	CA:122584	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	Y253H	CA:122584	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	Y253F		Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Imatinib
BCR::ABL1	Fusion		Cancer	DOID:162	Bafetinib
ABL1	Y253F		Cancer	DOID:162	Nilotinib
ABL1	Y253F		Cancer	DOID:162	Dasatinib
ABL1	Y253F		Cancer	DOID:162	Bafetinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	E355G	CA:16602556	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	T315I	CA:122575	Cancer	DOID:162	Bafetinib
ABL1	T315I	CA:122575	Cancer	DOID:162	Nilotinib
ABL1	T315I	CA:122575	Cancer	DOID:162	Dasatinib
ABL1	T315I	CA:122575	Cancer	DOID:162	Imatinib
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	F317L	CA:16602555	Cancer	DOID:162	Nilotinib
ABL1	F317L	CA:16602555	Cancer	DOID:162	Bafetinib
ABL1	S417Y	CA:375250115	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABCB1	Overexpression		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABCB1	Overexpression		Chronic Myeloid Leukemia	DOID:8552	Bafetinib
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	M351T	CA:122590	Cancer	DOID:162	Nilotinib
ABL1	M351T	CA:122590	Cancer	DOID:162	Bafetinib
ABL1	M351T	CA:122590	Cancer	DOID:162	Dasatinib
ABL1	H396R	CA:16602558	Chronic Myeloid Leukemia	DOID:8552	Imatinib
TP53	Overexpression		Ovarian Cancer	DOID:2394	
TP53	Y234C	CA:000337	Ovarian Cancer	DOID:2394	Carboplatin
TP53	Y234C	CA:000337	Ovarian Cancer	DOID:2394	Cisplatin
TP53	ALTERATION		Ovarian Cancer	DOID:2394	Cisplatin
TP53	ALTERATION		Ovarian Cancer	DOID:2394	Carboplatin
TP53	DNA Binding Domain Mutation		Breast Cancer	DOID:1612	Tamoxifen
TP53	Mutation		Breast Cancer	DOID:1612	Tamoxifen
TP53	Overexpression		Stomach Cancer	DOID:10534	Cisplatin
TP53	Overexpression		Stomach Cancer	DOID:10534	Etoposide
TP53	Overexpression		Stomach Cancer	DOID:10534	Mitomycin
TP53	R282L	CA:000456	Stomach Carcinoma	DOID:5517	EAP Protocol
TP53	R213P	CA:10580932	Stomach Carcinoma	DOID:5517	EAP Protocol
TP53	Mutation		Stomach Carcinoma	DOID:5517	Doxorubicin
TP53	Mutation		Stomach Carcinoma	DOID:5517	Etoposide
TP53	Mutation		Stomach Carcinoma	DOID:5517	Cisplatin
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ATM	c.7089+1del		Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	c.7515+1_2del		Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	K293*	CA:16041383	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	F1025L	CA:382547708	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	D1930V	CA:382548326	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	E2187*	CA:382554382	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	L2427P	CA:382559785	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	F2732V	CA:16619250	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	K468FS	CA:163840	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	D1682H	CA:115932	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	A2062V	CA:382550752	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ATM	C2488Y	CA:196568	Chronic Lymphocytic Leukemia	DOID:1040	Doxorubicin
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	E292V	CA:375249260	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	F359C	CA:16602582	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	F359C	CA:16602582	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	L384M	CA:375249885	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	L384M	CA:375249885	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	L387F	CA:375249910	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	G398R	CA:375249980	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
PIK3CA	I391M	CA:161490	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
BRCA2	Mutation		Ovarian Cancer	DOID:2394	Rucaparib
BRCA1	Q1467*	CA:002821	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	M1R	CA:017013	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	M1I	CA:019369	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	V159M	CA:020781	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	V211L	CA:16619647	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	V211I	CA:023848	Ovarian Cancer	DOID:2394	Rucaparib
BRCA2	R2336P	CA:024716	Ovarian Cancer	DOID:2394	Rucaparib
KIT	D820Y	CA:16602408	Melanoma	DOID:1909	Imatinib
KIT	D820Y	CA:16602408	Melanoma	DOID:1909	Sunitinib
KIT	K642E	CA:123547	Mucosal Melanoma	DOID:50929	Imatinib
GNAS	c.393T>C	CA:409455494	Bladder Urothelial Carcinoma	DOID:4006	
GNAS	c.393T>C	CA:409455494	Colorectal Cancer	DOID:9256	
GNAS	c.393T>C	CA:409455494	Esophageal Cancer	DOID:5041	Cisplatin
GNAS	c.393T>C	CA:409455494	Esophageal Cancer	DOID:5041	Fluorouracil
GNAS	c.393T>C	CA:409455494	Clear Cell Renal Cell Carcinoma	DOID:4467	
GNAS	c.393T>C	CA:409455494	Chronic Lymphocytic Leukemia	DOID:1040	
GNAS	c.393T>C	CA:409455494	Melanoma	DOID:1909	
MGMT	Underexpression		Glioblastoma	DOID:3068	Temozolomide
MGMT	Underexpression		High Grade Glioma	DOID:3070	Temozolomide
MGMT	Underexpression		Oligodendroglioma	DOID:3181	Temozolomide
MGMT	Underexpression		Neuroendocrine Tumor	DOID:169	Temozolomide
RRM1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Gemcitabine
RRM1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Cisplatin
EGFR	S768I	CA:135840	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
NRAS	Q61K	CA:151263	Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
NRAS	Q61K	CA:151263	Lung Non-small Cell Carcinoma	DOID:3908	Selumetinib
RET	C609Y	CA:007824	Medullary Thyroid Carcinoma	DOID:3973	
FGFR1	Expression		Sarcoma	DOID:1115	Infigratinib
FGFR1	Expression		Sarcoma	DOID:1115	FGF/VEGF Receptor Tyrosine Kinase Inhibitor
FGFR1	Expression		Sarcoma	DOID:1115	PD173074
FGFR1	Expression		Sarcoma	DOID:1115	Fexagratinib
KIT	N822K	CA:16602411	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	Y823D	CA:16602561	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	C809G	CA:356911727	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	D820A	CA:356911952	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	D820G	CA:123516	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	D816H	CA:123540	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	T670I	CA:16602525	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
DNMT3A	Mutation		Cancer	DOID:162	Pembrolizumab
DNMT3A	Mutation		Cancer	DOID:162	Atezolizumab
DNMT3A	Mutation		Cancer	DOID:162	Nivolumab
BRAF	Amplification		Colorectal Cancer	DOID:9256	Dabrafenib
BRAF	Amplification		Colorectal Cancer	DOID:9256	Panitumumab
NRAS	Mutation		Skin Melanoma	DOID:8923	Ribociclib
IDH1	Mutation		Brain Glioma	DOID:60108	Olaparib
MAP2K1	K57N	CA:356995	Lung Adenocarcinoma	DOID:3910	
MAP2K1	K57N	CA:356995	Lung Adenocarcinoma	DOID:3910	Selumetinib
EGFR	Mutation		Lung Cancer	DOID:1324	Gefitinib
CTAG1B	Overexpression		Multiple Myeloma	DOID:9538	Letetresgene Autoleucel
CTAG2	Overexpression		Multiple Myeloma	DOID:9538	Letetresgene Autoleucel
KRAS	A146T	CA:245262	Colorectal Cancer	DOID:9256	Cetuximab
v::NTRK1	Fusion		Solid Tumor		Entrectinib
v::NTRK3	Fusion		Cancer	DOID:162	Entrectinib
v::ROS1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Entrectinib
v::ALK	Fusion		Cancer	DOID:162	Entrectinib
v::NTRK1	Fusion		Cancer	DOID:162	Larotrectinib
LMNA::NTRK1	Fusion		Sarcoma	DOID:1115	Larotrectinib
NTRK1	Amplification		Cancer	DOID:162	Entrectinib
NTRK3	Amplification		Cancer	DOID:162	Entrectinib
LMNA::NTRK1	Fusion		Colorectal Adenocarcinoma	DOID:50861	Entrectinib
NTRK1	G595R		Colorectal Adenocarcinoma	DOID:50861	Entrectinib
NTRK1	G667C		Colorectal Adenocarcinoma	DOID:50861	Entrectinib
TP53	Wildtype		Cancer	DOID:162	Rebemadlin
TP53	Wildtype		Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	Wildtype		Leukemia	DOID:1240	RG7112
TP53	Deleterious Mutation		Leukemia	DOID:1240	RG7112
TP53	Deleterious Mutation		Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	Deleterious Mutation		Cancer	DOID:162	Rebemadlin
DCC	EXPRESSION		Colorectal Cancer	DOID:9256	
CTNNB1	T41A	CA:127269	Desmoid Tumor	DOID:80366	
CTNNB1	S45F	CA:127283	Desmoid Tumor	DOID:80366	
CTNNB1	S45P	CA:127285	Desmoid Tumor	DOID:80366	
ARID1A	Loss		Ovarian Clear Cell Carcinoma	DOID:50934	Dasatinib
ARID1A	Loss		Ovarian Clear Cell Carcinoma	DOID:50934	GSK126
PIK3CA	E545K	CA:123334	Cervix Carcinoma	DOID:2893	Cisplatin
PIK3CA	E545K	CA:123334	Cervix Carcinoma	DOID:2893	Pictilisib
PIK3CA	E545K	CA:123334	Cervical Cancer	DOID:4362	Cisplatin
VHL	W8* (c.24G>A)	CA:351747069	Renal Cell Carcinoma	DOID:4450	
ALK	F1245V	CA:345003	Neuroblastoma	DOID:769	Entrectinib
CTNNB1	Activating Mutation		Melanoma	DOID:1909	Anti-CTLA-4 Monoclonal Antibody
CTNNB1	Activating Mutation		Melanoma	DOID:1909	Anti-PD-L1 Monoclonal Antibody
MERTK	OVEREXPRESSION		Melanoma	DOID:1909	UNC1062
TP53	CONSERVED DOMAIN MUT		Ovarian Cancer	DOID:2394	
TP53	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	
CD274	Expression		Head And Neck Squamous Cell Carcinoma	DOID:5520	Radiation Therapy
MYC	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Olaparib
MYC	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Cisplatin
MYC	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Prexasertib
ERBB2	L755S	CA:16602502	Cancer	DOID:162	Lapatinib
ERBB2	L755P	CA:123587	Cancer	DOID:162	Lapatinib
ERBB2	T798M	CA:913012048	Cancer	DOID:162	Lapatinib
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Tandutinib
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Sunitinib
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Cytarabine
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Daunorubicin
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Quizartinib
TP53	Overexpression		Ovarian Cancer	DOID:2394	Carboplatin
TP53	Overexpression		Ovarian Cancer	DOID:2394	Cisplatin
TP53	ALTERATION		Ovarian Cancer	DOID:2394	
EGFR	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Rociletinib
BRAF	V600E	CA:123643	Lung Non-small Cell Carcinoma	DOID:3908	Dabrafenib
BRAF	V600E	CA:123643	Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
FGFR1	Amplification		Lung Non-small Cell Carcinoma	DOID:3908	Dovitinib
KIT	V559D	CA:123522	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	V559D	CA:123522	Cancer	DOID:162	Imatinib
KIT	V559D	CA:123522	Cancer	DOID:162	Sunitinib
KIT	V559D	CA:123522	Cancer	DOID:162	Tandutinib
KIT	V559D	CA:123522	Cancer	DOID:162	Dasatinib
KIT	V559D	CA:123522	Cancer	DOID:162	PD-180970
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Tyrphostin AG 1296
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	AS602868
MET	Overexpression		Uveal Melanoma	DOID:6039	Trametinib
MET	Overexpression		Uveal Melanoma	DOID:6039	Selumetinib
AKT1	E17K	CA:123660	Cancer	DOID:162	Capivasertib
TP53	R248Q	CA:000387	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
GNAS	R201H		Follicular Thyroid Carcinoma	DOID:3962	Radioactive Iodine
BRAF	Non-V600		Colorectal Cancer	DOID:9256	
PIK3CA	H1047R	CA:123326	Breast Tubular Carcinoma	DOID:6587	
PIK3CA	H1047L	CA:123328	Breast Tubular Carcinoma	DOID:6587	
GNA11	Mutation		Uveal Melanoma	DOID:6039	Cabozantinib
NRAS	Q61H	CA:16602358	Colorectal Cancer	DOID:9256	Cetuximab
NRAS	Q61H	CA:16602358	Colorectal Cancer	DOID:9256	Irinotecan
KRAS	G12A	CA:135567	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Teprotumumab
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	
PIK3CA	E545K	CA:123334	Melanoma	DOID:1909	Vemurafenib
PIK3CA	E545G	CA:123336	Melanoma	DOID:1909	Vemurafenib
PIK3CA	Exon 21 Mutation		Colorectal Cancer	DOID:9256	
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Chemotherapy
PIK3CA	H1047R	CA:123326	Colorectal Cancer	DOID:9256	Vemurafenib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	FOLFOX-4 Regimen
BRAF	V600E	CA:123643	Skin Melanoma	DOID:8923	Trametinib
BRAF	V600E	CA:123643	Skin Melanoma	DOID:8923	Dabrafenib
BRAF	V600E	CA:123643	Childhood Pilocytic Astrocytoma	DOID:6812	Vemurafenib
BRAF	V600E	CA:123643	Ovarian Serous Carcinoma	DOID:50933	Vemurafenib
EGFR	L858R	CA:126713	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	Exon 19 Deletion		Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	L861Q	CA:176021	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	T790M	CA:090928	Cancer	DOID:162	Erlotinib
EGFR	T790M	CA:090928	Cancer	DOID:162	Gefitinib
EGFR	T790M	CA:090928	Cancer	DOID:162	Multikinase Inhibitor AEE788
EGFR	L858R	CA:126713	Cancer	DOID:162	Gefitinib
EGFR	L858R	CA:126713	Cancer	DOID:162	Erlotinib
EGFR	L858R	CA:126713	Cancer	DOID:162	Multikinase Inhibitor AEE788
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Axitinib
PIK3CA	R88Q	CA:16602516	Colorectal Cancer	DOID:9256	Irinotecan
PIK3CA	R88Q	CA:16602516	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	H1047R	CA:123326	Colorectal Cancer	DOID:9256	Irinotecan
NRAS	G13R	CA:151261	Colorectal Cancer	DOID:9256	Panitumumab
NRAS	G12C	CA:297020	Colorectal Cancer	DOID:9256	Cetuximab
NRAS	G12C	CA:297020	Colorectal Cancer	DOID:9256	Chemotherapy
PIK3CA	G1049R	CA:16602520	Colorectal Cancer	DOID:9256	Cetuximab
HRAS	G13D	CA:256488	Skin Squamous Cell Carcinoma	DOID:3151	Vemurafenib
HRAS	G13D	CA:256488	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	A146T	CA:245262	Colorectal Cancer	DOID:9256	FOLFOX-4 Regimen
KRAS	Q61H	CA:180922	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	Q61H	CA:180922	Colorectal Cancer	DOID:9256	Chemotherapy
EGFR	Mutation		Lung Cancer	DOID:1324	Erlotinib
KRAS	Q61L	CA:210876	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	Q61L	CA:210876	Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	Q61R	CA:261702	Colorectal Cancer	DOID:9256	Irinotecan
KRAS	Q61R	CA:261702	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	Q61K	CA:180750	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	Q61K	CA:180750	Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G13D	CA:122534	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	Q61		Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	Q61		Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12V	CA:122540	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	A146		Colorectal Cancer	DOID:9256	Cetuximab
KRAS	A146		Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G12D	CA:122538	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	G12D	CA:122538	Melanoma	DOID:1909	Vemurafenib
KRAS	G12D	CA:122538	Ovarian Cancer	DOID:2394	Cetuximab
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	G12R	CA:122531	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12R	CA:122531	Colorectal Cancer	DOID:9256	Chemotherapy
KRAS	G12R	CA:122531	Colorectal Cancer	DOID:9256	Regorafenib
KRAS	G12S	CA:135565	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12S	CA:135565	Colorectal Cancer	DOID:9256	Regorafenib
AKT1	E17K	CA:123660	Melanoma	DOID:1909	Vemurafenib
PIK3CA	N345K	CA:16602517	Colorectal Cancer	DOID:9256	Cetuximab
AKT1	S473 Phosphorylation		Colorectal Cancer	DOID:9256	
KRAS	Exon 2 Mutation		Rectum Cancer	DOID:1993	
PDGFRA	V561D	CA:123203	Cancer	DOID:162	Sunitinib
PDGFRA	D842V	CA:123194	Cancer	DOID:162	Sunitinib
KIT	V560_L576DEL		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K550_K558del	CA:123524	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	V560D	CA:16602396	Cancer	DOID:162	Sunitinib
KIT	W557_K558del	CA:356974	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	W557_K558del	CA:356974	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	W557_K558del	CA:356974	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	W557_K558del	CA:356974	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K558_V559del	CA:645516838	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	A502_Y503insAY	unregistered	Cancer	DOID:162	Sunitinib
KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
BRAF	Exon 15 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	V560D	CA:16602396	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	V560D	CA:16602396	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	V560D	CA:16602396	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	V560D	CA:16602396	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	L576P	CA:16602401	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	L576P	CA:16602401	Cancer	DOID:162	Imatinib
KIT	L576P	CA:16602401	Cancer	DOID:162	Dasatinib
KIT	D579del	CA:16611553	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	Wildtype		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K642E	CA:123547	Melanoma	DOID:1909	Dasatinib
KIT	N822K	CA:16602411	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	N822K	CA:16602411	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
BRAF	V600K	CA:16602420	Skin Melanoma	DOID:8923	Trametinib
BRAF	V600K	CA:16602420	Skin Melanoma	DOID:8923	Dabrafenib
EGFR	R108K	CA:16602662	High Grade Glioma	DOID:3070	Erlotinib
EGFR	T263P	CA:16602663	High Grade Glioma	DOID:3070	Erlotinib
EGFR	A289V	CA:16602664	High Grade Glioma	DOID:3070	Erlotinib
EGFR	G719		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	G719		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	V742A	CA:16602541	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	E746_T751>I		Lung Adenocarcinoma	DOID:3910	Gefitinib
EGFR	G719D	CA:16602537	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	G719D	CA:16602537	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L747P	CA:135800	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L747P	CA:135800	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	V774A	CA:367578723	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	V774M	CA:158928427	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	K806E	CA:4266068	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	N826Y	CA:367580076	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	V834I		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L838P	CA:367580150	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	N842S	CA:367580172	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	T847I	CA:367580204	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	V851I	CA:367580229	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L747_P753delinsS	CA:126710	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	S768I	CA:135840	Cancer	DOID:162	Gefitinib
EGFR	S768I	CA:135840	Cancer	DOID:162	Erlotinib
EGFR	D770_N771insSVD	CA:135844	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	H773_V774insH	CA:135866	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	R831H	CA:4266102	Cancer	DOID:162	Erlotinib
EGFR	L838V	CA:350916	Cancer	DOID:162	Gefitinib
EGFR	L838V	CA:350916	Cancer	DOID:162	Erlotinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
EGFR	L858R	CA:126713	Lung Adenocarcinoma	DOID:3910	Cetuximab
EGFR	L858R	CA:126713	Lung Small Cell Carcinoma	DOID:5409	Erlotinib
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	L858R	CA:126713	High Grade Glioma	DOID:3070	Erlotinib
EGFR	L861		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	L861		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	L861Q	CA:176021	High Grade Glioma	DOID:3070	Erlotinib
EGFR	E868G	CA:367580333	Cancer	DOID:162	Erlotinib
ABL1	M244V	CA:16602545	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	M244V	CA:16602545	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	L248V	CA:16602546	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	Q252H	CA:16602548	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	Q252H	CA:16602548	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	Y253H	CA:122584	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	Y253H	CA:122584	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	Y253H	CA:122584	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	Y253F		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	Y253F		Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Axitinib
BCR::ABL1	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Dasatinib
ABL1	T315I	CA:122575	Acute Lymphoblastic Leukemia	DOID:9952	Dasatinib
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	E355G	CA:16602556	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E355G	CA:16602556	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	L387M	CA:375249905	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	H396R	CA:16602558	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	H396R	CA:16602558	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	H396R	CA:16602558	Chronic Myeloid Leukemia	DOID:8552	Axitinib
PIK3CA	E542K	CA:333572	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12A	CA:135567	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	H1047L	CA:123328	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	H1047L	CA:123328	Colorectal Cancer	DOID:9256	Irinotecan
ABL1	L364I	CA:375249753	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E255V	CA:16602552	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	V559D	CA:123522	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	V559D	CA:123522	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
PIK3CA	S158L	CA:355274155	Colorectal Cancer	DOID:9256	Irinotecan
PIK3CA	S158L	CA:355274155	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	E81K	CA:16602912	Colorectal Cancer	DOID:9256	Fluorouracil
PIK3CA	E81K	CA:16602912	Colorectal Cancer	DOID:9256	Oxaliplatin
PIK3CA	E81K	CA:16602912	Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	R93W	CA:355272477	Colorectal Cancer	DOID:9256	Oxaliplatin
PIK3CA	R93W	CA:355272477	Colorectal Cancer	DOID:9256	Fluorouracil
PIK3CA	R93W	CA:355272477	Colorectal Cancer	DOID:9256	Cetuximab
EGFR	R776C	CA:367578749	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
ABL1	L298V	CA:375249299	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F311I	CA:375249388	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F311I	CA:375249388	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F359C	CA:16602582	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F359C	CA:16602582	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E453Q	CA:375251170	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ARID1A	Q456*	CA:339267901	Colorectal Cancer	DOID:9256	Dasatinib
BRAF	V600D	CA:16602419	Melanoma	DOID:1909	Vemurafenib
EGFR	H773_V774insNPH	CA:180983	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	D770_N771insGL	CA:645561585	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	A864T	CA:367580302	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	N826S	CA:367580077	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	A763_Y764insFQEA	CA:135833	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	VIII		High Grade Glioma	DOID:3070	Erlotinib
KIT	T670I	CA:16602525	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
ERBB2	L755S	CA:16602502	Cecum Adenocarcinoma	DOID:3039	Cetuximab
AKT3	E17K	CA:130584	Melanoma	DOID:1909	Vemurafenib
ABL1	L384M	CA:375249885	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	L384M	CA:375249885	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	F359I	CA:16602580	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F359I	CA:16602580	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F359I	CA:16602580	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	M343T	CA:375249596	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F317V	CA:16602578	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E279K	CA:375249162	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	Q300R	CA:375249312	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F311L	CA:122587	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	N331S	CA:5285356	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	L364P	CA:375249757	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	L387F	CA:375249910	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	H396P	CA:375249969	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	D421G	CA:375250143	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	G398R	CA:375249980	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E450V	CA:375251155	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E453K	CA:375251169	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	E453A	CA:375251172	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	P480A	CA:375251559	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
KIT	K550_W557del	CA:645516733	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	K550_W557del	CA:645516733	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K550_W557del	CA:645516733	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	K550_W557del	CA:645516733	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	D820Y	CA:16602408	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K558delinsNP	CA:645516857	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	K558delinsNP	CA:645516857	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	K558delinsNP	CA:645516857	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	K558delinsNP	CA:645516857	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
PDGFRA	D842V	CA:123194	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
BRCA1	W1815X	CA:003600	Endometrioid Ovary Carcinoma	DOID:5828	Olaparib
KIT	A502_Y503insAY	unregistered	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	A502_Y503insAY	unregistered	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	A502_Y503insAY	unregistered	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	D816E	CA:356911882	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	D816E	CA:356911882	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
EGFR	D770_N771insGT	CA:645561586	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	Exon 20 Insertion		Lung Adenocarcinoma	DOID:3910	Erlotinib
SMO	L412F	CA:10584652	Basal Cell Carcinoma	DOID:2513	Vismodegib
EGFR	W731L	CA:367583965	Cancer	DOID:162	Erlotinib
EGFR	E734Q	CA:367583997	Cancer	DOID:162	Erlotinib
EGFR	T785A	CA:367578819	Cancer	DOID:162	Erlotinib
EGFR	C797Y	CA:367578897	Cancer	DOID:162	Erlotinib
EGFR	Y801H	CA:4266065	Cancer	DOID:162	Erlotinib
EGFR	A767_V769dupASV	CA:180588	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	L747_S752delinsQ	CA:645561524	Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	L861R	CA:135940	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
ABL1	D363G		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	V379I	CA:375249852	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	A397P	CA:375249974	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E98G		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	E255K	CA:16602551	Acute Lymphoblastic Leukemia	DOID:9952	Dasatinib
BRAF	G596R	CA:16602422	Colorectal Cancer	DOID:9256	Vemurafenib
EGFR	Rare Exon 18-21 Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Rare Exon 18-21 Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
ABL1	C475V		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	N336S	CA:375249553	Chronic Myeloid Leukemia	DOID:8552	Bosutinib
POLD1	C284Y		Lung Adenocarcinoma	DOID:3910	Pembrolizumab
POLD1	E374K		Lung Non-small Cell Carcinoma	DOID:3908	Pembrolizumab
PIK3R2	N561D		Melanoma	DOID:1909	Vemurafenib
PIK3CA	D350G	CA:355281594	Melanoma	DOID:1909	Vemurafenib
NRAS	Q179X		Colorectal Cancer	DOID:9256	Cetuximab
ABL1	R351W	CA:5285359	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
ABL1	G340L	unregistered	Lung Non-small Cell Carcinoma	DOID:3908	Dasatinib
ABL1	G340L	unregistered	Lung Non-small Cell Carcinoma	DOID:3908	Imatinib Mesylate
KIT	S628N	CA:356908374	Cancer	DOID:162	Dasatinib
KIT	S628N	CA:356908374	Cancer	DOID:162	Imatinib
EGFR	M766_A767insAI	CA:645561560	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Y764_V765insHH	CA:2573051277	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	D770delinsGY		Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR	P772_H773insYNP	CA:2573051294	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	P772_V774insPHV		Lung Adenocarcinoma	DOID:3910	Erlotinib
ESR1	D538G	CA:366085705	Breast Cancer	DOID:1612	Palbociclib
ESR1	D538G	CA:366085705	Breast Cancer	DOID:1612	Letrozole
JAK2	Splice Site (c.1641+2T>G)	CA:372825751	Melanoma	DOID:1909	Pembrolizumab
ARID1A	P1175FS*5		Ovarian Clear Cell Carcinoma	DOID:50934	Dasatinib
VHL	Mutation		Renal Cell Carcinoma	DOID:4450	Anti-VEGF Monoclonal Antibody
IDH2	Mutation		Acute Myeloid Leukemia	DOID:9119	Enasidenib
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Brigatinib
BRCA1	Loss-of-function		Breast Cancer	DOID:1612	Talazoparib
BRCA2	Loss-of-function		Breast Cancer	DOID:1612	Talazoparib
ERBB2	Overexpression		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Abemaciclib
CD274	Expression		Breast Cancer	DOID:1612	
ACVR1	Gain-of-Function		Malignant Astrocytoma	DOID:3069	
ACVR1	G328V	CA:16602802	Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
v::RET	Fusion		Lung Adenocarcinoma	DOID:3910	Cabozantinib
v::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Vandetanib
v::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
CD274	Expression		Cancer	DOID:162	
CD274	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Durvalumab
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Dacomitinib
FGFR2::CCDC6	Fusion		Adrenal Carcinoma	DOID:3950	Erdafitinib
FGFR3::TACC3	Fusion		Adrenal Carcinoma	DOID:3950	Erdafitinib
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Nivolumab
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Atezolizumab
KRAS	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Immune Checkpoint Inhibitor
KRAS	Mutation		Colorectal Cancer	DOID:9256	Palbociclib
KRAS	Mutation		Colorectal Cancer	DOID:9256	Binimetinib
CDK4	EXPRESSION		Sarcoma	DOID:1115	Palbociclib
CHEK1	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Cisplatin
CHEK1	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Olaparib
CHEK1	Overexpression		Lung Small Cell Carcinoma	DOID:5409	Prexasertib
BRCA2	Loss-of-function		Ovarian Cancer	DOID:2394	Talazoparib
BRCA1	Loss-of-function		Ovarian Cancer	DOID:2394	Talazoparib
EGFR	Expression		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
TP53	R248W	CA:000382	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R175H	CA:000251	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R273C	CA:000432	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R273H	CA:000434	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	G245S	CA:000367	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	Y220C	CA:000315	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	M237I	CA:287488024	Glioblastoma	DOID:3068	MDM2 Inhibitor AMGMDS3
TP53	R158H	CA:000227	Vulva Squamous Cell Carcinoma	DOID:2101	MDM2 Inhibitor AMGMDS3
TP53	V157F	CA:000222	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R249S		Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R280K		Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R280T		Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
TP53	R158L	CA:397842028	Cancer	DOID:162	MDM2 Inhibitor AMGMDS3
VHL	E46* (c.136G>T)	CA:351748085	Von Hippel-Lindau Disease	DOID:14175	
VHL	E52K (c.154G>A)	CA:020056	Von Hippel-Lindau Disease	DOID:14175	
VHL	E55* (c.163G>T)	CA:351748495	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y98H (c.292T>C)	CA:020246	Von Hippel-Lindau Disease	DOID:14175	
VHL	H115Q (c.345C>A)	CA:351753631	Von Hippel-Lindau Disease	DOID:14175	
VHL	F119L (c.357C>G)	CA:351753726	Von Hippel-Lindau Disease	DOID:14175	
VHL	A149T (c.445G>A)	CA:357066	Von Hippel-Lindau Disease	DOID:14175	
VHL	T157I (c.470C>T)	CA:357133	Von Hippel-Lindau Disease	DOID:14175	
VHL	R161Q (c.482G>A)	CA:020413	Von Hippel-Lindau Disease	DOID:14175	
VHL	R167W (c.499C>T)	CA:020450	Von Hippel-Lindau Disease	DOID:14175	
VHL	R167Q (c.500G>A)	CA:020454	Von Hippel-Lindau Disease	DOID:14175	
VHL	L178P (c.533T>C)	CA:351756245	Von Hippel-Lindau Disease	DOID:14175	
VHL	V62Cfs*5 (c.180del)		Von Hippel-Lindau Disease	DOID:14175	
VHL	S65W (c.194C>G)	CA:020099	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q73* (c.217C>T)	CA:357036	Von Hippel-Lindau Disease	DOID:14175	
VHL	F76del (c.227_229del)	CA:357012	Von Hippel-Lindau Disease	DOID:14175	
VHL	N78H (c.232A>C)	CA:351749283	Von Hippel-Lindau Disease	DOID:14175	
VHL	N78S (c.233A>G)	CA:020131	Von Hippel-Lindau Disease	DOID:14175	
VHL	N78T (c.233A>C)	CA:357095	Von Hippel-Lindau Disease	DOID:14175	
VHL	S80I (c.239G>T)	CA:16621914	Von Hippel-Lindau Disease	DOID:14175	
VHL	P86fs (c.254_255insC)	CA:2497028737	Von Hippel-Lindau Disease	DOID:14175	
VHL	P86A (c.256C>G)	CA:020174	Von Hippel-Lindau Disease	DOID:14175	
VHL	P86L (c.257C>T)	CA:020186	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88R (c.262T>A)	CA:351750671	Von Hippel-Lindau Disease	DOID:14175	
VHL	S111FS (c.331delA)	CA:432420649	Von Hippel-Lindau Disease	DOID:14175	
VHL	S111N (c.332G>A)	CA:357091	Von Hippel-Lindau Disease	DOID:14175	
VHL	S111R (c.333C>G)	CA:040305	Von Hippel-Lindau Disease	DOID:14175	
EGFR	Gain-of-function		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
VHL	Y112* (c.336C>A)	CA:16602183	Von Hippel-Lindau Disease	DOID:14175	
VHL	W117C (c.351G>T)	CA:020294	Von Hippel-Lindau Disease	DOID:14175	
VHL	L129Q (c.386insAGA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	L135* (c.404T>A)	CA:351754021	Von Hippel-Lindau Disease	DOID:14175	
VHL	N150fs (c.449del)		Von Hippel-Lindau Disease	DOID:14175	
VHL	P154fs (c.462delA)	CA:432421926	Von Hippel-Lindau Disease	DOID:14175	
VHL	L158P (c.473T>C)	CA:020399	Von Hippel-Lindau Disease	DOID:14175	
VHL	C162R (c.484T>C)	CA:351756117	Von Hippel-Lindau Disease	DOID:14175	
VHL	C162F (c.485G>T)	CA:020418	Von Hippel-Lindau Disease	DOID:14175	
VHL	C162W (c.486C>G)	CA:357016	Von Hippel-Lindau Disease	DOID:14175	
VHL	V166D (c.497T>A)	CA:351756176	Von Hippel-Lindau Disease	DOID:14175	
VHL	L184P (c.551T>C)	CA:16617792	Von Hippel-Lindau Disease	DOID:14175	
VHL	E186* (c.556G>T)	CA:16604432	Von Hippel-Lindau Disease	DOID:14175	
VHL	E186K (c.556G>A)	CA:020480	Von Hippel-Lindau Disease	DOID:14175	
VHL	R167fs (c.502insTTGTCCGT)		Von Hippel-Lindau Disease	DOID:14175	
VHL	R176fs (c.526del)	CA:16602180	Von Hippel-Lindau Disease	DOID:14175	
ERBB2	L755S	CA:16602502	Colorectal Adenocarcinoma	DOID:50861	Fluorouracil
ERBB2	L755S	CA:16602502	Colorectal Adenocarcinoma	DOID:50861	Trastuzumab
ERBB2	L755S	CA:16602502	Colorectal Adenocarcinoma	DOID:50861	Leucovorin
VHL	A56fs (c.166_167insA)	CA:432536366	Von Hippel-Lindau Disease	DOID:14175	
VHL	S65L (c.194C>T)	CA:020104	Von Hippel-Lindau Disease	DOID:14175	
VHL	C77fs (c.228dup)	CA:658795177	Von Hippel-Lindau Disease	DOID:14175	
VHL	R79P (c.236G>C)	CA:351749311	Von Hippel-Lindau Disease	DOID:14175	
VHL	S80R (c.240T>G)	CA:351750515	Von Hippel-Lindau Disease	DOID:14175	
VHL	L89P (c.266T>C)	CA:020207	Von Hippel-Lindau Disease	DOID:14175	
VHL	G114C (c.340G>T)	CA:351751376	Von Hippel-Lindau Disease	DOID:14175	
VHL	L118P (c.353T>C)	CA:70049399	Von Hippel-Lindau Disease	DOID:14175	
VHL	N131fs (c.390_391del)	CA:658795179	Von Hippel-Lindau Disease	DOID:14175	
VHL	F136S (c.407T>C)	CA:040847	Von Hippel-Lindau Disease	DOID:14175	
VHL	L153fs (c.457delC)	CA:432421924	Von Hippel-Lindau Disease	DOID:14175	
VHL	P154L (c.461C>T)	CA:351754410	Von Hippel-Lindau Disease	DOID:14175	
VHL	L158V (c.472C>G)	CA:351756068	Von Hippel-Lindau Disease	DOID:14175	
VHL	V170F (c.508G>T)	CA:351756193	Von Hippel-Lindau Disease	DOID:14175	
VHL	I180V (c.538A>G)	CA:020469	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q195* (c.583C>T)	CA:70052558	Von Hippel-Lindau Disease	DOID:14175	
VHL	V170D (c.509T>A)	CA:351756195	Von Hippel-Lindau Disease	DOID:14175	
POLE	P286R		Colorectal Cancer	DOID:9256	
POLE	V411L		Colorectal Cancer	DOID:9256	
POLE	S459F		Colorectal Cancer	DOID:9256	
VHL	L116V (c.346C>G)	CA:351753642	Von Hippel-Lindau Disease	DOID:14175	
VHL	V166F (c.496G>T)	CA:020436	Von Hippel-Lindau Disease	DOID:14175	
VHL	S65* (c.194C>A)	CA:357085	Von Hippel-Lindau Disease	DOID:14175	
VHL	E70* (c.208G>T)	CA:16602179	Von Hippel-Lindau Disease	DOID:14175	
VHL	F76S (c.227T>C)	CA:020125	Von Hippel-Lindau Disease	DOID:14175	
VHL	L101G (c.301_302delinsGG)	CA:915940707	Von Hippel-Lindau Disease	DOID:14175	
VHL	T105P (c.313A>C)	CA:351751116	Von Hippel-Lindau Disease	DOID:14175	
VHL	R107P (c.320G>C)	CA:020262	Von Hippel-Lindau Disease	DOID:14175	
VHL	R113* (c.337C>T)	CA:348491	Von Hippel-Lindau Disease	DOID:14175	
VHL	L118fs (c.352_353insA)	CA:357125	Von Hippel-Lindau Disease	DOID:14175	
VHL	N131T (c.392A>C)	CA:351753944	Von Hippel-Lindau Disease	DOID:14175	
VHL	T133fs (c.397del)	CA:432421843	Von Hippel-Lindau Disease	DOID:14175	
VHL	D143fs (c.430delG)		Von Hippel-Lindau Disease	DOID:14175	
VHL	R161* (c.481C>T)	CA:020408	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q164* (c.490C>T)	CA:357060	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175D (c.523T>G)	CA:351756228	Von Hippel-Lindau Disease	DOID:14175	
VHL	V181fs (c.540_543del)	CA:357022	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y185* (c.555C>G)	CA:357075	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q96* (c.286C>T)	CA:351750811	Von Hippel-Lindau Disease	DOID:14175	
VHL	P86R (c.257C>G)	CA:357142	Von Hippel-Lindau Disease	DOID:14175	
VHL	G144* (c.430G>T)	CA:357109	Von Hippel-Lindau Disease	DOID:14175	
VHL	L188P (c.563T>C)	CA:351756399	Von Hippel-Lindau Disease	DOID:14175	
VHL	S111C (c.330_331delinsTT)	CA:2573106137	Von Hippel-Lindau Disease	DOID:14175	
GNAQ	Mutation		Uveal Melanoma	DOID:6039	Cabozantinib
VHL	G93D (c.278G>A)	CA:351750781	Von Hippel-Lindau Disease	DOID:14175	
VHL	R64P (c.191G>C)	CA:020089	Von Hippel-Lindau Disease	DOID:14175	
VHL	E189fs (c.565del)	CA:432423686	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.340+1G>A)	CA:357042	Von Hippel-Lindau Disease	DOID:14175	
VHL	G93S (c.277G>A)	CA:020230	Von Hippel-Lindau Disease	DOID:14175	
VHL	I151T (c.452T>C)	CA:351754359	Von Hippel-Lindau Disease	DOID:14175	
VHL	S68P (c.202T>C)	CA:16621912	Von Hippel-Lindau Disease	DOID:14175	
VHL	N78H (c.232A>C)	CA:351749283	Renal Cell Carcinoma	DOID:4450	
VHL	Q132P (c.395A>C)	CA:351753958	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q164R (c.491A>G)	CA:020429	Von Hippel-Lindau Disease	DOID:14175	
VHL	E94* (c.280G>T)	CA:70046202	Von Hippel-Lindau Disease	DOID:14175	
VHL	P103FS (c.309_310delTG)	CA:658795178	Von Hippel-Lindau Disease	DOID:14175	
VHL	H115P (c.344A>C)	CA:351753626	Von Hippel-Lindau Disease	DOID:14175	
VHL	L128R (c.383T>G)	CA:351753891	Von Hippel-Lindau Disease	DOID:14175	
VHL	L169P (c.506T>C)	CA:351756191	Von Hippel-Lindau Disease	DOID:14175	
VHL	L178R (c.533T>G)	CA:351756248	Von Hippel-Lindau Disease	DOID:14175	
VHL	M54fs (c.161dup)	CA:2586965629	Von Hippel-Lindau Disease	DOID:14175	
VHL	F91* (c.272_273delinsAA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	P59fs (c.176delC)	CA:432536374	Von Hippel-Lindau Disease	DOID:14175	
VHL	P86S (c.256C>T)	CA:020180	Von Hippel-Lindau Disease	DOID:14175	
VHL	S65P (c.193T>C)	CA:351748798	Von Hippel-Lindau Disease	DOID:14175	
VHL	S72P (c.214T>C)	CA:357006	Von Hippel-Lindau Disease	DOID:14175	
VHL	S72fs (c.214del)	CA:658795180	Von Hippel-Lindau Disease	DOID:14175	
VHL	L135fs (c.404del)	CA:432421852	Von Hippel-Lindau Disease	DOID:14175	
VHL	R177fs (c.528del)	CA:432423454	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88* (c.264G>A)	CA:351750677	Von Hippel-Lindau Disease	DOID:14175	
VHL	V155E (c.464T>A)	CA:351756032	Von Hippel-Lindau Disease	DOID:14175	
VHL	V170G (c.509T>G)	CA:351756196	Von Hippel-Lindau Disease	DOID:14175	
VHL	F76fs (c.223_224insT)	CA:913189239	Von Hippel-Lindau Disease	DOID:14175	
VHL	K196* (c.586A>T)	CA:020507	Von Hippel-Lindau Disease	DOID:14175	
VHL	R120G (c.358A>G)	CA:357028	Von Hippel-Lindau Disease	DOID:14175	
VHL	R167L (c.500G>T)	CA:351756178	Von Hippel-Lindau Disease	DOID:14175	
VHL	D126FS (c.375_376insC)	CA:16621931	Von Hippel-Lindau Disease	DOID:14175	
VHL	E160fs (c.479_480delAG)	CA:16621940	Von Hippel-Lindau Disease	DOID:14175	
VHL	H115Y (c.343C>T)	CA:16621930	Von Hippel-Lindau Disease	DOID:14175	
VHL	L153P (c.458T>C)	CA:16621942	Von Hippel-Lindau Disease	DOID:14175	
VHL	L184R (c.551T>G)	CA:351756355	Von Hippel-Lindau Disease	DOID:14175	
VHL	L188R (c.563T>G)	CA:351756400	Von Hippel-Lindau Disease	DOID:14175	
VHL	P138T (c.412C>A)	CA:16621932	Von Hippel-Lindau Disease	DOID:14175	
ATM	Underexpression		Stomach Cancer	DOID:10534	Olaparib
ATM	Underexpression		Stomach Cancer	DOID:10534	Paclitaxel
VHL	Y98C (c.293A>G)	CA:357072	Von Hippel-Lindau Disease	DOID:14175	
VHL	R69fs (c.204insG)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Region (c.340+5G>C)	CA:020288	Von Hippel-Lindau Disease	DOID:14175	
VHL	G144fs (c.432insG)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Q145* (c.433C>T)	CA:351754219	Von Hippel-Lindau Disease	DOID:14175	
FLT3	Mutation		Acute Myeloid Leukemia	DOID:9119	Midostaurin
VHL	N131K (c.393C>A)	CA:16617789	Von Hippel-Lindau Disease	DOID:14175	
VHL	P71fs (c.211insT)		Von Hippel-Lindau Disease	DOID:14175	
VHL	E70K (c.208G>A)	CA:020108	Von Hippel-Lindau Disease	DOID:14175	
VHL	H115Q (c.345C>G)	CA:351753634	Von Hippel-Lindau Disease	DOID:14175	
VHL	H191FS (c.571delC)	CA:658795182	Von Hippel-Lindau Disease	DOID:14175	
VHL	L140fs (c.417_418delTC)		Von Hippel-Lindau Disease	DOID:14175	
VHL	K159fs (c.473dup)		Von Hippel-Lindau Disease	DOID:14175	
VHL	P154= (c.462A>C)	CA:16621934	Von Hippel-Lindau Disease	DOID:14175	
VHL	S80R (c.238A>C)	CA:16621913	Von Hippel-Lindau Disease	DOID:14175	
VHL	S80N (c.239G>A)	CA:70046108	Von Hippel-Lindau Disease	DOID:14175	
VHL	R60FS (c.179delG)	CA:020069	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88S (c.263G>C)	CA:020202	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y156D (c.466T>G)	CA:351756043	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y156C (c.467A>G)	CA:020394	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y156* (c.468T>G)	CA:351756053	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175* (c.525C>G)	CA:020466	Von Hippel-Lindau Disease	DOID:14175	
VHL	V130L (c.388G>C)	CA:020325	Von Hippel-Lindau Disease	DOID:14175	
VHL	G114R (c.340G>C)	CA:357101	Von Hippel-Lindau Disease	DOID:14175	
VHL	Mutation		Renal Cell Carcinoma	DOID:4450	Everolimus
VHL	R177* (c.529A>T)	CA:351756239	Von Hippel-Lindau Disease	DOID:14175	
VHL	*214L (c.641G>T)	CA:357103	Von Hippel-Lindau Disease	DOID:14175	
VHL	*214W (c.642A>G)	CA:351756723	Von Hippel-Lindau Disease	DOID:14175	
VHL	*214C (c.642A>T)	CA:351756724	Von Hippel-Lindau Disease	DOID:14175	
ERBB2	Mutation		Breast Cancer	DOID:1612	Neratinib
BAP1	Mutation		Renal Cell Carcinoma	DOID:4450	Everolimus
BAP1	Mutation		Renal Cell Carcinoma	DOID:4450	Sunitinib
VHL	Splice Site (c.464-1G>T)	CA:357144	Von Hippel-Lindau Disease	DOID:14175	
NRAS	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
KRAS	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
PDGFRA	D842V	CA:123194	Cancer	DOID:162	Imatinib Mesylate
PDGFRA	V561D	CA:123203	Cancer	DOID:162	Imatinib Mesylate
KIT	V560D	CA:16602396	Cancer	DOID:162	Imatinib Mesylate
VHL	Splice Site (c.464-2A>T)	CA:70052157	Von Hippel-Lindau Disease	DOID:14175	
VHL	R161G (c.481C>G)	CA:16621941	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.463+2T>C)	CA:16621936	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.464-1G>A)	CA:020389	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q132* (c.394C>T)	CA:10606205	Von Hippel-Lindau Disease	DOID:14175	
VHL	C77_N78insL (c.230_231insTCT)	CA:2499214029	Von Hippel-Lindau Disease	DOID:14175	
VHL	L129fs (c.384delT)	CA:70049452	Von Hippel-Lindau Disease	DOID:14175	
VHL	L178Q (c.533T>A)	CA:70052370	Von Hippel-Lindau Disease	DOID:14175	
VHL	P81S (c.241C>T)	CA:020148	Von Hippel-Lindau Disease	DOID:14175	
VHL	S183* (c.548C>A)	CA:020473	Renal Cell Carcinoma	DOID:4450	
VHL	S80N (c.239G>A)	CA:70046108	Renal Cell Carcinoma	DOID:4450	
VHL	Splice Site (c.463+1G>C)	CA:357023	Renal Cell Carcinoma	DOID:4450	
VHL	V74G (c.221T>G)	CA:70042528	Von Hippel-Lindau Disease	DOID:14175	
VHL	R161* (c.481C>T)	CA:020408	Renal Cell Carcinoma	DOID:4450	
VHL	H115R (c.344A>G)	CA:70049376	Von Hippel-Lindau Disease	DOID:14175	
VHL	N131S (c.392A>G)	CA:351753941	Von Hippel-Lindau Disease	DOID:14175	
VHL	C162Y (c.485G>A)	CA:357010	Von Hippel-Lindau Disease	DOID:14175	
VHL	R107G (c.319C>G)	CA:020257	Von Hippel-Lindau Disease	DOID:14175	
VHL	R161P (c.482G>C)	CA:351756111	Von Hippel-Lindau Disease	DOID:14175	
VHL	G93C (c.277G>T)	CA:357106	Von Hippel-Lindau Disease	DOID:14175	
VHL	G93V (c.278G>T)	CA:351750779	Von Hippel-Lindau Disease	DOID:14175	
VHL	L188V (c.562C>G)	CA:020488	Von Hippel-Lindau Disease	DOID:14175	
VHL	L198Q (c.593T>A)	CA:351756548	Von Hippel-Lindau Disease	DOID:14175	
VHL	F136C (c.407T>G)	CA:70049495	Von Hippel-Lindau Disease	DOID:14175	
VHL	S65A (c.193T>G)	CA:357048	Von Hippel-Lindau Disease	DOID:14175	
VHL	S68W (c.203C>G)	CA:351748895	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y156N (c.466T>A)	CA:351756038	Von Hippel-Lindau Disease	DOID:14175	
VHL	P61fs (c.183insC)		Von Hippel-Lindau Disease	DOID:14175	
VHL	V84L (c.250G>T)	CA:020170	Von Hippel-Lindau Disease	DOID:14175	
VHL	L85P (c.254T>C)	CA:16602675	Von Hippel-Lindau Disease	DOID:14175	
VHL	G93R (c.277G>C)	CA:357130	Von Hippel-Lindau Disease	DOID:14175	
VHL	R108dup (c.322_324dup)	CA:916832608	Von Hippel-Lindau Disease	DOID:14175	
VHL	D121G (c.362A>G)	CA:357083	Von Hippel-Lindau Disease	DOID:14175	
VHL	V194fs (c.581_582del)	CA:70052556	Von Hippel-Lindau Disease	DOID:14175	
VHL	A149fs (c.449del14-nt)		Von Hippel-Lindau Disease	DOID:14175	
VHL	3'UTR alteration (c.639+10C>G)	CA:16042064	Von Hippel-Lindau Disease	DOID:14175	
VHL	G114S (c.340G>A)	CA:351751372	Von Hippel-Lindau Disease	DOID:14175	
VHL	W117fs (c.349dup)	CA:432421788	Von Hippel-Lindau Disease	DOID:14175	
VHL	A122I (c.364_365GC>AT)	CA:658820874	Von Hippel-Lindau Disease	DOID:14175	
VHL	N150fs (c.445_458del)	CA:658820719	Von Hippel-Lindau Disease	DOID:14175	
VHL	I151M (c.453C>G)	CA:351754364	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.464-2A>G)	CA:357046	Von Hippel-Lindau Disease	DOID:14175	
VHL	L163H (c.488T>A)	CA:351756137	Von Hippel-Lindau Disease	DOID:14175	
VHL	S183* (c.548C>A)	CA:020473	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y112H (c.334T>C)	CA:020277	Von Hippel-Lindau Disease	DOID:14175	
VHL	L128F (c.382C>T)	CA:351753886	Von Hippel-Lindau Disease	DOID:14175	
VHL	L129P (c.386T>C)	CA:351753904	Von Hippel-Lindau Disease	DOID:14175	
VHL	C162fs (c.483del)	CA:658795183	Von Hippel-Lindau Disease	DOID:14175	
VHL	Null (Partial deletion of Exons 2 & 3)		Von Hippel-Lindau Disease	DOID:14175	
VHL	N78I (c.233A>T)	CA:357063	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88FS (c.263_265delGGCinsTT)	CA:658683075	Von Hippel-Lindau Disease	DOID:14175	
VHL	K159fs (c.477_478insCA)	CA:645525053	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q73FS (c.217delC)	CA:432536422	Von Hippel-Lindau Disease	DOID:14175	
VHL	A149fs (c.445delG)	CA:432421902	Von Hippel-Lindau Disease	DOID:14175	
MYC	Overexpression		Multiple Myeloma	DOID:9538	JQ-1
RRM1	Underexpression		Pancreatic Cancer	DOID:1793	Gemcitabine
VHL	R82P (c.245G>C)	CA:020159	Von Hippel-Lindau Disease	DOID:14175	
VHL	G104A (c.311G>C)	CA:16611067	Von Hippel-Lindau Disease	DOID:14175	
VHL	R107H (c.320G>A)	CA:357135	Von Hippel-Lindau Disease	DOID:14175	
VHL	S111C (c.331A>T)	CA:351751322	Von Hippel-Lindau Disease	DOID:14175	
VHL	V155L (c.463G>C)		Von Hippel-Lindau Disease	DOID:14175	
DICER1	E1705K	CA:390865421	Sertoli-Leydig Cell Tumor	DOID:2997	
DICER1	D1709N		Sertoli-Leydig Cell Tumor	DOID:2997	
DICER1	E1813Q	CA:390864655	Sertoli-Leydig Cell Tumor	DOID:2997	
VHL	P81S (c.241C>T) and L188V (c.562C>G)		Von Hippel-Lindau Disease	DOID:14175	
VHL	P146fs (c.437del)	CA:432421892	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88R (c.262T>C)	CA:351750667	Von Hippel-Lindau Disease	DOID:14175	
VHL	H115fs (c.344del)	CA:70049370	Von Hippel-Lindau Disease	DOID:14175	
VHL	P102fs (c.305delC)	CA:658820710	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175N (c.523T>A)	CA:351756226	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175C (c.524A>G)	CA:020462	Von Hippel-Lindau Disease	DOID:14175	
RRM1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Paclitaxel
RRM1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Vinorelbine
VHL	R82_V84del (c.243_251del)	CA:658820713	Von Hippel-Lindau Disease	DOID:14175	
VHL	P40fs (c.118ins)		Von Hippel-Lindau Disease	DOID:14175	
VHL	T152fs (c.455insA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	T157fs (c.472ins)		Von Hippel-Lindau Disease	DOID:14175	
VHL	L158fs (c.471dupT)	CA:357050	Von Hippel-Lindau Disease	DOID:14175	
VHL	G93_Y98del (c.275_292del)	CA:891843321	Von Hippel-Lindau Disease	DOID:14175	
VHL	E160fs (c.477del)	CA:020404	Von Hippel-Lindau Disease	DOID:14175	
VHL	V66del (c.197_220del)	unregistered	Von Hippel-Lindau Disease	DOID:14175	
VHL	V84M (c.250G>A)	CA:351750580	Von Hippel-Lindau Disease	DOID:14175	
ARID1A	Underexpression		Stomach Cancer	DOID:10534	
ARID1A	Underexpression		Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	E94FS (c.279delC)	CA:658820711	Von Hippel-Lindau Disease	DOID:14175	
VHL	G114dup (c.342dupGGT)		Von Hippel-Lindau Disease	DOID:14175	
VHL	S65FS (c.194delC)	CA:432536395	Von Hippel-Lindau Disease	DOID:14175	
VHL	Q73fs (c.214insGCCC)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.341-2A>C)	CA:351753579	Renal Cell Carcinoma	DOID:4450	
VHL	Intronic deletion (c.341-13delCGTTTCCAACAATTTCTCGGTGT)		Von Hippel-Lindau Disease	DOID:14175	
VHL	G123fs (c.369_375delGACACAC)	CA:913189240	Von Hippel-Lindau Disease	DOID:14175	
VHL	H125fs (c.374insA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	K159fs (c.474_476delGAAinsC)	CA:658683298	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175* (c.525delC)	CA:913185019	Von Hippel-Lindau Disease	DOID:14175	
VHL	L188fs (c.562delC)	CA:432423671	Von Hippel-Lindau Disease	DOID:14175	
VHL	K196fs (c.584_585delAG)	CA:645529570	Von Hippel-Lindau Disease	DOID:14175	
VHL	D197FS (c.589delG)	CA:913189233	Von Hippel-Lindau Disease	DOID:14175	
VHL	T202fs (c.606insA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	R113FS (c.337delC)	CA:432420675	Von Hippel-Lindau Disease	DOID:14175	
VHL	A56fs (c.166dup)	CA:645524645	Von Hippel-Lindau Disease	DOID:14175	
VHL	P61FS (c.182_185delCCGT)	CA:658820712	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.464-1G>C)	CA:357081	Von Hippel-Lindau Disease	DOID:14175	
VHL	Splice Site (c.341-2A>C)	CA:351753579	Von Hippel-Lindau Disease	DOID:14175	
VHL	Exon 3 Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	R161= (c.481C>A)	CA:432423146	Von Hippel-Lindau Disease	DOID:14175	
VHL	I151F (c.451A>T)	CA:351754353	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88* (c.263G>A)	CA:020197	Von Hippel-Lindau Disease	DOID:14175	
VHL	3'UTR alteration (c.*70C>A)	CA:658820858	Von Hippel-Lindau Disease	DOID:14175	
ARID1A	Underexpression		Ovarian Clear Cell Carcinoma	DOID:50934	
VHL	Y98FS (c.291delC)	CA:432420512	Von Hippel-Lindau Disease	DOID:14175	
VHL	N150S (c.449A>G)	CA:041030	Von Hippel-Lindau Disease	DOID:14175	
SLC3A2::NRG1	Fusion		Lung Adenocarcinoma	DOID:3910	
BRCA1	Loss-of-function		Her2-receptor Negative Breast Cancer	DOID:60080	Olaparib
BRCA2	Loss-of-function		Her2-receptor Negative Breast Cancer	DOID:60080	Olaparib
RAD50	L1237F		Ureter Small Cell Carcinoma	DOID:6886	Irinotecan
RAD50	L1237F		Ureter Small Cell Carcinoma	DOID:6886	Checkpoint Kinase Inhibitor AZD7762
BRCA1	Mutation		Her2-receptor Negative Breast Cancer	DOID:60080	Olaparib
BRCA2	Mutation		Breast Cancer	DOID:1612	Olaparib
BTK	MUTATION		Chronic Lymphocytic Leukemia	DOID:1040	
PLCG2	MUTATION		Chronic Lymphocytic Leukemia	DOID:1040	
MET	Overexpression		Stomach Carcinoma	DOID:5517	Rilotumumab
KRAS	Amplification		Endometrial Cancer	DOID:1380	
PTEN	Loss		Cancer	DOID:162	Everolimus
ATP1B1::NRG1	Fusion		Cholangiocarcinoma	DOID:4947	Afatinib
SDC4::NRG1	Fusion		Lung Adenocarcinoma	DOID:3910	Afatinib
VHL	R177ins (c.531insCTGAGAGTAAAGCCTGAA)		Von Hippel-Lindau Disease	DOID:14175	
DICER1	D1709G		Sertoli-Leydig Cell Tumor	DOID:2997	
DICER1	D1709E		Sertoli-Leydig Cell Tumor	DOID:2997	
DICER1	D1709G		Granulosa Cell Tumor	DOID:2999	
DICER1	D1709N		Glandular Pattern Ovarian Yolk Sac Tumor	DOID:6511	
DICER1	D1709E		Glandular Pattern Ovarian Yolk Sac Tumor	DOID:6511	
BRAF	V600E	CA:123643	Cholangiocarcinoma	DOID:4947	Trametinib
BRAF	V600E	CA:123643	Cholangiocarcinoma	DOID:4947	Dabrafenib
BRAF	V600E	CA:123643	Intrahepatic Cholangiocarcinoma	DOID:4928	Trametinib
BRAF	V600E	CA:123643	Intrahepatic Cholangiocarcinoma	DOID:4928	Dabrafenib
BRAF	V600		Cholangiocarcinoma	DOID:4947	Vemurafenib
BRAF	V600E	CA:123643	Cholangiocarcinoma	DOID:4947	Irinotecan
BRAF	V600E	CA:123643	Cholangiocarcinoma	DOID:4947	Vemurafenib
BRAF	V600E	CA:123643	Cholangiocarcinoma	DOID:4947	Panitumumab
EGFR::RAD51	Fusion		Lung Adenocarcinoma	DOID:3910	Erlotinib
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Olaparib
BRCA1	Mutation		Pancreatic Cancer	DOID:1793	Olaparib
BRCA1	Mutation		Pancreatic Cancer	DOID:1793	Cisplatin
BRCA1	Mutation		Pancreatic Cancer	DOID:1793	Oxaliplatin
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Platinum Compound
EGFR	Mutation		Peritoneal Mesothelioma	DOID:1788	Cytoreductive Surgery
EGFR	Mutation		Peritoneal Mesothelioma	DOID:1788	Hyperthermic Intraperitoneal Chemotherapy
BAP1	ALTERNATIVE TRANSCRIPT (ATI)		Malignant Mesothelioma	DOID:1790	Olaparib
BAP1	ALTERNATIVE TRANSCRIPT (ATI)		Malignant Mesothelioma	DOID:1790	Apitolisib
BRCA1	Mutation		Pancreatic Cancer	DOID:1793	Gemcitabine
BRCA1	Mutation		Pancreatic Cancer	DOID:1793	Veliparib
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Gemcitabine
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Cisplatin
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Veliparib
BRCA2	Mutation		Pancreatic Cancer	DOID:1793	Iniparib
EGFR	M766_A767insASV		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	D770_N771insNPG	CA:2573051057	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	D770_N771insNPG	CA:2573051057	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
STRN::ALK	Fusion		Colon Adenocarcinoma	DOID:234	Ceritinib
BARD1	Loss-of-function		Colorectal Cancer	DOID:9256	Olaparib
v::ALK	Fusion		Anaplastic Thyroid Carcinoma	DOID:80522	Crizotinib
ERBB2	Overexpression		Pancreatic Cancer	DOID:1793	Capecitabine
ERBB2	Overexpression		Pancreatic Cancer	DOID:1793	Trastuzumab
ERBB2	Overexpression		Pancreatic Cancer	DOID:1793	Gemcitabine
PTEN	Loss		Solid Tumor		Paclitaxel
PTEN	Loss		Solid Tumor		Buparlisib
PTEN	Loss		Solid Tumor		Carboplatin
BRAF	V600E	CA:123643	Lung Non-small Cell Carcinoma	DOID:3908	Vemurafenib
BRAF	V600E	CA:123643	Ovarian Cancer	DOID:2394	Vemurafenib
BRAF	V600E	CA:123643	Anaplastic Thyroid Carcinoma	DOID:80522	Pertuzumab
BRAF	V600E	CA:123643	Anaplastic Thyroid Carcinoma	DOID:80522	Vemurafenib
BRAF	V600E	CA:123643	Laryngeal Squamous Cell Carcinoma	DOID:2876	Vemurafenib
BRAF	G464V	CA:135076	Cancer	DOID:162	Vemurafenib
BRAF	G469A	CA:123655	Cancer	DOID:162	Vemurafenib
BRAF	G496A		Cancer	DOID:162	Vemurafenib
BRAF	N581S	CA:180747	Cancer	DOID:162	Vemurafenib
BRAF	G466V	CA:123647	Cancer	DOID:162	Vemurafenib
BRAF	G596R	CA:16602422	Cancer	DOID:162	Vemurafenib
BRAF	G606E	CA:369542941	Cancer	DOID:162	Vemurafenib
BRAF	L597Q	CA:16602257	Cancer	DOID:162	Vemurafenib
BRAF	P731T	CA:369537254	Cancer	DOID:162	Vemurafenib
BRAF	intron 9 rearrangement		Cancer	DOID:162	Vemurafenib
BRAF	intron 10 rearrangement		Cancer	DOID:162	Vemurafenib
MACF1::BRAF	Fusion		Cancer	DOID:162	Vemurafenib
CUX1::BRAF	Fusion		Pancreatic Cancer	DOID:1793	Vemurafenib
PTCH1	Mutation		Cancer	DOID:162	Vismodegib
SMO	Mutation		Cancer	DOID:162	Vismodegib
ERBB2	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab
ERBB2	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Pertuzumab
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Pertuzumab
ERBB2	Amplification		Bladder Carcinoma	DOID:4007	Pertuzumab
ERBB2	Amplification		Bladder Carcinoma	DOID:4007	Trastuzumab
ERBB2	Amplification		Biliary Tract Cancer	DOID:4607	Pertuzumab
ERBB2	Amplification		Biliary Tract Cancer	DOID:4607	Trastuzumab
ERBB2	Amplification		Salivary Gland Carcinoma	DOID:50904	Pertuzumab
ERBB2	Amplification		Salivary Gland Carcinoma	DOID:50904	Trastuzumab
ERBB2	Amplification		Pancreatic Cancer	DOID:1793	Pertuzumab
ERBB2	Amplification		Pancreatic Cancer	DOID:1793	Trastuzumab
ERBB2	Amplification		Uterine Cancer	DOID:363	Pertuzumab
ERBB2	Amplification		Uterine Cancer	DOID:363	Trastuzumab
IDH1	R132H	CA:170874	Pancreatic Ductal Adenocarcinoma	DOID:3498	Ivosidenib
ASS1	Loss		Sarcoma	DOID:1115	Pegargiminase
ASS1	Loss		Sarcoma	DOID:1115	Chloroquine
ASS1	Loss		Ovarian Cancer	DOID:2394	Taxol
ASS1	Loss		Ovarian Cancer	DOID:2394	Cisplatin
ASS1	Loss		Ovarian Cancer	DOID:2394	Carboplatin
BCL2	Mutation		Follicular Lymphoma	DOID:50873	
RASA1	Loss-of-function		Lung Non-small Cell Carcinoma	DOID:3908	Trametinib
TLK2	Amplification		Breast Cancer	DOID:1612	Go6983
TLK2	Amplification		Breast Cancer	DOID:1612	GF109203X
BRAF	D594G	CA:123657	Skin Melanoma	DOID:8923	Sorafenib
BRAF	D594G	CA:123657	Skin Melanoma	DOID:8923	U0126
BRAF	G469E	CA:279970	Skin Melanoma	DOID:8923	Sorafenib
BRAF	G469E	CA:279970	Skin Melanoma	DOID:8923	U0126
EGFR	L747_P753delinsS	CA:126710	Pancreatic Adenocarcinoma	DOID:4074	Erlotinib
EGFR	T790M	CA:090928	Pancreatic Adenocarcinoma	DOID:4074	Osimertinib
MYCN	Amplification		Neuroblastoma	DOID:769	Panobinostat
MYCN	Amplification		Neuroblastoma	DOID:769	JQ1
VHL	L184P (c.551T>C)	CA:16617792	Renal Cell Carcinoma	DOID:4450	
FOXL2	C134W	CA:16602790	Ovarian Sex-cord Stromal Tumor	DOID:80369	
v::ALK	Fusion		Vagina Sarcoma	DOID:1901	Crizotinib
v::ALK	Fusion		Epithelioid Inflammatory Myofibroblastic Sarcoma	DOID:80372	Crizotinib
BRAF	V600		Colorectal Cancer	DOID:9256	Encorafenib
BRAF	V600		Colorectal Cancer	DOID:9256	Alpelisib
CTNNB1	S45F	CA:127283	Desmoid Tumor	DOID:80366	Meloxicam
VHL	R82_V84del (c.244_252del)	CA:658820713	Von Hippel-Lindau Disease	DOID:14175	
VHL	L188Q (c.563T>A)	CA:351756398	Von Hippel-Lindau Disease	DOID:14175	
VHL	A56_P59del (c.166_178del)		Renal Cell Carcinoma	DOID:4450	
ACVR1	G328E		Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
v::NRG1	Fusion		Mucinous Adenocarcinoma	DOID:3030	Afatinib
STRN::NTRK2	Fusion		Sarcoma	DOID:1115	Larotrectinib
ETV6::NTRK3	Fusion		Congenital Fibrosarcoma	DOID:8418	Larotrectinib
TPM3::NTRK1	Fusion		Sarcoma	DOID:1115	Larotrectinib
PDE4DIP::NTRK1	Fusion		Sarcoma	DOID:1115	Larotrectinib
SQSTM1::NTRK1	Fusion		Congenital Fibrosarcoma	DOID:8418	Larotrectinib
VHL	G144E (c.431G>A)	CA:351754206	Adrenal Gland Pheochromocytoma	DOID:50892	
VHL	Splice Region (c.463+8C>T)	CA:020379	Adrenal Gland Pheochromocytoma	DOID:50892	
VHL	G104= (c.312C>G)	CA:432420538	Von Hippel-Lindau Disease	DOID:14175	
VHL	F91L (c.273C>G)	CA:351750747	Von Hippel-Lindau Disease	DOID:14175	
VHL	W88fs (c.261dup)	CA:2573050932	Von Hippel-Lindau Disease	DOID:14175	
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Trametinib
BRAF	V600E	CA:123643	Colorectal Adenocarcinoma	DOID:50861	Trametinib
BRAF	V600E	CA:123643	Colorectal Adenocarcinoma	DOID:50861	Panitumumab
VHL	S65L (c.194C>T)	CA:020104	Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	L184P (c.551T>C)	CA:16617792	Clear Cell Renal Cell Carcinoma	DOID:4467	
ERBB2	Overexpression		Salivary Gland Cancer	DOID:8850	Paclitaxel
ERBB2	Overexpression		Salivary Gland Cancer	DOID:8850	Trastuzumab
ERBB2	Overexpression		Salivary Gland Cancer	DOID:8850	Capecitabine
ERBB2	Overexpression		Salivary Gland Cancer	DOID:8850	Zoledronic Acid
ERBB2	T798I	CA:399303242	Breast Cancer	DOID:1612	Osimertinib
EGFR	G719A	CA:135775	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	R705K	CA:367583561	Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
EGFR	R705K	CA:367583561	Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR	Rare Mutation		Lung Adenocarcinoma	DOID:3910	Gefitinib
PIK3CA	Mutation		Estrogen-receptor Positive Breast Cancer	DOID:60075	Tamoxifen
ABL1	T315A	CA:16602576	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	FEC Regimen
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	FAC Regimen
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	FEC Regimen
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	FAC Regimen
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	FEC Regimen
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	FAC Regimen
ABL1	T315I	CA:122575	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
PIK3CA	Exon 21 Mutation		Breast Cancer	DOID:1612	
PIK3CA	Exon 10 Mutation		Breast Cancer	DOID:1612	
PIK3CA	H1047R	CA:123326	Her2-receptor Positive Breast Cancer	DOID:60079	Dactolisib
ABL1	F317V	CA:16602578	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	L248R	CA:375263224	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	L248R	CA:375263224	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	Dactolisib
ABL1	F317I	CA:16602577	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	F317S	CA:375249431	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	F311L	CA:122587	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	F311L	CA:122587	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	H396P	CA:375249969	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	H396P	CA:375249969	Chronic Myeloid Leukemia	DOID:8552	Nilotinib
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	M244V	CA:16602545	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	G250E	CA:16602547	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	Q252H	CA:16602548	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	D276G	CA:200645023	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	F317C	CA:16602579	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	F317L	CA:16602555	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	M351T	CA:122590	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	E355G	CA:16602556	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	F359V	CA:16602557	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	V379I	CA:375249852	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	H396R	CA:16602558	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
AKT1	Overexpression		Melanoma	DOID:1909	Vemurafenib
AKT1	Q79K	CA:16602625	Melanoma	DOID:1909	Dabrafenib
AKT3	Overexpression		Melanoma	DOID:1909	Vemurafenib
BRAF	Amplification		Melanoma	DOID:1909	Dabrafenib
BRAF	Amplification		Melanoma	DOID:1909	Vemurafenib
NRAS	Mutation		Melanoma	DOID:1909	Vemurafenib
NRAS	Mutation		Melanoma	DOID:1909	Dabrafenib
KRAS	Mutation		Melanoma	DOID:1909	Dabrafenib
KRAS	Mutation		Melanoma	DOID:1909	Vemurafenib
PIK3R2	Overexpression		Melanoma	DOID:1909	Vemurafenib
PREX2	R172I	CA:371196220	Melanoma	DOID:1909	Vemurafenib
PTEN	Loss		Melanoma	DOID:1909	Vemurafenib
v::NRG1	Fusion		Pancreatic Adenocarcinoma	DOID:4074	Afatinib
PIK3CA	Amplification		Melanoma	DOID:1909	Vemurafenib
VHL	3p26.3-25.3 11Mb del		Von Hippel-Lindau Disease	DOID:14175	
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Oxaliplatin
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Irinotecan
KRAS	G12/G13		Colorectal Cancer	DOID:9256	Bevacizumab
KRAS	G13		Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G12		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Oxaliplatin
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Irinotecan
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Bevacizumab
BRAF	Mutation		Colorectal Cancer	DOID:9256	
BRAF	Mutation		Colorectal Cancer	DOID:9256	Oxaliplatin
BRAF	Mutation		Colorectal Cancer	DOID:9256	Irinotecan
BRAF	Mutation		Colorectal Cancer	DOID:9256	Bevacizumab
ABL1	E459K	CA:200648598	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	TKD Mutation		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
KRAS	G13V	CA:645572107	Colorectal Cancer	DOID:9256	Cetuximab
KRAS	G13V	CA:645572107	Colorectal Cancer	DOID:9256	Panitumumab
PTEN	Loss		Colorectal Cancer	DOID:9256	Panitumumab
KRAS	Amplification		Melanoma	DOID:1909	Vemurafenib
KRAS	G12A	CA:135567	Colorectal Cancer	DOID:9256	Panitumumab
VHL	c.128-?_250+?		Von Hippel-Lindau Disease	DOID:14175	
ABL1	TKD Mutation		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	P-Loop Mutation		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	Non-P-Loop Mutation		Chronic Myeloid Leukemia	DOID:8552	Bosutinib
ABL1	TKD Mutation		Chronic Myeloid Leukemia	DOID:8552	Nilotinib
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Panitumumab
PIK3CA	Mutation		Colorectal Cancer	DOID:9256	Aspirin
ABL1	R351W	CA:5285359	Lung Non-small Cell Carcinoma	DOID:3908	Imatinib
CSF3R	T618I	CA:204418	Chronic Neutrophilic Leukemia	DOID:80187	Ruxolitinib
CALR	Mutation		Essential Thrombocythemia	DOID:2224	
LMNA::NTRK1	Fusion		Lipofibromatosis-like Neural Tumor	DOID:80894	
TRIM63::NTRK1	Fusion		Melanoma	DOID:1909	Larotrectinib
DDR2::NTRK1	Fusion		Melanoma	DOID:1909	Larotrectinib
GON4L::NTRK1	Fusion		Melanoma	DOID:1909	Larotrectinib
ETV6::NTRK2	Fusion		Acute Myeloid Leukemia	DOID:9119	Larotrectinib
BRAF	intron 10 rearrangement		Melanoma	DOID:1909	Dabrafenib
BRAF	intron 10 rearrangement		Melanoma	DOID:1909	Vemurafenib
BRAF	intron 9 rearrangement		Melanoma	DOID:1909	Vemurafenib
BRAF	intron 9 rearrangement		Melanoma	DOID:1909	Dabrafenib
BRAF	D594K		Colorectal Cancer	DOID:9256	Irinotecan
BRAF	D594K		Colorectal Cancer	DOID:9256	Oxaliplatin
FGFR3	V555M	CA:355981674	Myeloid Neoplasm	DOID:70004	AZ12908010
FGFR3	V555M	CA:355981674	Myeloid Neoplasm	DOID:70004	Fexagratinib
FGFR3	V555M	CA:355981674	Myeloid Neoplasm	DOID:70004	PD173074
FGFR3::TACC3	Fusion		Transitional Cell Carcinoma	DOID:2671	Infigratinib
IDH1	R132		Intrahepatic Cholangiocarcinoma	DOID:4928	Dasatinib
STK11	Mutation		Lung Adenocarcinoma	DOID:3910	Pembrolizumab
STK11	Mutation		Lung Adenocarcinoma	DOID:3910	Atezolizumab
STK11	Mutation		Lung Adenocarcinoma	DOID:3910	Nivolumab
SDHB	p.193_196dupSTSC (c.577_588dupAGCACCAGCTGC)	CA:658820851	Paraganglioma	DOID:50773	
SMAD4	R361C		Juvenile Polyposis Syndrome	DOID:50787	
H3-3A	K28M	CA:16602870	Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
H3-3B	K36M		Chondroblastoma	DOID:2649	
H3-3A	G34W		Bone Giant Cell Tumor	DOID:4305	
ETV6::NTRK3	Fusion		Papillary Thyroid Carcinoma	DOID:3969	
ETV6::NTRK3	Fusion		Breast Secretory Carcinoma	DOID:4922	Larotrectinib
KMT2C	Loss		Breast Cancer	DOID:1612	Aromatase Inhibitor
VHL	c.−213− ?_463 ?del		Von Hippel-Lindau Disease	DOID:14175	
VHL	V87fs (c.259_260insA)	CA:913189242	Von Hippel-Lindau Disease	DOID:14175	
VHL	c.341-59_341-14del		Von Hippel-Lindau Disease	DOID:14175	
VHL	V166A (c.497T>C)	CA:020442	Von Hippel-Lindau Disease	DOID:14175	
VHL	Rearrangement		Von Hippel-Lindau Disease	DOID:14175	
VHL	V66Gfs*89 (c.197_209del)		Von Hippel-Lindau Disease	DOID:14175	
VHL	R79_S80del (c.236_241delGCAGTC)		Von Hippel-Lindau Disease	DOID:14175	
VHL	D92G (c.275A>G)	CA:351750765	Von Hippel-Lindau Disease	DOID:14175	
v::NTRK1	Fusion		Solid Tumor		Larotrectinib
v::NTRK3	Fusion		Solid Tumor		Larotrectinib
v::NTRK1	Fusion		Sarcoma	DOID:1115	Larotrectinib
VHL	V155G (c.464T>G)	CA:16621938	Von Hippel-Lindau Disease	DOID:14175	
VHL	Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	G114Vfs*45 (c.339delA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Q164L (c.491A>T)	CA:351756149	Von Hippel-Lindau Disease	DOID:14175	
VHL	R167P (c.500G>C)	CA:351756177	Von Hippel-Lindau Disease	DOID:14175	
VHL	Y175* (c.525C>A)	CA:351756231	Von Hippel-Lindau Disease	DOID:14175	
VHL	L178P (c.532C>T)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Exon 2 Deletion		Von Hippel-Lindau Disease	DOID:14175	
VHL	EXON 2-3 DELETION		Von Hippel-Lindau Disease	DOID:14175	
PRKCB	D427N		Adult T-cell Leukemia/lymphoma	DOID:50523	
VHL	*214G (c.640T>G)	CA:351756720	Von Hippel-Lindau Disease	DOID:14175	
VHL	*214C (c.641_642insC)	CA:913189243	Von Hippel-Lindau Disease	DOID:14175	
VHL	S65L (c.194C>T)	CA:020104	Renal Carcinoma	DOID:4451	
VHL	L118P (c.353T>C)	CA:70049399	Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	D121_A122del (c.361_366del)		Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	P138R (c.413C>G)	CA:351754085	Clear Cell Renal Cell Carcinoma	DOID:4467	
VHL	N150fs (c.447del)	CA:432421904	Renal Carcinoma	DOID:4451	
VHL	Q164* (c.490C>T)	CA:357060	Clear Cell Renal Cell Carcinoma	DOID:4467	
ETV6::NTRK3	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Larotrectinib
EZH2	Y646F	CA:16602259	Skin Melanoma	DOID:8923	JQEZ5
BRAF	V600E	CA:123643	Skin Melanoma	DOID:8923	JQEZ5
HRAS	Q61		Follicular Thyroid Carcinoma	DOID:3962	
v::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ETV6::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
BRAF	V600E	CA:123643	Anaplastic Thyroid Carcinoma	DOID:80522	Dabrafenib
BRAF	V600E	CA:123643	Anaplastic Thyroid Carcinoma	DOID:80522	Trametinib
EBF1::PDGFRB	Fusion		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Imatinib
ABL1	C475V		Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	N336S	CA:375249553	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	E453A	CA:375251172	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	L387F	CA:375249910	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	Q300R	CA:375249312	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	F359I	CA:16602580	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
PDGFRB	C843G		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	CHZ868
AGGF1::PDGFRB	Fusion		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	CHZ868
GOLGA5::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Ruxolitinib
HEY1::NCOA2	Fusion		Mesenchymal Chondrosarcoma	DOID:4545	
PAX3::FOXO1	Fusion		Alveolar Rhabdomyosarcoma	DOID:4051	
PAX7::FOXO1	Fusion		Alveolar Rhabdomyosarcoma	DOID:4051	
PAX3::FOXO1	Fusion		Alveolar Rhabdomyosarcoma	DOID:4051	BET Inhibitor
PARP1	OVEREXPRESSION		Malignant Peripheral Nerve Sheath Tumor	DOID:5940	Olaparib
BRD4::NUTM1	Fusion		NUT Midline Carcinoma	DOID:60463	Birabresib
BRD4::NUTM1	Fusion		NUT Midline Carcinoma	DOID:60463	
JAK2	F694L		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Ruxolitinib
ABL1	A397P	CA:375249974	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
ABL1	E459K	CA:200648598	Chronic Myeloid Leukemia	DOID:8552	Imatinib Mesylate
RET	Overexpression		Lung Adenocarcinoma	DOID:3910	
v::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Selpercatinib
RET	V804M		Medullary Thyroid Carcinoma	DOID:3973	Selpercatinib
v::RET	Fusion		Papillary Thyroid Carcinoma	DOID:3969	Selpercatinib
RET	Mutation		Medullary Thyroid Carcinoma	DOID:3973	Selpercatinib
EGFR	V441F	CA:367579353	Colorectal Cancer	DOID:9256	Cetuximab
EGFR	V441F	CA:367579353	Colorectal Cancer	DOID:9256	Panitumumab
EBF1::PDGFRB	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dasatinib
VHL	G104V (c.311G>T)	CA:357033	Von Hippel-Lindau Disease	DOID:14175	
CBL	Y371H		Juvenile Myelomonocytic Leukemia	DOID:50458	
KIAA1549::BRAF	Fusion		Pilocytic Astrocytoma	DOID:4851	
SMARCA4	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Palbociclib
SMARCA4	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Abemaciclib
TP53	R248Q	CA:000387	Lymphoma	DOID:60058	
TP53	C238Y	CA:000351	Breast Cancer	DOID:1612	
PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Aspirin
PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Celecoxib
PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Sulindac
TERT	Promoter Mutation		Childhood Low-grade Glioma	DOID:80830	
H3-3A	MUTATION		Childhood Low-grade Glioma	DOID:80830	
ATRX	Underexpression		Childhood Low-grade Glioma	DOID:80830	
BRAF	V600E	CA:123643	Childhood Low-grade Glioma	DOID:80830	
CDKN2A	Deletion		Childhood Low-grade Glioma	DOID:80830	
KIAA1549::BRAF	Fusion		Childhood Low-grade Glioma	DOID:80830	
MYB	AMPLIFICATION		Childhood Low-grade Glioma	DOID:80830	
KIT	M541L	CA:160347	Colon Signet Ring Adenocarcinoma	DOID:3033	Imatinib
KIAA1549::BRAF	Fusion		Childhood Low-grade Glioma	DOID:80830	Trametinib
KIAA1549::BRAF	Fusion		Childhood Low-grade Glioma	DOID:80830	Everolimus
FGFR1	Internal Duplication		Childhood Low-grade Glioma	DOID:80830	
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Vincristine
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dasatinib
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dexamethasone
IGH::CRLF2	Fusion		B-cell Adult Acute Lymphocytic Leukemia	DOID:60592	
TP53	C238Y	CA:000351			
PIK3CA	Exon 21 Mutation		Rectum Cancer	DOID:1993	
PIK3CA	Exon 10 Mutation		Rectum Cancer	DOID:1993	
CDKN1A	rs1801270		Retinoblastoma	DOID:768	
IGH::CRLF2	Fusion		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	
SNX2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
FGFR1	Amplification		Breast Cancer	DOID:1612	Pazopanib
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Imatinib
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dasatinib
RCSD1::ABL2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dasatinib
FOXP1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
SNX2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
SSBP2::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Ruxolitinib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Binimetinib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Encorafenib
FGFR2	Mutation		Transitional Cell Carcinoma	DOID:2671	Erdafitinib
FGFR2::v	Fusion		Transitional Cell Carcinoma	DOID:2671	Erdafitinib
FGFR2::?	Fusion		Transitional Cell Carcinoma	DOID:2671	Erdafitinib
BRAF	V600E	CA:123643	Biliary Tract Cancer	DOID:4607	Trametinib
BRAF	V600E	CA:123643	Biliary Tract Cancer	DOID:4607	Dabrafenib
MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Tepotinib
IDH1	Mutation		Acute Myeloid Leukemia	DOID:9119	Ivosidenib
FLT3	Mutation		Acute Myeloid Leukemia	DOID:9119	Gilteritinib
v::ALK	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
BRAF	V600		Melanoma	DOID:1909	Encorafenib
BRAF	V600		Melanoma	DOID:1909	Binimetinib
KIT	V555_V559DEL		Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	K550_K559DEL	CA:645516734	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
PAX5	P80R		B-lymphoblastic Leukemia With PAX5 P.P80R	DOID:81411	
FOXP1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
v::NTRK1	Fusion		Lipofibromatosis-like Neural Tumor	DOID:80894	
CDKN2A	Mutation		Pancreatic Cancer	DOID:1793	Palbociclib
CDKN2A	Mutation		Cholangiocarcinoma	DOID:4947	Palbociclib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Alpelisib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Fulvestrant
EGFR::RAD51	Fusion		Lung Adenocarcinoma	DOID:3910	Icotinib
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	Q546R	CA:136371	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	Q546R	CA:136371	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	Q546E	CA:123331	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	Q546E	CA:123331	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	H1047Y	CA:130471	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	H1047Y	CA:130471	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	H1047R	CA:123326	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	H1047L	CA:123328	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	H1047L	CA:123328	Breast Cancer	DOID:1612	Fulvestrant
FGFR2::?	Fusion		Intrahepatic Cholangiocarcinoma	DOID:4928	Derazantinib
FGFR2::v	Fusion		Intrahepatic Cholangiocarcinoma	DOID:4928	Derazantinib
CCNE1	Underexpression		Breast Cancer	DOID:1612	Palbociclib
CCNE1	Underexpression		Breast Cancer	DOID:1612	Fulvestrant
BRAF	V600		Colorectal Cancer	DOID:9256	Irinotecan
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Fludarabine
IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Ponatinib
KIT	N822K	CA:16602411	Acute Myeloid Leukemia	DOID:9119	Sorafenib
KIT	N822K	CA:16602411	Acute Myeloid Leukemia	DOID:9119	Sunitinib
v::FGFR1	Fusion		Acute Myeloid Leukemia	DOID:9119	Sunitinib
v::FGFR1	Fusion		Acute Myeloid Leukemia	DOID:9119	Sorafenib
FIP1L1::PDGFRA	Fusion		Acute Myeloid Leukemia	DOID:9119	Sorafenib
FIP1L1::PDGFRA	Fusion		Acute Myeloid Leukemia	DOID:9119	Sunitinib
KIT	N822K	CA:16602411	Acute Myeloid Leukemia	DOID:9119	Ponatinib
FGFR1OP2::FGFR1	Fusion		Acute Myeloid Leukemia	DOID:9119	Ponatinib
FLT3	ITD		Leukemia	DOID:1240	Sorafenib
FLT3	ITD		Leukemia	DOID:1240	Sunitinib
IKZF1	Loss-of-function		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	
BRCA1	Loss-of-function		Pancreatic Adenocarcinoma	DOID:4074	Olaparib
BRCA2	Loss-of-function		Pancreatic Adenocarcinoma	DOID:4074	Olaparib
KIT	A502_Y503insAY	unregistered	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	V560_L576DEL		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	V560_L576DEL		Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	V560G	CA:16602398	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	V560G	CA:16602398	Gastrointestinal Stromal Tumor	DOID:9253	Regorafenib
KIT	V560G	CA:16602398	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	K642E	CA:123547	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	K642E	CA:123547	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	D816E	CA:356911882	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIAA1549::BRAF	Fusion		Childhood Pilocytic Astrocytoma	DOID:6812	Sorafenib
KIAA1549::BRAF	Fusion		Childhood Pilocytic Astrocytoma	DOID:6812	Vemurafenib
KIT	A829P	CA:16602413	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
KIT	N822K	CA:16602411	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	V560_Y578del		Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	V560_Y578del		Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	A829P	CA:16602413	Gastrointestinal Stromal Tumor	DOID:9253	Imatinib
KIT	A829P	CA:16602413	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	T670I	CA:16602525	Gastrointestinal Stromal Tumor	DOID:9253	Sunitinib
KIT	T670I	CA:16602525	Gastrointestinal Stromal Tumor	DOID:9253	Ponatinib
TPM3::NTRK1	Fusion		Spindle Cell Sarcoma	DOID:4235	Larotrectinib
ALK	Alternative Transcript (ATI)		Mucosal Melanoma	DOID:50929	Entrectinib
FGFR3	Mutation		Transitional Cell Carcinoma	DOID:2671	Erdafitinib
TP53	R273H	CA:000434	Osteosarcoma	DOID:3347	Methotrexate
TP53	R273H	CA:000434	Osteosarcoma	DOID:3347	Doxorubicin
CDKN2A	Loss		Lung Non-small Cell Carcinoma	DOID:3908	Palbociclib
NFE2L2	Mutation		Lung Squamous Cell Carcinoma	DOID:3907	Sapanisertib
IDH1	Mutation		Cholangiocarcinoma	DOID:4947	Ivosidenib
RICTOR	Amplification		Lung Small Cell Carcinoma	DOID:5409	Vistusertib
STAG2	MUTATION		Acute Myeloid Leukemia	DOID:9119	
KIT	S628N	CA:356908374	Melanoma	DOID:1909	Imatinib
KIT	D816V	CA:123513	Cancer	DOID:162	Dasatinib
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	E545D	CA:16602698	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	E545D	CA:16602698	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	E545G	CA:123336	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	E545G	CA:123336	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	E545A	CA:123342	Breast Cancer	DOID:1612	Fulvestrant
PIK3CA	E545A	CA:123342	Breast Cancer	DOID:1612	Alpelisib
CCDC6::RET	Fusion		Colorectal Cancer	DOID:9256	Agerafenib
CAD::ALK	Fusion		Colorectal Cancer	DOID:9256	Entrectinib
GOPC::ROS1	e7::e35		Glioblastoma	DOID:3068	Lorlatinib
NF1	Mutation		Childhood Low-grade Glioma	DOID:80830	Selumetinib
FGFR1	Amplification		Breast Cancer	DOID:1612	Lucitanib
ATP1B1::NRG1	Fusion		Pancreatic Ductal Adenocarcinoma	DOID:3498	Afatinib
APP::NRG1	Fusion		Pancreatic Ductal Adenocarcinoma	DOID:3498	Afatinib
ETV6::NTRK3	Fusion		Solid Tumor		Larotrectinib
MET	R1004G	CA:368987455	Head And Neck Cancer	DOID:11934	Crizotinib
TP53	R248Q	CA:000387			
TP53	Y220C	CA:000315			
TP53	M237I	CA:287488024			
TP53	R273H	CA:000434			
TP53	R282W				
SLC4A4::ROS1	Fusion		Lung Adenocarcinoma	DOID:3910	DS-6501b
ROS1	G2032R	CA:16602597	Lung Adenocarcinoma	DOID:3910	DS-6501b
TP53	Mutation		Solid Tumor		Pazopanib
TP53	Mutation		Solid Tumor		Vorinostat
BRAF	G466V	CA:123647	Colorectal Cancer	DOID:9256	Panitumumab
BRAF	G466V	CA:123647	Colorectal Cancer	DOID:9256	Irinotecan
BRAF	G466V	CA:123647	Colorectal Cancer	DOID:9256	Vemurafenib
BRAF	G466V	CA:123647	Solid Tumor		Vemurafenib
BRAF	D594G	CA:123657	Cancer	DOID:162	Vemurafenib
FGFR3	Mutation		Urinary Bladder Cancer	DOID:11054	Gemcitabine
FGFR3	Mutation		Urinary Bladder Cancer	DOID:11054	Cisplatin
KRAS	G12C	CA:122528	Solid Tumor		Adagrasib
BRAF	V600E	CA:123643	Langerhans Cell Sarcoma	DOID:7146	Vemurafenib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Anti-PD1 Monoclonal Antibody
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Anti-PD-L1 Monoclonal Antibody
H3-3A	K28M	CA:16602870	Glioma		Dordaviprone
EGFR	Exon 20 Insertion		Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
BRAF	A728V	CA:369537269			
BRAF	V600D	CA:16602419	Melanoma	DOID:1909	BRAF Inhibitor
BRAF	V600D	CA:16602419	Melanoma	DOID:1909	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	V600_K601>E		Melanoma	DOID:1909	BRAF Inhibitor
BRAF	V600_K601>E		Melanoma	DOID:1909	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	G469		Melanoma	DOID:1909	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	G469		Melanoma	DOID:1909	BRAF Inhibitor
BRAF	A598V	CA:369543099	Melanoma	DOID:1909	Mitogen-Activated Protein Kinase Kinase Inhibitor
BRAF	A598V	CA:369543099	Melanoma	DOID:1909	BRAF Inhibitor
FGF19	Overexpression		Hepatocellular Carcinoma	DOID:684	Fisogatinib
ERBB2	Amplification		Cholangiocarcinoma	DOID:4947	Pertuzumab
ERBB2	Amplification		Cholangiocarcinoma	DOID:4947	Trastuzumab
MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
ERBB2	Amplification		Stomach Cancer	DOID:10534	Trastuzumab Deruxtecan
FOXP1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ATF7IP::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
EBF1::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
PPFIBP1::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
STRN3::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
TPR::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
BRAF	Amplification		Melanoma	DOID:1909	Trametinib
SNX2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
ETV6::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
BCR::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
PAX5::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
TERF2::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
PCM1::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
USP25::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ZNF274::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RFX3::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	Cabozantinib
BRCA2	K3326*		Glioblastoma	DOID:3068	Temozolomide
BRCA2	K3326*		Glioblastoma	DOID:3068	Olaparib
IDH1	Mutation		Chondrosarcoma	DOID:3371	
IDH2	Mutation		Chondrosarcoma	DOID:3371	
BRAF	N486_P490del		Pancreatic Cancer	DOID:1793	Trametinib
NRF1::BRAF	Fusion		Transitional Cell Carcinoma	DOID:2671	Trametinib
CDKN2A	c.151-1G>C		Melanoma	DOID:1909	
ABL1	T315V	CA:645556983	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	T315A	CA:16602576	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	H396P	CA:375249969	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	M244V	CA:16602545	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	E279K	CA:375249162	Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	E292L		Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	F317R		Chronic Myeloid Leukemia	DOID:8552	Axitinib
ABL1	L248R	CA:375263224	Chronic Myeloid Leukemia	DOID:8552	Axitinib
BCR::ABL1	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Axitinib
BCR::ABL1	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Ponatinib
ABL1	T315I	CA:122575	Acute Lymphoblastic Leukemia	DOID:9952	Axitinib
ABL1	T315I	CA:122575	Acute Lymphoblastic Leukemia	DOID:9952	Ponatinib
BCR::ABL1	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Nilotinib
BCR::ABL1	Fusion		Acute Lymphoblastic Leukemia	DOID:9952	Imatinib
ABL1	T315I	CA:122575	Acute Lymphoblastic Leukemia	DOID:9952	Nilotinib
ABL1	T315I	CA:122575	Acute Lymphoblastic Leukemia	DOID:9952	Imatinib
ABL1	E255K	CA:16602551	Chronic Myeloid Leukemia	DOID:8552	Ponatinib
ABL1	V299L	CA:16602575	Chronic Myeloid Leukemia	DOID:8552	Ponatinib
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
CTNNB1	Exon 3 Mutation		Desmoid Tumor	DOID:80366	
DPYD	EXON 11-19 DELETION		Head And Neck Squamous Cell Carcinoma	DOID:5520	Leucovorin
DPYD	EXON 11-19 DELETION		Head And Neck Squamous Cell Carcinoma	DOID:5520	Fluorouracil
MET::ATXN7L1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Crizotinib
MET	Exon 14 Skipping Mutation		Histiocytic And Dendritic Cell Cancer	DOID:5621	Crizotinib
MET	Exon 14 Skipping Mutation		Cancer	DOID:162	Capmatinib
CDK4	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Dexamethasone
CDK4	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Ribociclib
CDK6	Overexpression		Glioblastoma Proneural Subtype	DOID:50804	Palbociclib
CDK6	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Ribociclib
CDK6	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	Dexamethasone
ERBB2	Amplification		Colorectal Cancer	DOID:9256	Afatinib
FGFR1	Amplification		Adenosquamous Lung Carcinoma	DOID:4829	Pazopanib
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Thioguanine
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Mercaptopurine
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Mercaptopurine
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Thioguanine
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Mercaptopurine
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Thioguanine
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Cytarabine
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Doxorubicin
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Gemcitabine
NT5C2	R367Q	CA:16602791	Childhood Acute Lymphocytic Leukemia	DOID:80144	Prednisolone
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Doxorubicin
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Prednisolone
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Cytarabine
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	Gemcitabine
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Doxorubicin
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Cytarabine
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Gemcitabine
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	Prednisolone
NT5C2	Mutation		Childhood Acute Lymphocytic Leukemia	DOID:80144	
ABL1	D363G		Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	E98G		Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	L364I	CA:375249753	Chronic Myeloid Leukemia	DOID:8552	Imatinib
FGFR2	P253R		Head And Neck Squamous Cell Carcinoma	DOID:5520	Pazopanib
BCR::ABL1	Fusion		Chronic Myeloid Leukemia	DOID:8552	Bafetinib
ABL1	F317L	CA:16602555	Cancer	DOID:162	Imatinib
ABL1	F317L	CA:16602555	Cancer	DOID:162	Dasatinib
ABL1	M351T	CA:122590	Cancer	DOID:162	Imatinib
ABL1	T315A	CA:16602576	Cancer	DOID:162	Bafetinib
ABL1	T315A	CA:16602576	Cancer	DOID:162	Nilotinib
ABL1	F317V	CA:16602578	Cancer	DOID:162	Nilotinib
ABL1	F317V	CA:16602578	Cancer	DOID:162	Imatinib
ABL1	F317V	CA:16602578	Cancer	DOID:162	Bafetinib
ABL1	T315A	CA:16602576	Cancer	DOID:162	Imatinib
ABL1	T315A	CA:16602576	Cancer	DOID:162	Dasatinib
ABL1	F317V	CA:16602578	Cancer	DOID:162	Dasatinib
ABL1	H396P	CA:375249969	Cancer	DOID:162	Bafetinib
ABL1	H396P	CA:375249969	Cancer	DOID:162	Nilotinib
ABL1	H396P	CA:375249969	Cancer	DOID:162	Imatinib
ABL1	Y253F		Cancer	DOID:162	Imatinib
ABL1	Q252H	CA:16602548	Cancer	DOID:162	Bafetinib
ABL1	Q252H	CA:16602548	Cancer	DOID:162	Imatinib
ABL1	M244V	CA:16602545	Cancer	DOID:162	Bafetinib
JAK1	OVEREXPRESSION		Sarcoma	DOID:1115	Ruxolitinib
ABL1	G250E	CA:16602547	Cancer	DOID:162	Bafetinib
ABL1	G250E	CA:16602547	Cancer	DOID:162	Imatinib
BRAF	Non-V600		Solid Tumor		Trametinib
NT5C2	R238W	CA:377975023	Childhood Acute Lymphocytic Leukemia	DOID:80144	
NT5C2	S445F	CA:377969059	Childhood Acute Lymphocytic Leukemia	DOID:80144	
PRPS1	PRPS1 MUTATION		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
LYN	OVEREXPRESSION		Chronic Myeloid Leukemia	DOID:8552	Bafetinib
LYN	OVEREXPRESSION		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
LYN	OVEREXPRESSION		Chronic Myeloid Leukemia	DOID:8552	Nilotinib
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
VHL	106insR (c.316insGCC)		Von Hippel-Lindau Disease	DOID:14175	
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	S103I		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	S103I		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Lometrexol
PRPS1	D139G		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	D139G		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	C77S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	C77S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	I72V		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	I72V		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	V53A		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	V53A		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	A87T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	A87T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	M115T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Thioguanine
PRPS1	M115T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Mercaptopurine
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Cytarabine
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Asparaginase
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Daunorubicin
PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
KRAS	R164Q	CA:6486860	Cancer	DOID:162	
KRAS	Q61H	CA:180922	Cancer	DOID:162	
FGFR3	S249C	CA:126380	Lung Squamous Cell Carcinoma	DOID:3907	
ABL1	E450Q	CA:375251152	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	N146S		Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	V289I	CA:375249232	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	Y253H	CA:122584	Acute Lymphoblastic Leukemia	DOID:9952	Dasatinib
ABL1	S438C	CA:375251077	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
ABL1	M388L	CA:375249914	Chronic Myeloid Leukemia	DOID:8552	Dasatinib
FGFR3	Amplification		Breast Cancer	DOID:1612	Pazopanib
IL6	Overexpression		Rhabdomyosarcoma	DOID:3247	Bazedoxifene
CHEK2	R474C c.1420C>T		Cancer	DOID:162	
CTNNB1	Exon 3 Mutation		Childhood Medulloblastoma	DOID:3869	
FUS::DDIT3	Fusion		Liposarcoma	DOID:3382	
HMGA2::LPP	Fusion		Liposarcoma	DOID:3382	
LPP::HMGA2	Fusion		Liposarcoma	DOID:3382	
CDKN2A	Loss		Acute Lymphoblastic Leukemia	DOID:9952	
PDGFRA	Overexpression		Rhabdomyosarcoma	DOID:3247	Sunitinib
BCR::PDGFRA	Fusion		B-cell Acute Lymphoblastic Leukemia	DOID:80638	Imatinib
COL1A1::PDGFB	Fusion		Dermatofibrosarcoma Protuberans	DOID:3507	Sunitinib
PDGFRB	Overexpression		Dermatofibrosarcoma Protuberans	DOID:3507	Sunitinib
ETV6::NTRK3	Fusion		Acute Myeloid Leukemia	DOID:9119	Entrectinib
SMU1::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
OFD1::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
SNX29::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ZNF430::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	PI-103
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	PI-103
PIK3CA	H1047L	CA:123328	Breast Cancer	DOID:1612	PI-103
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	PI-103
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	PI-103
PIK3CA	E542K	CA:333572	Her2-receptor Positive Breast Cancer	DOID:60079	PI3Ka/Di
PIK3CA	E542K	CA:333572	Breast Cancer	DOID:1612	PI3Ka/Di
PIK3CA	E545K	CA:123334	Her2-receptor Positive Breast Cancer	DOID:60079	PI3Ka/Di
PIK3CA	E545K	CA:123334	Breast Cancer	DOID:1612	PI3Ka/Di
PIK3CA	H1047L	CA:123328	Breast Cancer	DOID:1612	PI3Ka/Di
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	PI3Ka/Di
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	PI3Ka/Di
TPM3::NTRK1	Fusion		Papillary Thyroid Carcinoma	DOID:3969	Larotrectinib
PIK3CA	V955I	CA:355281422	Colorectal Cancer	DOID:9256	Cetuximab
SMARCA4	INACTIVATING MUTATION		Small-cell Carcinoma Of The Ovary Of Hypercalcemic Type	DOID:7651	
NF2	c.1396C>T		Adult Spinal Cord Ependymoma	DOID:7788	
ABL1	F486S	CA:375251598	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	E459K	CA:200648598	Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	Double Ph		Chronic Myeloid Leukemia	DOID:8552	Imatinib
ABL1	P-Loop Mutation		Chronic Myeloid Leukemia	DOID:8552	Imatinib
SSBP2::JAK2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
FLT3	D835Y	CA:126347	Cancer	DOID:162	Gilteritinib
FLT3	D835Y	CA:126347	Acute Myeloid Leukemia	DOID:9119	Gilteritinib
PIK3CA	E545K	CA:123334	Cervical Cancer	DOID:4362	Ionizing Radiotherapy
CCND1	Overexpression		Childhood B-cell Acute Lymphoblastic Leukemia	DOID:80146	
FGFR2::?	Fusion		Cholangiolocellular Carcinoma	DOID:7642	Pemigatinib
FGFR2::v	Fusion		Cholangiolocellular Carcinoma	DOID:7642	Pemigatinib
PML	A216V	CA:393121894	Acute Promyelocytic Leukemia	DOID:60318	Arsenic Trioxide
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	Dactolisib
PIK3CA	K111N	CA:16602917	Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
BCL2	G101V	CA:402632336	Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma	DOID:6354	Venetoclax
MYOD1	L122R	CA:379790889	Spindle Cell Rhabdomyosarcoma	DOID:3260	
KIF5B::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Selpercatinib
RET	G810C		Lung Non-small Cell Carcinoma	DOID:3908	Selpercatinib
RET	G810S		Lung Non-small Cell Carcinoma	DOID:3908	Selpercatinib
RET	G810R		Lung Non-small Cell Carcinoma	DOID:3908	Selpercatinib
RET	G810S		Medullary Thyroid Carcinoma	DOID:3973	Selpercatinib
RET	M918T	CA:009082	Medullary Thyroid Carcinoma	DOID:3973	Selpercatinib
EBF1::PDGFRB	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Chemotherapy
PIK3CA	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
PIK3CA	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Dactolisib
PIK3CA	Amplification		Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Dactolisib
FGFR3	R248C	CA:126378	Cancer	DOID:162	R3Mab
FLT3	D835		Myelodysplastic Syndrome	DOID:50908	
ETV6::NTRK3	Fusion		Congenital Fibrosarcoma	DOID:8418	
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	FLT3/ABL/Aurora Kinase Inhibitor KW-2449
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	Sorafenib
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	Sunitinib
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	Lestaurtinib
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	Midostaurin
FLT3	F691L		Acute Myeloid Leukemia	DOID:9119	Lestaurtinib
FLT3	F691L		Acute Myeloid Leukemia	DOID:9119	Midostaurin
TP53	Mutation		Medulloblastoma SHH Activated	DOID:80703	
FLT3	D835I		Acute Myeloid Leukemia	DOID:9119	Gilteritinib
PIK3CA	H1047R	CA:123326	Colorectal Cancer	DOID:9256	Akt Inhibitor MK2206
KRAS	Exon 2 Mutation		Colorectal Cancer	DOID:9256	Vemurafenib
GOLGA4::RAF1	Fusion		Melanoma	DOID:1909	Cobimetinib
GOLGA4::RAF1	Fusion		Melanoma	DOID:1909	Trametinib
BCL2	F104I	CA:402632320	Follicular Lymphoma	DOID:50873	Venetoclax
PALB2	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
ATM	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Erlotinib
MN1::BEND2	Fusion		Astroblastoma, MN1-altered	DOID:80904	
FLT3	D835H	CA:280208	Acute Myeloid Leukemia	DOID:9119	Gilteritinib
FLT3	D835V	CA:126344	Acute Myeloid Leukemia	DOID:9119	Gilteritinib
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
PIK3CA	C420R	CA:180900	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
ETV6::RUNX1	Fusion		B-lymphoblastic Leukemia/lymphoma With ETV6-RUNX1	DOID:80645	
VHL	F148* (c.443_455delinsA)		Von Hippel-Lindau Disease	DOID:14175	
ZFTA::RELA	Fusion		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
FGFR3	S249C	CA:126380	Transitional Cell Carcinoma	DOID:2671	Cisplatin
KANK1::NTRK2	Fusion		Pilocytic Astrocytoma	DOID:4851	
FLT3	Y842C		Acute Myeloid Leukemia	DOID:9119	Quizartinib
PIK3CA	I391M	CA:161490	Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Capecitabine
PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	DOID:60079	Lapatinib
PTEN	Loss		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
ERBB3	Overexpression		Her2-receptor Positive Breast Cancer	DOID:60079	Trastuzumab Emtansine
KRAS	Mutation		Ovary Serous Adenocarcinoma	DOID:5744	Binimetinib
KRAS	Wildtype		Colorectal Cancer	DOID:9256	Regorafenib
BCL2	G101V	CA:402632336	Chronic Lymphocytic Leukemia	DOID:1040	Venetoclax
BRCA2	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Capmatinib
v::RET	Fusion		Thyroid Cancer	DOID:1781	Selpercatinib
FGFR3	S249C	CA:126380	Bladder Urothelial Carcinoma	DOID:4006	
FGFR3	S249C	CA:126380			
FGFR3	S249C	CA:126380	Transitional Cell Carcinoma	DOID:2671	
IDH1	Mutation		Acute Myeloid Leukemia	DOID:9119	Venetoclax
IDH2	Mutation		Acute Myeloid Leukemia	DOID:9119	Venetoclax
FLT3	N841I		Acute Myeloid Leukemia	DOID:9119	Midostaurin
SMARCB1	Loss		Atypical Teratoid Rhabdoid Tumor	DOID:2129	
ATRX	Mutation		Malignant Astrocytoma	DOID:3069	
LMNA::NTRK1	Fusion		Congenital Fibrosarcoma	DOID:8418	Crizotinib
FGFR3	Y373C	CA:341413	Urinary Bladder Cancer	DOID:11054	
LMNA::NTRK1	Fusion		Colorectal Cancer	DOID:9256	Entrectinib
LMNA::NTRK1	Fusion		Colorectal Cancer	DOID:9256	
LMNA::NTRK1	Fusion		Spindle Cell Sarcoma	DOID:4235	TRK Inhibitor
LMNA::NTRK1	Fusion		Spitzoid Melanoma	DOID:70326	
ETV6::NTRK3	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Etoposide
ETV6::NTRK3	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Methotrexate
FLT3	ITD		Acute Myeloid Leukemia	DOID:9119	Gilteritinib
ETV6::NTRK3	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
NRAS	Q61K	CA:151263	Ovary Serous Adenocarcinoma	DOID:5744	Trametinib
KIAA1549::BRAF	Fusion		Childhood Pilocytic Astrocytoma	DOID:6812	Selumetinib
KIAA1549::BRAF	Fusion		Childhood Pilocytic Astrocytoma	DOID:6812	Trametinib
TP53	Overexpression		Renal Wilms' Tumor	DOID:5176	
FGFR3	R248C	CA:126378			
VHL	Null (Large deletion)		Von Hippel-Lindau Disease	DOID:14175	
VHL	R120fs (c.358_359insAC)	CA:2573106245	Von Hippel-Lindau Disease	DOID:14175	
VHL	S80fs (c.239del)	CA:913189245	Von Hippel-Lindau Disease	DOID:14175	
VHL	C77fs (c.230del)		Von Hippel-Lindau Disease	DOID:14175	
VHL	Q96_P97delinsH (c.288_290del)	CA:2573106244	Von Hippel-Lindau Disease	DOID:14175	
VHL	G144fs (c.429_439del)	CA:2573106247	Von Hippel-Lindau Disease	DOID:14175	
CIC::DUX4	Fusion		CIC-rearranged Sarcoma	DOID:81250	
ANO10::RAF1	Fusion		Melanoma	DOID:1909	Trametinib
ETV6::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RANBP2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ZMIZ1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
CENPC::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
NUP153::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
LSM14A::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
ABL1	G250E	CA:16602547	Cancer	DOID:162	Dasatinib
ABL1	H396P	CA:375249969	Cancer	DOID:162	Dasatinib
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Ponatinib
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Nilotinib
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
ZMIZ1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
SFPQ::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
SFPQ::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
SFPQ::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
SFPQ::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Dasatinib
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Tyrosine Kinase Inhibitor
ETV6::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib
SNX2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
RANBP2::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Dasatinib
PPP2R1A	P179R				
RCSD1::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Ponatinib
CHD7::BEND2	Fusion		Pancreatic Endocrine Carcinoma	DOID:1798	
EGFR	A767_V769dupASV	CA:180588	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	N771_P772insL		Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	D770_N771insG	CA:645561591	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	S768_D770dup		Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EGFR	A763_Y764insFQEA	CA:135833	Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
EML4::ALK	Fusion		Malignant Pleural Mesothelioma	DOID:7474	Alectinib
ATRX	Deletion		Cancer	DOID:162	Cisplatin
ATRX	Deletion		Cancer	DOID:162	Fluorouracil
CDKN1A	rs1059234		Retinoblastoma	DOID:768	
TP53	P250L				
TP53	A161T	CA:000234			
PIK3CA	C604R				
PIK3CA	D350N				
KRAS	G10_A11insG		Colorectal Cancer	DOID:9256	
KRAS	A11_G12insGA		Colorectal Cancer	DOID:9256	
EGFR	R222C	CA:367577392			
KDR	R1032Q		Colorectal Cancer	DOID:9256	Lenvatinib
KDR	R1032Q		Colorectal Cancer	DOID:9256	Dovitinib
KDR	R1032Q		Colorectal Cancer	DOID:9256	Cabozantinib
KDR	R1032Q		Colorectal Cancer	DOID:9256	Axitinib
MEF2D::CSF1R	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	Imatinib
TBL1XR1::CSF1R	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
EZH2	Y646H	CA:16602260	Diffuse Large B-cell Lymphoma	DOID:50745	Tazemetostat
ALK	I1171T		Neuroblastoma	DOID:769	Ceritinib
EZH2	Y646				
PIK3R2	G373R				
PTEN	C136R				
CD44	CD44v6		Ovarian Cancer	DOID:2394	
KRAS	G12C	CA:122528	Lung Non-small Cell Carcinoma	DOID:3908	Sotorasib
TP53	C242F	CA:501203			
TP53	C242S				
TP53	C242Y	CA:000361			
MTOR	T1977K				
TP53	E285K				
TP53	G154S				
EZH2	Y646F	CA:16602259			
EZH2	Y646N	CA:16602670			
EZH2	Y646H	CA:16602260			
EZH2	Y646S	CA:16602671			
H3-3A	G34R		Diffuse Glioma, H3 G34 Mutant	DOID:80880	
BRAF	G463E		Cancer	DOID:162	
MYOD1	L122R	CA:379790889	Rhabdomyosarcoma	DOID:3247	
PIK3CA	G1007R				
H3C2	K27M		Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
PIK3CA	N1044K				
MTOR	R2152C				
NFE2L2	G31A				
H3C2	K27M		Brain Glioblastoma Multiforme	DOID:3073	
EGFR	E114K	CA:367575828			
LMNA::NTRK1	Fusion		Solid Tumor		Larotrectinib
NTRK3	F617L		Gastrointestinal Stromal Tumor	DOID:9253	Larotrectinib
NTRK1	G595R		Lung Non-small Cell Carcinoma	DOID:3908	Larotrectinib
NTRK1	G667S		Lung Non-small Cell Carcinoma	DOID:3908	Larotrectinib
TP53	ALTERATION		Rhabdomyosarcoma	DOID:3247	
HRAS	Mutation		Bladder Urothelial Carcinoma	DOID:4006	Tipifarnib
HRAS	Mutation		Head And Neck Squamous Cell Carcinoma	DOID:5520	Tipifarnib
ERBB2	V777L	CA:135387	Cancer	DOID:162	Lapatinib
EZH2	Activating Mutation		Follicular Lymphoma	DOID:50873	Tazemetostat
NUP98::NSD1	Fusion		Acute Myeloid Leukemia	DOID:9119	
ERBB2	Amplification		Childhood Ependymoma	DOID:5509	Lapatinib
COL1A1::PDGFB	Fusion		Dermatofibrosarcoma Protuberans	DOID:3507	
TP53	R342P				
TP53	L330P				
TP53	L330R				
TP53	R337P				
TP53	L344P				
EZH2	Y646C	CA:369713035			
ASPSCR1::TFE3	Fusion		Alveolar Soft Part Sarcoma	DOID:4239	
PIM1	L2V		Diffuse Large B-cell Lymphoma Activated B-cell Type	DOID:80996	Ibrutinib
PIM1	P81S		Diffuse Large B-cell Lymphoma Activated B-cell Type	DOID:80996	Ibrutinib
PIM1	S97N		Diffuse Large B-cell Lymphoma Activated B-cell Type	DOID:80996	Ibrutinib
ACVR1	R206H		Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
ACVR1	G328W	CA:128481	Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
ACVR1	Mutation		Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
ACVR1	G356D		Diffuse Midline Glioma, H3 K27M-mutant	DOID:80684	
ABCB1	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Alectinib
ABCB1	Overexpression		Lung Non-small Cell Carcinoma	DOID:3908	Lorlatinib
PIK3CA	K944N		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	F930S		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	V955G		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	K966E		Colorectal Cancer	DOID:9256	Cetuximab
PIK3CA	L938*		Colorectal Cancer	DOID:9256	Cetuximab
TP53	T125T				
EGFR	G598V	CA:4265696	Cancer	DOID:162	Erlotinib
ABL2	W469C		Lung Adenocarcinoma	DOID:3910	Imatinib
ABL2	W469C		Lung Adenocarcinoma	DOID:3910	Dasatinib
PTPRB	Loss-of-function		Angiosarcoma	DOID:1816	
NTRK3	G623R	CA:393914380	Cancer	DOID:162	Entrectinib
NTRK3	G623R	CA:393914380	Cancer	DOID:162	Larotrectinib
NTRK3	G623R	CA:393914380	Cancer	DOID:162	ALK/TRK Inhibitor TSR-011
NTRK3	G623R	CA:393914380	Cancer	DOID:162	Crizotinib
ETV6::NTRK3	Fusion		Cancer	DOID:162	Entrectinib
ETV6::NTRK3	Fusion		Cancer	DOID:162	Larotrectinib
ETV6::NTRK3	Fusion		Cancer	DOID:162	ALK/TRK Inhibitor TSR-011
ETV6::NTRK3	Fusion		Cancer	DOID:162	Crizotinib
TPM3::NTRK1	Fusion		Cancer	DOID:162	Entrectinib
LMNA::NTRK1	Fusion		Cancer	DOID:162	Entrectinib
ETV6::NTRK1	Fusion		Cancer	DOID:162	Entrectinib
VCL::NTRK2	Fusion		Cancer	DOID:162	Entrectinib
AFAP1::NTRK2	Fusion		Cancer	DOID:162	Entrectinib
ETV6::NTRK2	Fusion		Cancer	DOID:162	Entrectinib
AR	R726L				
FLCN	c.1285dupC	CA:090951	Renal Cell Carcinoma	DOID:4450	Everolimus
IGF1R	Overexpression		Breast Cancer	DOID:1612	Metformin
IGF1R	Overexpression		Breast Cancer	DOID:1612	Exemestane
SF3B1	K700E	CA:2042597	Leukemia	DOID:1240	Olaparib
SF3B1	K700E	CA:2042597	Leukemia	DOID:1240	Etoposide
ERBB2	Exon 20 Insertion		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERCC1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
ERCC1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Gemcitabine
RRM1	Underexpression		Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
IDH1	R132C	CA:16602374	Cancer	DOID:162	Olaparib
SLC29A1	Overexpression		Pancreatic Adenocarcinoma	DOID:4074	Gemcitabine
ERCC1	Underexpression		Epithelial Ovarian Cancer	DOID:2152	Platinum Compound
v::TFE3	Fusion		Renal Cell Carcinoma With MiT Translocations	DOID:81413	
NTRK1	Amplification		Solid Tumor		Larotrectinib
VHL	V87fs (c.255_256insC)		Von Hippel-Lindau Disease	DOID:14175	
VHL	N150fs (c.448delA)		Von Hippel-Lindau Disease	DOID:14175	
VHL	E55fs (c.163delG)		Von Hippel-Lindau Disease	DOID:14175	
CTCF	K365T				
KIT	EXPRESSION		Glioblastoma	DOID:3068	Sunitinib
SSTR5	expression		Neuroendocrine Tumor	DOID:169	Pasireotide
TP53	P98S				
TP53	P98L				
TP53	Y126D				
TP53	Y126S				
TP53	K139E				
TP53	P151S				
TP53	P151H				
TP53	P152L				
TP53	I162F				
TP53	Y163H				
TP53	Y236S				
TP53	L252F				
TP53	E258K				
TP53	G262D				
TP53	G266R				
TP53	G266E				
TP53	A276V	CA:397836916			
TP53	P278S				
TP53	L308M				
TP53	L323P				
TP53	Q144P				
TP53	R158H	CA:000227			
TP53	P219H				
TP53	Y220H				
TP53	E224K				
TP53	Y234H				
TP53	T230S				
TP53	H168Y				
TP53	P177S				
TP53	P177F				
TP53	P177H				
TP53	H179Y				
TP53	N239S				
TP53	S241T				
TP53	S241F				
TP53	G244S				
TP53	G245S	CA:000367			
TP53	G245D				
TP53	M246L				
TP53	R273C	CA:000432			
TP53	V274F				
TP53	G279E				
TP53	D281N				
TP53	D281E				
TP53	R248W	CA:000382			
TP53	P152T				
TP53	R156P				
TP53	R181C				
TP53	R181G				
TP53	R181H				
TP53	D259V				
TP53	E286K				
TP53	R283H				
TP53	Y163N				
TP53	L257P				
EGFR	R252C				
FGFR1	N546K	CA:357830	Pilocytic Astrocytoma	DOID:4851	Pemigatinib
QKI::RAF1	Fusion		Spindle Cell Sarcoma	DOID:4235	Trametinib
KANK4::ALK	Fusion		Pancreatic Acinar Cell Adenocarcinoma	DOID:5742	Alectinib
FGFR3	Overexpression		Cancer	DOID:162	R3Mab
FGFR3	G370C	CA:129946	Cancer	DOID:162	R3Mab
FGFR3	Y373C	CA:341413	Cancer	DOID:162	R3Mab
FGFR3	K650E	CA:126376	Cancer	DOID:162	R3Mab
KANK1::NTRK2	Fusion		Anaplastic Ependymoma	DOID:5889	Larotrectinib
KANK1::NTRK2	Fusion		Glioblastoma	DOID:3068	Larotrectinib
KANK1::NTRK2	Fusion		Sarcoma	DOID:1115	
MS4A1	Mutation		Diffuse Large B-cell Lymphoma	DOID:50745	R-CHOP Regimen
FGFR3	K650N	CA:280221			
FGFR3	K650Q	CA:170755			
EML4::NTRK3	Fusion		Congenital Fibrosarcoma	DOID:8418	
FGFR3	K650M	CA:126382			
FGFR3	K650E	CA:126376			
FGFR3	K650T	CA:345185			
v::NTRK2	Fusion		Solid Tumor		Larotrectinib
EZH2	Y646F	CA:16602259	B-cell Lymphoma	DOID:707	
FGFR3	K650D	CA:2573130206			
FGFR3	K650L	CA:2573130207			
FGFR3	G380R	CA:280218			
EML4::NTRK3	Fusion		Congenital Mesoblastic Nephroma	DOID:4773	
EML4::NTRK3	Fusion		Cervical Sarcoma		
EML4::NTRK3	Fusion		Pancreatic Ductal Adenocarcinoma	DOID:3498	
EML4::NTRK3	Fusion		Colon Adenocarcinoma	DOID:234	
EML4::NTRK3	Fusion		Glioblastoma	DOID:3068	
EML4::NTRK3	Fusion		Poorly Differentiated Thyroid Carcinoma		
FGFR3	A391E	CA:249860			
TP53	R175H	CA:000251			
TP53	R156H				
TP53	H178P				
TP53	H179R				
TP53	R181P				
TP53	R249S				
TP53	E68G				
TP53	L111R				
TP53	H115Y				
TP53	C124R				
TP53	C135W	CA:16602987			
TP53	L139N				
TP53	R158G				
TP53	G266V				
TP53	F270S				
TP53	V272G				
EML4::NTRK3	Fusion		Papillary Thyroid Carcinoma	DOID:3969	Entrectinib
EML4::NTRK3	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Entrectinib
EML4::NTRK3	Fusion		Colon Cancer	DOID:219	
BCOR	ITD		Central Nervous System Tumor With BCOR Internal Tandem Duplication	DOID:81315	
BCOR	ITD		Kidney Clear Cell Sarcoma	DOID:4880	
FGFR3	G697C	CA:16602701	Cancer	DOID:162	
ETV6::NTRK3	Fusion		Congenital Mesoblastic Nephroma	DOID:4773	Larotrectinib
ETV6::NTRK3	Fusion		Congenital Mesoblastic Nephroma	DOID:4773	
IDH1	R132		Cholangiocarcinoma	DOID:4947	Ivosidenib
KANK1::NTRK2	Fusion		Brain Glioblastoma Multiforme	DOID:3073	
SCP2::NTRK1	Fusion		Breast Cancer	DOID:1612	
EGFR	Amplification		Colon Adenocarcinoma	DOID:234	Erlotinib
EGFR::SEPTIN14	Fusion		Colon Adenocarcinoma	DOID:234	Erlotinib
EGFR::PURB	Fusion		Lung Adenocarcinoma	DOID:3910	Erlotinib
EGFR::RAD51	Fusion		Lung Adenocarcinoma	DOID:3910	Osimertinib
KIF5B::EGFR	Fusion		Lung Adenocarcinoma	DOID:3910	Afatinib
SRSF2	P95L	CA:8790423	Myeloid Neoplasm	DOID:70004	CTX-712
SRSF2	P95H	CA:8790422	Myeloid Neoplasm	DOID:70004	CTX-712
KLF5	E419K				
KLF5	E419Q				
H3-3A	K28M	CA:16602870	Brain Glioblastoma Multiforme	DOID:3073	
SMAD2	S276L				
SMARCA2	R1159Q				
SMARCA2	K755R				
RAF1	R391W	CA:2259575			
MYB::QKI	Fusion		Angiocentric Glioma	DOID:81261	
EML4::NTRK3	Fusion		Lung Adenocarcinoma	DOID:3910	Entrectinib
EML4::NTRK3	Fusion		High Grade Glioma	DOID:3070	Larotrectinib
EZH2	expression		Diffuse Large B-cell Lymphoma Germinal Center B-cell Type	DOID:80997	Tazemetostat
EZH2	Y646H	CA:16602260	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	Y646S	CA:16602671	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	Y646N	CA:16602670	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	Y646F	CA:16602259	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	A682G	CA:16602672	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	A692V	CA:369712244	Follicular Lymphoma	DOID:50873	Tazemetostat
EZH2	Y646C	CA:369713035	Follicular Lymphoma	DOID:50873	Tazemetostat
EML4::ALK	Fusion		Malignant Pleural Mesothelioma	DOID:7474	Lorlatinib
ALK	I1171N	CA:16602371	Malignant Pleural Mesothelioma	DOID:7474	Lorlatinib
ALK	L1196M	CA:16602593	Malignant Pleural Mesothelioma	DOID:7474	Lorlatinib
ALK	G1202R	CA:16602592	Malignant Pleural Mesothelioma	DOID:7474	Lorlatinib
ALK	I1171N	CA:16602371	Malignant Pleural Mesothelioma	DOID:7474	Alectinib
ALK	L1196M	CA:16602593	Malignant Pleural Mesothelioma	DOID:7474	Alectinib
v::NTRK3	Fusion		Solid Tumor		Entrectinib
EGFR	S645C		Lung Cancer	DOID:1324	
EGFR	K754E		Lung Cancer	DOID:1324	
ARAF	S214F		Lung Cancer	DOID:1324	
ARAF	S214C	CA:16602595	Lung Cancer	DOID:1324	
ARAF	V145L		Lung Cancer	DOID:1324	
GNA11	R183C				
GNA11	Q209L				
KIT	D816V	CA:123513	Systemic Mastocytosis	DOID:349	Imatinib Mesylate
SMARCB1	Loss		Renal Medullary Carcinoma		
BRCA1	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
CDK12	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
CHEK2	mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
PPP2R2A	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
RAD54L	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
BRIP1	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
BARD1	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
CHEK1	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
RAD51B	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
RAD51D	Mutation		Castration-resistant Prostate Carcinoma	DOID:80909	Olaparib
BRCA1	Loss-of-function		Triple-receptor Negative Breast Cancer	DOID:60081	Olaparib
BRCA2	Loss-of-function		Triple-receptor Negative Breast Cancer	DOID:60081	Olaparib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Osimertinib
v::NTRK2	Fusion		Solid Tumor		Entrectinib
EGFR	Exon 20 Insertion		Lung Non-small Cell Carcinoma	DOID:3908	Amivantamab
EGFR	Exon 20 Insertion		Lung Non-small Cell Carcinoma	DOID:3908	Mobocertinib
EGFR	G719A	CA:135775	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
EGFR	S768I	CA:135840	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
EGFR	L861Q	CA:176021	Lung Non-small Cell Carcinoma	DOID:3908	Afatinib
v::RET	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Pralsetinib
v::RET	Fusion		Thyroid Cancer	DOID:1781	Pralsetinib
BRAF	V600		Melanoma	DOID:1909	Atezolizumab
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Ramucirumab
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Ramucirumab
BRCA2	Mutation		Epithelial Ovarian Cancer	DOID:2152	Niraparib
BRCA1	Mutation		Epithelial Ovarian Cancer	DOID:2152	Niraparib
ERBB2	Amplification		Breast Cancer	DOID:1612	Margetuximab
PIK3CA	C420R	CA:180900	Breast Cancer	DOID:1612	Alpelisib
PIK3CA	C420R	CA:180900	Breast Cancer	DOID:1612	Fulvestrant
FGFR1	Translocation		Myeloid Neoplasm	DOID:70004	Pemigatinib
TRIM24::FGFR1	Fusion		Myeloid Neoplasm	DOID:70004	Pemigatinib
ZMYM2::FGFR1	Fusion		Myeloid Neoplasm	DOID:70004	Pemigatinib
CEP43::FGFR1	Fusion		Myeloid Neoplasm	DOID:70004	Pemigatinib
BCR::FGFR1	Fusion		Myeloid Neoplasm	DOID:70004	Pemigatinib
ETV6::NTRK3	Fusion		Breast Secretory Carcinoma	DOID:4922	
LMNA::NTRK1	Fusion		Cancer	DOID:162	Repotrectinib
NTRK1	G595R		Cancer	DOID:162	Repotrectinib
NTRK1	F589L		Cancer	DOID:162	Repotrectinib
LMNA::NTRK1	Fusion		Cancer	DOID:162	Larotrectinib
NTRK1	G595R		Cancer	DOID:162	Larotrectinib
NTRK1	F589L		Cancer	DOID:162	Larotrectinib
NTRK1	F589L		Cancer	DOID:162	Entrectinib
NTRK1	G595R		Cancer	DOID:162	Entrectinib
NTRK1	G667C		Cancer	DOID:162	Entrectinib
NTRK1	G667C		Cancer	DOID:162	Larotrectinib
EWSR1::WT1	Fusion		Desmoplastic Small Round Cell Tumor	DOID:6785	
ZFTA::NCOA1	Fusion		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
ZFTA::NCOA2	Fusion		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
ZFTA::MAML2	Fusion		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
MN1::ZFTA	Fusion		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
QKI::NTRK2	Fusion		Low Grade Glioma	DOID:80829	
QKI::NTRK2	Fusion		Polymorphous Low Grade Neuroepithelial Tumour Of The Young	DOID:81305	
ESR1	Mutation		Breast Cancer	DOID:1612	Elacestrant
Methylation signature	ST-EPN-ZFTA		Supratentorial Ependymoma, ZFTA Fusion–positive	DOID:81252	
QKI::NTRK2	Fusion		Pilocytic Astrocytoma	DOID:4851	
QKI::NTRK2	Fusion		Malignant Astrocytoma	DOID:3069	
QKI::NTRK2	Fusion				
DICER1	E1705K	CA:390865421	Gynandroblastoma		
IDH1	R132H	CA:170874	Low Grade Glioma	DOID:80829	Vorasidenib
IDH1	R132L	CA:16602372	Low Grade Glioma	DOID:80829	Vorasidenib
IDH1	R132G	CA:16602375	Low Grade Glioma	DOID:80829	Vorasidenib
IDH1	R132S	CA:16602376	Low Grade Glioma	DOID:80829	Vorasidenib
IDH1	R132C	CA:16602374	Low Grade Glioma	DOID:80829	Vorasidenib
IDH2	R172W		Low Grade Glioma	DOID:80829	Vorasidenib
IDH2	R172G		Low Grade Glioma	DOID:80829	Vorasidenib
IDH2	R172K	CA:16602462	Low Grade Glioma	DOID:80829	Vorasidenib
NTRK3	G623R	CA:393914380	Lung Non-small Cell Carcinoma	DOID:3908	Entrectinib
EML4::NTRK3	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Repotrectinib
NTRK3	G623R	CA:393914380	Lung Non-small Cell Carcinoma	DOID:3908	Repotrectinib
NTRK3::SCAPER	Fusion		Pigmented Epithelioid Melanocytoma		
FOXR2	Rearrangement		CNS Neuroblastoma With FOXR2 Activation	DOID:80906	
ASPSCR1::TFE3	Fusion		Renal Cell Carcinoma With MiT Translocations	DOID:81413	
v::TFEB	Fusion		Renal Cell Carcinoma With MiT Translocations	DOID:81413	
YAP1::TFE3	Fusion		Malignant Epithelioid Hemangioendothelioma	DOID:80190	
SQSTM1::NTRK1	Fusion		Lung Adenocarcinoma	DOID:3910	Larotrectinib
SQSTM1::NTRK1	Fusion		Papillary Thyroid Carcinoma	DOID:3969	Larotrectinib
LMNA::NTRK1	Fusion		Lipofibromatosis-like Neural Tumor	DOID:80894	Entrectinib
BCOR	ITD		Sarcoma	DOID:1115	
KRAS	G12C	CA:122528	Lung Non-small Cell Carcinoma	DOID:3908	Divarasib
CDKN2A	Loss		Pancreatic Cancer	DOID:1793	Palbociclib
CDKN2A	Mutation		Biliary Tract Cancer	DOID:4607	Palbociclib
CDKN2A	Loss		Biliary Tract Cancer	DOID:4607	Palbociclib
RB1	Wildtype		Lung Non-small Cell Carcinoma	DOID:3908	Palbociclib
CDKN2A	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Palbociclib
BRCA2	Mutation		Prostate Cancer	DOID:10283	Olaparib
BRCA1	Mutation		Prostate Cancer	DOID:10283	Olaparib
FLT3	Amplification		Colorectal Cancer	DOID:9256	Sunitinib
ERBB2	Mutation		Colorectal Cancer	DOID:9256	Pertuzumab
ERBB2	Mutation		Colorectal Cancer	DOID:9256	Trastuzumab
ERBB3	Mutation		Colorectal Cancer	DOID:9256	Pertuzumab
ERBB3	Mutation		Colorectal Cancer	DOID:9256	Trastuzumab
BRAF	K601E	CA:123645	Colorectal Cancer	DOID:9256	Cobimetinib
BRAF	K601E	CA:123645	Colorectal Cancer	DOID:9256	Vemurafenib
BRAF	V600E	CA:123643	Colorectal Cancer	DOID:9256	Cobimetinib
v::ALK	Fusion		Cancer	DOID:162	Crizotinib
v::ROS1	Fusion		Cancer	DOID:162	Crizotinib
BRAF	V600E	CA:123643	Cancer	DOID:162	Trametinib
BRAF	V600E	CA:123643	Cancer	DOID:162	Dabrafenib
CCND3	Amplification		Cancer	DOID:162	Palbociclib
CCND1	Amplification		Cancer	DOID:162	Palbociclib
CCND2	Amplification		Cancer	DOID:162	Palbociclib
NRAS	Mutation		Solid Tumor		Binimetinib
ERBB2	Activating Mutation		Cancer	DOID:162	Afatinib
MSH2	Loss		Cancer	DOID:162	Nivolumab
MLH1	Loss		Cancer	DOID:162	Nivolumab
PIK3CA	Mutation		Cancer	DOID:162	Copanlisib
PIK3CA	Mutation		Cancer	DOID:162	Taselisib
BRAF	V600E	CA:123643	Cancer	DOID:162	Selumetinib
KRAS	Mutation		Cancer	DOID:162	Selumetinib
NF1	Mutation		Cancer	DOID:162	Selumetinib
NRAS	Mutation		Cancer	DOID:162	Selumetinib
ERBB2	D769Y	CA:16602466	Extramammary Paget Disease		Afatinib
ERBB2	D769Y	CA:16602466	Peritoneal Carcinoma	DOID:1791	Afatinib
ERBB2	V777L	CA:135387	Breast Cancer	DOID:1612	Afatinib
ERBB2	S310F		Breast Cancer	DOID:1612	Afatinib
TPM3::NTRK1	Fusion		Lung Carcinoma	DOID:3905	Larotrectinib
NF1	Inactivating Mutation		Cancer	DOID:162	Selumetinib
v::MITF	Fusion		Renal Cell Carcinoma With MiT Translocations	DOID:81413	
TPM3::NTRK1	Fusion		Solid Tumor		Larotrectinib Regimen
TPR::NTRK1	Fusion		Colorectal Cancer	DOID:9256	Larotrectinib
IDH2	Mutation		Glioma		Vorasidenib
IDH1	Mutation		Glioma		Vorasidenib
TP53	Mutation		Cancer	DOID:162	VEGF/VEGFR Inhibitors
TCF3::PBX1	Fusion		B-lymphoblastic Leukemia/lymphoma With TCF3-PBX1	DOID:80649	
ERBB2	Mutation		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
BRCA1	Loss-of-function		Malignant Mesothelioma	DOID:1790	Rucaparib
BAP1	Loss-of-function		Malignant Mesothelioma	DOID:1790	Rucaparib
TPR::NTRK1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Larotrectinib
TPR::NTRK1	Fusion		Papillary Thyroid Carcinoma	DOID:3969	Larotrectinib
ERBB2	S310F		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	L755A		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	L755M		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	L755P	CA:123587	Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	A775_G776insTVMA		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	A775_G776insV		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	A775_G776insVVMA		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G776_V777delinsVCD		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G776delinsCV		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G776delinsLC		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G776delinsVC		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G778_P780dup		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	G778_S779insLPS		Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
ERBB2	Y772_A775DUP	CA:135369	Lung Non-small Cell Carcinoma	DOID:3908	Trastuzumab Deruxtecan
BRAF	V600E	CA:123643	Low Grade Glioma	DOID:80829	Vemurafenib
MYB	Rearrangement		Angiocentric Glioma	DOID:81261	
MYB	Truncation		Angiocentric Glioma	DOID:81261	
MYB	Rearrangement		Isomorphic Diffuse Glioma		
MYB	Rearrangement		Diffuse Astrocytoma, MYB- Or MYBL1-altered	DOID:81279	
MYBL1	Rearrangement		Diffuse Astrocytoma, MYB- Or MYBL1-altered	DOID:81279	
YWHAE::NUTM2A	Fusion		Kidney Clear Cell Sarcoma	DOID:4880	
YWHAE::NUTM2B	Fusion		Kidney Clear Cell Sarcoma	DOID:4880	
YWHAE::NUTM2E	Fusion		Kidney Clear Cell Sarcoma	DOID:4880	
ARID1A	Wildtype		Ovarian Clear Cell Carcinoma	DOID:50934	Dasatinib
CBFB::MYH11	Fusion		Acute Myeloid Leukemia With Inv(16)(p13.1q22) Or T(16;16)(p13.1;q22)	DOID:81084	
RUNX1::RUNX1T1	Fusion		Acute Myeloid Leukemia With T(8;21); (q22; Q22.1)	DOID:81093	
CBFA2T3::GLIS2	Fusion		Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion		
YAP1::MAMLD1	Fusion		Supratentorial Ependymoma, YAP1 Fusion–positive	DOID:81253	
YAP1::FAM118B	Fusion		Supratentorial Ependymoma, YAP1 Fusion–positive	DOID:81253	
YAP1::v	Fusion		Supratentorial Ependymoma, YAP1 Fusion–positive	DOID:81253	
BCOR::CCNB3	Fusion		Kidney Clear Cell Sarcoma	DOID:4880	
v::NUTM1	Fusion		NUT Midline Carcinoma	DOID:60463	
ERBB2	Overexpression		Solid Tumor		Trastuzumab Deruxtecan
EGFR	Exon 20 Insertion		Lung Non-small Cell Carcinoma	DOID:3908	Chemotherapy
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Chemotherapy
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Chemotherapy
BRAF	V600E	CA:123643	Childhood Low-grade Glioma	DOID:80830	Tovorafenib
KIAA1549::BRAF	Fusion		Childhood Low-grade Glioma	DOID:80830	Tovorafenib
PIK3CA	Mutation		Breast Cancer	DOID:1612	Capivasertib
PTEN	Mutation		Breast Cancer	DOID:1612	Capivasertib
PTEN	Mutation		Breast Cancer	DOID:1612	Fulvestrant
AKT1	Mutation		Breast Cancer	DOID:1612	Capivasertib
AKT1	Mutation		Breast Cancer	DOID:1612	Fulvestrant
NF1	Mutation		Cancer	DOID:162	Trametinib
GNA11	Q209L		Cancer	DOID:162	Trametinib
v::BRAF	Fusion		Childhood Low-grade Glioma	DOID:80830	Tovorafenib
BRAF	V600		Childhood Low-grade Glioma	DOID:80830	Tovorafenib
TP53	Mutation		Myelodysplastic Syndrome	DOID:50908	Azacitidine
TP53	Mutation		Myelodysplastic Syndrome	DOID:50908	Eprenetapopt
v::NR4A3	Fusion		Acinic Cell Carcinoma	DOID:3025	
PIK3CA	R88Q	CA:16602516	Her2-receptor Negative Breast Cancer	DOID:60080	Fulvestrant
PIK3CA	R88Q	CA:16602516	Her2-receptor Negative Breast Cancer	DOID:60080	Capivasertib
BCR::NTRK2	Fusion		Brain Glioblastoma Multiforme	DOID:3073	Entrectinib
Kataegis	Positive		Breast Cancer	DOID:1612	
CK	High		Chronic Lymphocytic Leukemia	DOID:1040	
ESR1	Mutation		Breast Cancer	DOID:1612	Fulvestrant
ESR1	Mutation		Breast Cancer	DOID:1612	Palbociclib
RB1	Mutation		Breast Cancer	DOID:1612	Fulvestrant
RB1	Mutation		Breast Cancer	DOID:1612	Palbociclib
BCR::ABL1	Fusion		Acute Myeloid Leukemia With BCR-ABL1	DOID:80976	
BCR::NTRK2	Fusion		Ganglioglioma	DOID:5078	Entrectinib
v::RET	Fusion		Solid Tumor		Selpercatinib
RET	Mutation		Solid Tumor		Selpercatinib
EWSR1::CREB3L1	Fusion		Sclerosing Epithelioid Fibrosarcoma		
FUS::CREB3L2	Fusion		Low-grade Fibromyxoid Sarcoma		
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Adagrasib
PIK3CA	Mutation		Solid Tumor		Sapanisertib
PTEN	Mutation		Solid Tumor		Sapanisertib
AKT1	Mutation		Solid Tumor		Sapanisertib
AKT2	Mutation		Solid Tumor		Sapanisertib
MTOR	Mutation		Solid Tumor		Sapanisertib
MN1	Rearrangement		Astroblastoma, MN1-altered	DOID:80904	
TMB	High		Lung Non-small Cell Carcinoma	DOID:3908	Pembrolizumab
BCR::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma With BCR-ABL1	DOID:80643	
MNX1::ETV6	Fusion		Acute Myeloid Leukemia With MNX1::ETV6 Fusion		
BRD4::NUTM1	Fusion		NUT Midline Carcinoma	DOID:60463	Panobinostat
NTRK1	Amplification		Esophageal Carcinoma	DOID:1107	Larotrectinib
DEK::NUP214	Fusion		Acute Myeloid Leukemia With T(6;9) (p23;q34.1)	DOID:81080	
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Amivantamab
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Lazertinib
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Amivantamab
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Lazertinib
GOPC::ROS1	Fusion		Melanoma	DOID:1909	Entrectinib
IFNGR1	Loss		Melanoma	DOID:1909	Ipilimumab
TOP1	Amplification		Colorectal Cancer	DOID:9256	Cetuximab
TOP1	Amplification		Colorectal Cancer	DOID:9256	FOLFIRI Regimen
KAT6A::CREBBP	Fusion		AML With KAT6A::CREBBP Fusion		
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
EGFR	L858R	CA:126713	Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Carboplatin
EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	DOID:3908	Pemetrexed
MTAP	Deletion		Solid Tumor		Anvumetostat
BRAF	V600E	CA:123643	Solid Tumor		Dabrafenib
BRAF	V600E	CA:123643	Solid Tumor		Trametinib
BRAF	V600E	CA:123643	Low Grade Glioma	DOID:80829	Trametinib
BRAF	V600E	CA:123643	Low Grade Glioma	DOID:80829	Dabrafenib
TCF3::HLF	Fusion		B-lymphoblastic Leukemia/lymphoma With TCF3::HLF Fusion		
CEBPA	Mutation		Acute Myeloid Leukemia With Mutated CEBPA	DOID:81095	
MEF2D::v	Fusion		B-lymphoblastic Leukemia With MEF2D Rearrangement		
NUP214::ABL1	Fusion		B-lymphoblastic Leukemia/lymphoma	DOID:80630	Imatinib Mesylate
v::NUTM1	Fusion		B-lymphoblastic Leukemia With NUTM1 Rearrangement		
IGH::IL3	Fusion		B-lymphoblastic Leukemia/lymphoma With IGH::IL3 Fusion	DOID:80648	
v::NRG1	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Zenocutuzumab-zbco
v::NRG1	Fusion		Pancreatic Adenocarcinoma	DOID:4074	Zenocutuzumab-zbco
IGH::DUX4	Fusion		B-lymphoblastic Leukemia With DUX4 Rearrangement	DOID:81412	
LRP1B	Loss-of-function		Solid Tumor		Immune Checkpoint Inhibitor
v::IRF4	Fusion		Large B-cell Lymphoma With IRF4 Rearrangement		
AR	AR-V7		Prostate Cancer	DOID:10283	
RBM15::MRTFA	Fusion		Acute Myeloid Leukemia With T(1;22)(p13;q13)	DOID:81096	
KRAS	G12C	CA:122528	Colorectal Cancer	DOID:9256	Sotorasib
PML::RARA	Fusion		Acute Promyelocytic Leukemia With PML-RARA	DOID:81081	
FUS::ERG	Fusion		Acute Myeloid Leukaemia With FUS::ERG Fusion		
v::TFCP2	Fusion		Spindle Cell Rhabdomyosarcoma	DOID:3260	
FUS::TFCP2	Fusion		Spindle Cell Rhabdomyosarcoma	DOID:3260	
SMARCB1	LOSS OF NUCLEAR PROTEIN EXPRESSION		Cribriform Neuroepithelial Tumor		
EGFR::RAD51	e24::e4		Lung Non-small Cell Carcinoma	DOID:3908	Erlotinib
EGFR::RAD51	e24::e4		Lung Adenocarcinoma	DOID:3910	Afatinib
EGFR::RAD51	Fusion		Lung Non-small Cell Carcinoma	DOID:3908	Gefitinib
ETV6::RUNX1	Fusion		B-lymphoblastic Leukemia/lymphoma With ETV6-RUNX1	DOID:80645	Not Applicable
NUP98::v	Fusion		Acute Myeloid Leukemia With NUP98 Rearrangement		
IGH::MYC	Fusion		B-lymphoblastic Leukemia With MYC Rearrangement		
C19MC	Amplification		Embryonal Tumor With Multilayered Rosettes, C19MC-altered	DOID:80903	
C19MC	TTYH1::C19MC fusion		Embryonal Tumor With Multilayered Rosettes	DOID:81286	
C19MC	v::C19MC fusion		Embryonal Tumor With Multilayered Rosettes	DOID:81286	
IGH::EPOR	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
EPOR	rearrangements		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	DOID:80650	
MECOM	rearrangement		Acute Myeloid Leukemia With MECOM Rearrangement		
EGFR::USP42	Fusion		Lung Adenocarcinoma	DOID:3910	
ALK	Exon 2-18 Deletion		Spindle Cell Rhabdomyosarcoma	DOID:3260	
ALK	Exon 2-18 Deletion		Spindle Cell Rhabdomyosarcoma	DOID:3260	Alectinib
FUS::TFCP2	Fusion		Spindle Cell Rhabdomyosarcoma	DOID:3260	Alectinib
v::ZNF384	Fusion		B-lymphoblastic Leukaemia/lymphoma With Other Defined Genetic Alterations		
FGFR1	Amplification		Breast Cancer	DOID:1612	Erdafitinib
KMT2A::v	Fusion		B-lymphoblastic Leukaemia/lymphoma With KMT2A Rearrangement		
FGFR1	Amplification		Breast Cancer	DOID:1612	Sunitinib
FGFR1	Amplification		Breast Cancer	DOID:1612	
FGFR1	Amplification		Breast Cancer	DOID:1612	Endocrine Drug Therapy
FGFR1	Amplification		Breast Cancer	DOID:1612	Everolimus
